☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
91-1962278
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which registered
|
Common stock, par value $0.001 per share
|
|
SIVB
|
|
The Nasdaq Stock Market LLC
|
Depositary shares, each representing a 1/40th ownership interest in a share of 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A
|
|
SIVBP
|
|
The Nasdaq Stock Market LLC
|
|
Large accelerated filer
|
x
|
|
Accelerated filer
|
☐
|
|
|
|
Non-accelerated filer
|
¨
|
|
Smaller reporting company
|
☐
|
|
|
|
|
|
|
Emerging growth company
|
☐
|
|
|
Documents Incorporated by Reference
|
Parts of Form 10-K Into Which Incorporated
|
Definitive proxy statement for the Company's 2020 Annual Meeting of Stockholders to be filed within 120 days of the end of the fiscal year ended December 31, 2019
|
Part III
|
|
|
|
Page
|
|
|
|
|
PART I.
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 1B.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
PART II.
|
Item 5.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
Item 7.
|
||
|
|
|
|
|
Item 7A.
|
||
|
|
|
|
|
Item 8.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 9.
|
||
|
|
|
|
|
Item 9A.
|
||
|
|
|
|
|
Item 9B.
|
||
|
|
|
|
PART III.
|
Item 10.
|
||
|
|
|
|
|
Item 11.
|
||
|
|
|
|
|
Item 12.
|
||
|
|
|
|
|
Item 13.
|
||
|
|
|
|
|
Item 14.
|
||
|
|
|
|
PART IV.
|
Item 15.
|
||
|
|
|
|
|
Item 16.
|
||
|
|
|
|
•
|
Financial projections, including with respect to our net interest income, noninterest income, earnings per share, noninterest expenses (including professional services, compliance, compensation and other costs), cash flows, balance sheet positions, capital expenditures, liquidity and capitalization or other financial items;
|
•
|
Descriptions of our strategic initiatives, plans or objectives for future operations, including pending sales or acquisitions;
|
•
|
Forecasts of private equity and venture capital funding and investment levels;
|
•
|
Forecasts of future interest rates, economic performance, and income from investments;
|
•
|
Forecasts of expected levels of provisions for loan losses, loan growth and client funds; and
|
•
|
Descriptions of assumptions underlying or relating to any of the foregoing.
|
•
|
Market and economic conditions, including the interest rate environment, and the associated impact on us;
|
•
|
The credit profile and credit quality of our loan portfolio and volatility of our levels of nonperforming assets and charge-offs;
|
•
|
The adequacy of our allowance for loan losses and the need to make provisions for loan losses for any period;
|
•
|
The borrowing needs of our clients;
|
•
|
The sufficiency of our capital and liquidity positions;
|
•
|
The levels of loans, deposits and client investment fund balances;
|
•
|
The performance of our portfolio investments as well as the general condition of the public and private equity and mergers and acquisitions markets and their impact on our investments, including equity warrant assets, venture capital and private equity funds and direct equity investments;
|
•
|
Our overall investment plans and strategies as well as the realization, timing, valuation and performance of our equity or other investments;
|
•
|
The levels of public offerings, mergers and acquisitions and venture capital investment activity of our clients that may impact the borrowing needs of our clients and demand for our investment banking and other services;
|
•
|
The occurrence of fraudulent activity, including breaches of our information security or cyber security-related incidents;
|
•
|
Business disruptions and interruptions due to natural disasters and other external events;
|
•
|
The impact on our reputation and business from our interactions with business partners, counterparties, service providers and other third parties;
|
•
|
Expansion of our business internationally, and the impact of international market and economic events on us;
|
•
|
Our ability to maintain or increase our market share through successfully implementing our business strategy and undertaking new business initiatives, including through the integration of SVB Leerink;
|
•
|
The impact of governmental policy, legal requirements and regulations including regulations promulgated by the Board of Governors of the Federal Reserve System (the "Federal Reserve"), and other regulatory requirements;
|
•
|
The impact of lawsuits and claims, as well as legal or regulatory proceedings;
|
•
|
The impact of changes in accounting standards and tax laws;
|
•
|
The levels of equity capital available to our client or portfolio companies;
|
•
|
The effectiveness of our risk management framework and quantitative models; and
|
•
|
Other factors as discussed in “Risk Factors” under Part I, Item 1A of this report.
|
ITEM 1.
|
BUSINESS
|
•
|
Our SVB Accelerator practice focuses on serving our “emerging” or “early-stage” clients. These clients are generally privately-held companies in the start-up or early stages of their life cycles and funded by friends and family, “seed” or “angel” investors or have gone through an initial round of venture capital financing. They are typically engaged primarily in research and development activities and may have brought only a few products or services to market, if any. SVB Accelerator clients tend to have annual revenues below $5 million, and many are pre-revenue companies.
|
•
|
Our SVB Growth practice serves our “mid-stage” and “late-stage” clients. These clients are generally privately-held companies in the intermediate or later stages of their life cycles, and are often dependent on venture capital for funding. However, some of these clients are in the more advanced stages of their life cycles and may be publicly-held or poised to become publicly-held. Our SVB Growth clients generally have a more established product or service offering in the market and may be in a period of expansion. SVB Growth clients tend to have annual revenues between $5 million and $75 million.
|
•
|
Our SVB Corporate Finance practice primarily serves our large corporate clients, which are more mature and established companies. These clients are generally publicly-held or large privately-held companies and have a more sophisticated product or service offering in the market. SVB Corporate Finance clients tend to have annual revenues over $75 million.
|
•
|
Risk Management. Bank holding companies with $50 billion or more in total consolidated assets, including SVB Financial, are subject to risk committee and risk management requirements. In addition, bank holding companies with $100 billion or more in total consolidated assets are subject to liquidity risk management, liquidity buffer and liquidity stress testing requirements.
|
•
|
Comprehensive Capital Analysis and Review (“CCAR”). Bank holding companies with $100 billion or more in total consolidated assets are required to submit an annual capital plan to the Federal Reserve. For firms subject to CCAR, failure to submit a satisfactory plan can result in restrictions on capital distributions, including dividends and common stock repurchases.
|
•
|
Stress Testing. Bank holding companies with $100 billion or more in total consolidated assets are subject to supervisory stress tests conducted by the Federal Reserve and, except for Category IV firms, are also subject to company-run stress testing requirements (commonly referred to as Dodd-Frank Stress Tests or “DFAST”). Under the Tailoring Rules, bank holding companies with less than $100 billion in total consolidated assets are not subject to company-run or supervisory stress testing requirements.
|
•
|
Resolution Planning. Except for Category IV firms, bank holding companies with $100 billion or more in total consolidated
|
•
|
Liquidity Coverage Ratio. Banking organizations in Categories I-III and, in certain cases, Category IV are subject to the liquidity coverage ratio (“LCR”) requirements and must maintain high-quality liquid assets in accordance with specific quantitative requirements.
|
December 31, 2019
|
|
SVB Financial
|
|
Bank
|
|
Required Ratio (1)
|
CET 1 risk-based capital
|
|
12.58%
|
|
11.12%
|
|
7.0%
|
Tier 1 risk-based capital
|
|
13.43%
|
|
11.12%
|
|
8.5
|
Total risk-based capital
|
|
14.23%
|
|
11.96%
|
|
10.5
|
Tier 1 leverage
|
|
9.06%
|
|
7.30%
|
|
4.0
|
|
(1)
|
Percentages represent the minimum capital ratios plus, as applicable, the 2.5% CET1 capital conservation buffer under the Capital Rules.
|
ITEM 1A.
|
RISK FACTORS
|
•
|
changes in revenue or earnings estimates or publication of research reports and recommendations by financial analysts;
|
•
|
general market conditions and, in particular, developments related to market conditions for the financial services industry;
|
•
|
actual or anticipated changes in interest rates;
|
•
|
market perceptions about the innovation economy, including levels of funding or “exit” activities of companies in the industries we serve;
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS
|
ITEM 2.
|
PROPERTIES
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
ITEM 5.
|
MARKET FOR THE REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
Period ended
|
|
Total number of shares purchased
|
|
Average price paid per share
|
|
Total number of shares purchased as part of publicly announced programs
|
|
Maximum dollar value that may yet be purchased under the programs (1)
|
||||||
October 31, 2019
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
November 30, 2019
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
December 31, 2019
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
Total
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
(1)
|
On October 24, 2019, the Company announced that its Board of Directors had authorized a $350 million common stock repurchase program pursuant to which the Company may, from time to time and on or before the program’s expiration date, repurchase shares of its outstanding common stock in the open market, in privately-negotiated transactions, or otherwise, subject to applicable laws and regulations. The extent to which the Company repurchases its shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements, availability of funds, and other relevant considerations, as determined by the Company. The Company may, in its discretion, begin, suspend or terminate repurchases at any time prior to the program’s expiration, without any prior notice. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 under the Exchange Act, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so because of self-imposed trading blackout periods or other regulatory restrictions. The new stock repurchase program expires on October 29, 2020.
|
|
|
December 31,
|
||||||||||||||||||||||
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
|
2018
|
|
2019
|
||||||||||||
SVB Financial Group
|
|
$
|
100.00
|
|
|
$
|
102.44
|
|
|
$
|
147.89
|
|
|
$
|
201.40
|
|
|
$
|
163.63
|
|
|
$
|
216.28
|
|
S&P 500
|
|
100.00
|
|
|
101.38
|
|
|
113.51
|
|
|
138.29
|
|
|
132.23
|
|
|
173.86
|
|
||||||
NASDAQ Composite
|
|
100.00
|
|
|
106.96
|
|
|
116.45
|
|
|
150.96
|
|
|
146.67
|
|
|
200.49
|
|
||||||
NASDAQ Bank
|
|
100.00
|
|
|
107.08
|
|
|
147.27
|
|
|
155.68
|
|
|
129.17
|
|
|
160.44
|
|
ITEM 6.
|
SELECTED CONSOLIDATED FINANCIAL DATA
|
|
|
Year ended December 31,
|
||||||||||||||||||
(Dollars in thousands, except per share amounts and ratios)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Income statement summary:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest income
|
|
$
|
2,096,601
|
|
|
$
|
1,893,988
|
|
|
$
|
1,420,369
|
|
|
$
|
1,150,523
|
|
|
$
|
1,006,425
|
|
Provision for credit losses
|
|
(106,416
|
)
|
|
(87,870
|
)
|
|
(92,304
|
)
|
|
(106,679
|
)
|
|
(95,683
|
)
|
|||||
Noninterest income
|
|
1,221,479
|
|
|
744,984
|
|
|
557,231
|
|
|
456,552
|
|
|
472,794
|
|
|||||
Noninterest expense
|
|
(1,601,262
|
)
|
|
(1,188,193
|
)
|
|
(1,010,655
|
)
|
|
(859,797
|
)
|
|
(779,962
|
)
|
|||||
Income before income tax expense
|
|
1,610,402
|
|
|
1,362,909
|
|
|
874,641
|
|
|
640,599
|
|
|
603,574
|
|
|||||
Income tax expense
|
|
(425,685
|
)
|
|
(351,561
|
)
|
|
(355,463
|
)
|
|
(250,333
|
)
|
|
(228,754
|
)
|
|||||
Net income before noncontrolling interests
|
|
1,184,717
|
|
|
1,011,348
|
|
|
519,178
|
|
|
390,266
|
|
|
374,820
|
|
|||||
Net income attributable to noncontrolling interests
|
|
(47,861
|
)
|
|
(37,508
|
)
|
|
(28,672
|
)
|
|
(7,581
|
)
|
|
(30,916
|
)
|
|||||
Net income available to common stockholders
|
|
$
|
1,136,856
|
|
|
$
|
973,840
|
|
|
$
|
490,506
|
|
|
$
|
382,685
|
|
|
$
|
343,904
|
|
Common share summary:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Earnings per common share—basic
|
|
$
|
21.90
|
|
|
$
|
18.35
|
|
|
$
|
9.33
|
|
|
$
|
7.37
|
|
|
$
|
6.70
|
|
Earnings per common share—diluted
|
|
21.73
|
|
|
18.11
|
|
|
9.20
|
|
|
7.31
|
|
|
6.62
|
|
|||||
Book value per common share
|
|
118.67
|
|
|
97.29
|
|
|
79.11
|
|
|
69.71
|
|
|
61.97
|
|
|||||
Weighted average shares outstanding—basic
|
|
51,915
|
|
|
53,078
|
|
|
52,588
|
|
|
51,915
|
|
|
51,318
|
|
|||||
Weighted average shares outstanding—diluted
|
|
52,311
|
|
|
53,772
|
|
|
53,306
|
|
|
52,349
|
|
|
51,916
|
|
|||||
Year-end balance sheet summary:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Available-for-sale securities
|
|
$
|
14,014,919
|
|
|
$
|
7,790,043
|
|
|
$
|
11,120,664
|
|
|
$
|
12,620,411
|
|
|
$
|
16,380,748
|
|
Held-to-maturity securities
|
|
13,842,946
|
|
|
15,487,442
|
|
|
12,663,455
|
|
|
8,426,998
|
|
|
8,790,963
|
|
|||||
Loans, net of unearned income
|
|
33,164,636
|
|
|
28,338,280
|
|
|
23,106,316
|
|
|
19,899,944
|
|
|
16,742,070
|
|
|||||
Total assets
|
|
71,004,903
|
|
|
56,927,979
|
|
|
51,214,467
|
|
|
44,683,660
|
|
|
44,686,703
|
|
|||||
Deposits
|
|
61,757,807
|
|
|
49,328,900
|
|
|
44,254,075
|
|
|
38,979,868
|
|
|
39,142,776
|
|
|||||
Short-term borrowings
|
|
17,430
|
|
|
631,412
|
|
|
1,033,730
|
|
|
512,668
|
|
|
774,900
|
|
|||||
Long-term debt
|
|
347,987
|
|
|
696,465
|
|
|
695,492
|
|
|
795,704
|
|
|
796,702
|
|
|||||
SVBFG stockholders' equity
|
|
6,470,307
|
|
|
5,116,209
|
|
|
4,179,795
|
|
|
3,642,554
|
|
|
3,198,134
|
|
|||||
Average balance sheet summary:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Available-for-sale securities
|
|
$
|
9,597,712
|
|
|
$
|
9,789,211
|
|
|
$
|
12,424,137
|
|
|
$
|
13,331,315
|
|
|
$
|
14,436,140
|
|
Held-to-maturity securities
|
|
14,672,342
|
|
|
14,997,846
|
|
|
9,984,610
|
|
|
8,192,183
|
|
|
7,829,177
|
|
|||||
Loans, net of unearned income
|
|
29,916,207
|
|
|
25,630,520
|
|
|
21,159,394
|
|
|
18,283,591
|
|
|
14,762,941
|
|
|||||
Total assets
|
|
63,211,630
|
|
|
55,229,060
|
|
|
48,380,272
|
|
|
43,987,451
|
|
|
40,846,377
|
|
|||||
Deposits
|
|
55,056,950
|
|
|
48,075,344
|
|
|
42,745,148
|
|
|
38,759,059
|
|
|
36,293,362
|
|
|||||
Short-term borrowings
|
|
144,545
|
|
|
643,886
|
|
|
48,505
|
|
|
220,251
|
|
|
23,226
|
|
|||||
Long-term debt
|
|
685,445
|
|
|
695,938
|
|
|
766,943
|
|
|
796,302
|
|
|
770,848
|
|
|||||
SVBFG common stockholders' equity
|
|
5,674,531
|
|
|
4,734,417
|
|
|
3,961,405
|
|
|
3,509,526
|
|
|
3,075,371
|
|
|||||
Capital ratios:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
SVBFG CET 1 risk-based capital ratio
|
|
12.58
|
%
|
|
13.41
|
%
|
|
12.78
|
%
|
|
12.80
|
%
|
|
12.28
|
%
|
|||||
SVBFG total risk-based capital ratio
|
|
14.23
|
|
|
14.45
|
|
|
13.96
|
|
|
14.21
|
|
|
13.84
|
|
|||||
SVBFG tier 1 risk-based capital ratio
|
|
13.43
|
|
|
13.58
|
|
|
12.97
|
|
|
13.26
|
|
|
12.83
|
|
|||||
SVBFG tier 1 leverage ratio
|
|
9.06
|
|
|
9.06
|
|
|
8.34
|
|
|
8.34
|
|
|
7.63
|
|
|||||
SVBFG tangible common equity to tangible assets (1)
|
|
8.39
|
|
|
8.99
|
|
|
8.16
|
|
|
8.15
|
|
|
7.16
|
|
|||||
SVBFG tangible common equity to risk-weighted assets (1)
|
|
12.76
|
|
|
13.28
|
|
|
12.77
|
|
|
12.89
|
|
|
12.34
|
|
|||||
Bank CET 1 risk-based capital ratio
|
|
11.12
|
|
|
12.41
|
|
|
12.06
|
|
|
12.65
|
|
|
12.52
|
|
|||||
Bank total risk-based capital ratio
|
|
11.96
|
|
|
13.32
|
|
|
13.04
|
|
|
13.66
|
|
|
13.60
|
|
|||||
Bank tier 1 risk-based capital ratio
|
|
11.12
|
|
|
12.41
|
|
|
12.06
|
|
|
12.65
|
|
|
12.52
|
|
|||||
Bank tier 1 leverage ratio
|
|
7.30
|
|
|
8.10
|
|
|
7.56
|
|
|
7.67
|
|
|
7.09
|
|
|||||
Bank tangible common equity to tangible assets (1)
|
|
7.24
|
|
|
8.13
|
|
|
7.47
|
|
|
7.77
|
|
|
6.95
|
|
|||||
Bank tangible common equity to risk-weighted assets (1)
|
|
11.31
|
|
|
12.28
|
|
|
11.98
|
|
|
12.75
|
|
|
12.59
|
|
|||||
Average SVBFG stockholders' equity to average assets
|
|
8.98
|
|
|
8.57
|
|
|
8.19
|
|
|
7.98
|
|
|
7.53
|
|
|||||
Selected financial results:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Return on average assets
|
|
1.80
|
%
|
|
1.76
|
%
|
|
1.01
|
%
|
|
0.87
|
%
|
|
0.84
|
%
|
|||||
Return on average SVBFG common stockholders' equity
|
|
20.03
|
|
|
20.57
|
|
|
12.38
|
|
|
10.90
|
|
|
11.18
|
|
|||||
Net interest margin
|
|
3.51
|
|
|
3.57
|
|
|
3.05
|
|
|
2.72
|
|
|
2.57
|
|
|||||
Gross loan charge-offs to average total gross loans
|
|
0.31
|
|
|
0.26
|
|
|
0.31
|
|
|
0.53
|
|
|
0.34
|
|
|||||
Net loan charge-offs to average total gross loans
|
|
0.24
|
|
|
0.22
|
|
|
0.27
|
|
|
0.46
|
|
|
0.30
|
|
|||||
Nonperforming assets as a percentage of total assets
|
|
0.15
|
|
|
0.17
|
|
|
0.23
|
|
|
0.27
|
|
|
0.28
|
|
|||||
Allowance for loan losses as a percentage of total gross loans
|
|
0.91
|
|
|
0.99
|
|
|
1.10
|
|
|
1.13
|
|
|
1.29
|
|
|
(1)
|
See “Management's Discussion and Analysis of Financial Condition and Results of Operations-Capital Resources-Capital Ratios” under Part II, Item 7 of this report for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.
|
ITEM 7.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
BALANCE SHEET
|
|
EARNINGS
|
Assets. $63.2 billion in average total assets (up 14.5%). $71.0 billion in period-end total assets (up 24.7%).
Loans. $29.9 billion in average total loan balances, net of unearned income (up 16.7%). $33.2 billion in period-end total loan balances, net of unearned income (up 17.0%).
Total Client Funds. (on-balance sheet deposits and off-balance sheet client investment funds). $146.7 billion in average total client fund balances (up 19.1%). $161.0 billion in period-end total client fund balances (up 18.9%).
AFS/HTM Fixed Income Investments. $24.3 billion in average fixed income investment securities (down 2.1%). $27.9 billion in period-end fixed income investment securities (up 19.7%).
|
|
EPS. Earnings per diluted share of $21.73 (up 20.0%).
Net Income. Consolidated net income available to common stockholders of $1.1 billion (up 16.7%).
- Net interest income of $2.1 billion (up 10.7%).
- Net interest margin of 3.51% (down 6bps).
- Noninterest income of $1.2 billion (up 64.0%), non-GAAP core fee income+ of $641.8 million (up 24.4%) and non-GAAP core fee income plus investment banking revenue and commissions++ of $893.4 million (up 73.2%).
- Noninterest expense of $1.6 billion (up 34.8%).
ROE. Return on average equity (“ROE”) performance of 20.03%.
Operating Efficiency Ratio. Operating efficiency ratio of 48.26% with a non-GAAP core operating efficiency ratio of 48.06%+++.
|
|
|
|
CAPITAL
|
|
CREDIT QUALITY
|
Capital. Continued strong capital, with all capital ratios considered "well-capitalized" under banking regulations. SVBFG and SVB capital ratios, respectively, were:
- CET 1 risk-based capital ratio of 12.58% and 11.12%.
- Tier 1 risk-based capital ratio of 13.43% and 11.12%.
- Total risk-based capital ratio of 14.23% and 11.96%. - Tier 1 leverage ratio of 9.06% and 7.30%.
|
|
Credit Quality. Continued stable credit.
- Allowance for loan losses of 0.91% as a percentage of period-end total gross loans.
- Allowance for unfunded credit commitments of 0.28% as a percentage of total unfunded credit commitments.
- Provision for loan losses of 0.28% as a percentage of total gross loans.
- Net loan charge-offs of 0.24% as a percentage of average total gross loans.
|
+
|
Consists of fee income from client investments, foreign exchange, credit cards, deposit services, lending related activities and letters of credit and standby letters of credit. This is a non-GAAP financial measure. (See the non-GAAP reconciliation under “Results of Operations—Noninterest Income”).
|
++
|
Consists of non-GAAP core fee income plus investment banking revenue and commissions. This is a non-GAAP financial measure. (See the non-GAAP reconciliation under “Results of Operations—Noninterest Income”).
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands, except per share amounts, employees and ratios)
|
|
2019
|
|
2018
|
|
% Change
|
||||||
Income Statement:
|
|
|
|
|
|
|
|
|||||
Diluted earnings per share
|
|
$
|
21.73
|
|
|
$
|
18.11
|
|
|
20.0
|
|
%
|
Net income available to common stockholders
|
|
1,136,856
|
|
|
973,840
|
|
|
16.7
|
|
|
||
Net interest income
|
|
2,096,601
|
|
|
1,893,988
|
|
|
10.7
|
|
|
||
Net interest margin
|
|
3.51
|
%
|
|
3.57
|
%
|
|
(6
|
)
|
bps
|
||
Provision for credit losses
|
|
$
|
106,416
|
|
|
$
|
87,870
|
|
|
21.1
|
|
%
|
Noninterest income
|
|
1,221,479
|
|
|
744,984
|
|
|
64.0
|
|
|
||
Noninterest expense
|
|
1,601,262
|
|
|
1,188,193
|
|
|
34.8
|
|
|
||
Non-GAAP core fee income (1)
|
|
641,838
|
|
|
515,890
|
|
|
24.4
|
|
|
||
Non-GAAP core fee income, plus investment banking revenue and commissions (1)
|
|
893,361
|
|
|
515,890
|
|
|
73.2
|
|
|
||
Non-GAAP noninterest income, net of noncontrolling interests (1)
|
|
1,172,855
|
|
|
706,984
|
|
|
65.9
|
|
|
||
Non-GAAP noninterest expense, net of noncontrolling interests (2)
|
|
1,600,427
|
|
|
1,187,671
|
|
|
34.8
|
|
|
||
Balance Sheet:
|
|
|
|
|
|
|
|
|||||
Average available-for-sale-securities
|
|
$
|
9,597,712
|
|
|
$
|
9,789,211
|
|
|
(2.0
|
)
|
%
|
Average held-to-maturity securities
|
|
14,672,342
|
|
|
14,997,846
|
|
|
(2.2
|
)
|
|
||
Average loans, net of unearned income
|
|
29,916,207
|
|
|
25,630,520
|
|
|
16.7
|
|
|
||
Average noninterest-bearing demand deposits
|
|
38,783,470
|
|
|
39,633,118
|
|
|
(2.1
|
)
|
|
||
Average interest-bearing deposits
|
|
16,273,480
|
|
|
8,442,226
|
|
|
92.8
|
|
|
||
Average total deposits
|
|
55,056,950
|
|
|
48,075,344
|
|
|
14.5
|
|
|
||
Earnings Ratios:
|
|
|
|
|
|
|
|
|||||
Return on average assets (3)
|
|
1.80
|
%
|
|
1.76
|
%
|
|
2.3
|
|
%
|
||
Return on average SVBFG common stockholders’ equity (4)
|
|
20.03
|
|
|
20.57
|
|
|
(2.6
|
)
|
|
||
Asset Quality Ratios:
|
|
|
|
|
|
|
|
|||||
Allowance for loan losses as a percentage of total period-end gross loans
|
|
0.91
|
%
|
|
0.99
|
%
|
|
(8
|
)
|
bps
|
||
Allowance for loan losses for performing loans as a percentage of total gross performing loans
|
|
0.78
|
|
|
0.86
|
|
|
(8
|
)
|
|
||
Gross loan charge-offs as a percentage of average total gross loans
|
|
0.31
|
|
|
0.26
|
|
|
5
|
|
|
||
Net loan charge-offs as a percentage of average total gross loans
|
|
0.24
|
|
|
0.22
|
|
|
2
|
|
|
||
Capital Ratios:
|
|
|
|
|
|
|
|
|||||
SVBFG CET 1 risk-based capital ratio
|
|
12.58
|
%
|
|
13.41
|
%
|
|
(83
|
)
|
bps
|
||
SVBFG total risk-based capital ratio
|
|
14.23
|
|
|
14.45
|
|
|
(22
|
)
|
|
||
SVBFG tier 1 risk-based capital ratio
|
|
13.43
|
|
|
13.58
|
|
|
(15
|
)
|
|
||
SVBFG tier 1 leverage ratio
|
|
9.06
|
|
|
9.06
|
|
|
—
|
|
|
||
SVBFG tangible common equity to tangible assets (5)
|
|
8.39
|
|
|
8.99
|
|
|
(60
|
)
|
|
||
SVBFG tangible common equity to risk-weighted assets (5)
|
|
12.76
|
|
|
13.28
|
|
|
(52
|
)
|
|
||
Bank CET 1 risk-based capital ratio
|
|
11.12
|
|
|
12.41
|
|
|
(129
|
)
|
|
||
Bank total risk-based capital ratio
|
|
11.96
|
|
|
13.32
|
|
|
(136
|
)
|
|
||
Bank tier 1 risk-based capital ratio
|
|
11.12
|
|
|
12.41
|
|
|
(129
|
)
|
|
||
Bank tier 1 leverage ratio
|
|
7.30
|
|
|
8.10
|
|
|
(80
|
)
|
|
||
Bank tangible common equity to tangible assets (5)
|
|
7.24
|
|
|
8.13
|
|
|
(89
|
)
|
|
||
Bank tangible common equity to risk-weighted assets (5)
|
|
11.31
|
|
|
12.28
|
|
|
(97
|
)
|
|
||
Other Ratios:
|
|
|
|
|
|
|
|
|||||
GAAP operating efficiency ratio (6)
|
|
48.26
|
%
|
|
45.02
|
%
|
|
7.2
|
|
%
|
||
Non-GAAP core operating efficiency ratio (2)
|
|
48.06
|
|
|
48.06
|
|
|
—
|
|
|
||
Total costs of deposits (7)
|
|
0.32
|
|
|
0.06
|
|
|
NM
|
|
|
||
Book value per common share (8)
|
|
$
|
118.67
|
|
|
$
|
97.29
|
|
|
22.0
|
|
|
Other Statistics:
|
|
|
|
|
|
|
|
|||||
Average full-time equivalent employees
|
|
3,362
|
|
|
2,685
|
|
|
25.2
|
|
%
|
||
Period-end full-time equivalent employees
|
|
3,564
|
|
|
2,900
|
|
|
22.9
|
|
|
|
(1)
|
See “Results of Operations–Noninterest Income” for a description and reconciliation of non-GAAP core fee income and non-GAAP core fee income plus investment banking revenue and commissions.
|
(2)
|
See “Results of Operations–Noninterest Expense” for a description and reconciliation of non-GAAP noninterest expense and non-GAAP core operating efficiency ratio.
|
(3)
|
Ratio represents consolidated net income available to common stockholders divided by average assets.
|
(4)
|
Ratio represents consolidated net income available to common stockholders divided by average SVBFG common stockholders’ equity.
|
(5)
|
See “Capital Resources–Capital Ratios” for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.
|
(6)
|
The operating efficiency ratio is calculated by dividing total noninterest expense by total net interest income plus noninterest income.
|
(7)
|
Ratio represents total cost of deposits and is calculated by dividing interest expense from deposits by average total deposits.
|
(8)
|
Book value per common share is calculated by dividing total SVBFG common stockholders’ equity by total outstanding common shares at period-end.
|
|
|
December 31,
|
||||||||||||||
|
|
2019
|
|
2018
|
||||||||||||
(Dollars in thousands)
|
|
Total Balance
|
|
Level 3
|
|
Total Balance
|
|
Level 3
|
||||||||
Assets carried at fair value
|
|
$
|
14,672,330
|
|
|
$
|
161,172
|
|
|
$
|
8,388,011
|
|
|
$
|
146,278
|
|
As a percentage of total assets
|
|
20.7
|
%
|
|
0.2
|
%
|
|
14.7
|
%
|
|
0.3
|
%
|
||||
Liabilities carried at fair value
|
|
$
|
137,984
|
|
|
$
|
—
|
|
|
$
|
98,050
|
|
|
$
|
—
|
|
As a percentage of total liabilities
|
|
0.2
|
%
|
|
—
|
%
|
|
0.2
|
%
|
|
—
|
%
|
||||
As a percentage of assets carried at fair value
|
|
|
|
|
1.1
|
|
|
|
|
1.7
|
|
•
|
A reasonable and supportable forecast period of three years for all portfolio segments and classes of financing receivables and unfunded credit exposures leveraging the weighted-average of a range of macroeconomic scenarios. This period reflects management’s expectation of losses based on forward-looking economic scenarios over that time and closely aligns with other internal forecast periods. After the forecast period, our estimate of credit losses will revert to historical averages gradually over the remaining contractual lives, adjusted for prepayments. The macroeconomic scenarios are reviewed on a quarterly basis.
|
•
|
We will utilize a discounted cash flow ("DCF") approach to measure credit impairment for loans identified for individual assessment, which includes TDR's. Collateral-dependent loans identified for individual assessment will be carried at the fair value of collateral, net of selling costs (when applicable).
|
•
|
Our HTM debt securities portfolio, with the exception of our municipal bond portfolio, have been evaluated and currently carry zero risk of credit loss as they are securities that are either explicitly or implicitly guaranteed by the U.S. government. A reasonable and supportable forecast period of one year will be applied to our municipal bonds, however, we do not expect the allowance for credit losses to be significant for this portion of our HTM debt securities portfolio.
|
•
|
Under the prior guidance, our loan portfolio was disclosed by market segments. Going forward, our technology (software/internet and hardware) and life science/healthcare market segments will be disclosed by class of financing receivable that align with their underlying underwriting methodology. The technology (software/internet and hardware) and life science/healthcare market segments will be classified as investor dependent, balance sheet dependent or cash flow dependent and prior period amounts will be reclassified for comparability. There are no other material changes to our current market segments.
|
|
|
2019 compared to 2018
|
|
2018 compared to 2017
|
||||||||||||||||||||
|
|
Change due to
|
|
Change due to
|
||||||||||||||||||||
(Dollars in thousands)
|
|
Volume
|
|
Rate
|
|
Total
|
|
Volume
|
|
Rate
|
|
Total
|
||||||||||||
Interest income:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities
|
|
$
|
50,581
|
|
|
$
|
10,651
|
|
|
$
|
61,232
|
|
|
$
|
(3,606
|
)
|
|
$
|
17,309
|
|
|
$
|
13,703
|
|
Fixed income investment portfolio (taxable)
|
|
(22,833
|
)
|
|
50,079
|
|
|
27,246
|
|
|
53,911
|
|
|
75,561
|
|
|
129,472
|
|
||||||
Fixed income investment portfolio (non-taxable)
|
|
12,596
|
|
|
488
|
|
|
13,084
|
|
|
35,132
|
|
|
(105
|
)
|
|
35,027
|
|
||||||
Loans, net of unearned income
|
|
229,091
|
|
|
11,594
|
|
|
240,685
|
|
|
236,981
|
|
|
95,711
|
|
|
332,692
|
|
||||||
Increase in interest income, net
|
|
269,435
|
|
|
72,812
|
|
|
342,247
|
|
|
322,418
|
|
|
188,476
|
|
|
510,894
|
|
||||||
Interest expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest-bearing checking and savings accounts
|
|
(72
|
)
|
|
33
|
|
|
(39
|
)
|
|
118
|
|
|
11
|
|
|
129
|
|
||||||
Money market deposits
|
|
79,243
|
|
|
45,945
|
|
|
125,188
|
|
|
3,634
|
|
|
16,308
|
|
|
19,942
|
|
||||||
Money market deposits in foreign offices
|
|
(11
|
)
|
|
(1
|
)
|
|
(12
|
)
|
|
(5
|
)
|
|
(3
|
)
|
|
(8
|
)
|
||||||
Time deposits
|
|
560
|
|
|
600
|
|
|
1,160
|
|
|
24
|
|
|
28
|
|
|
52
|
|
||||||
Sweep deposits in foreign offices
|
|
10,137
|
|
|
11,932
|
|
|
22,069
|
|
|
(81
|
)
|
|
596
|
|
|
515
|
|
||||||
Total increase in deposits expense
|
|
89,857
|
|
|
58,509
|
|
|
148,366
|
|
|
3,690
|
|
|
16,940
|
|
|
20,630
|
|
||||||
Short-term borrowings
|
|
(12,408
|
)
|
|
1,421
|
|
|
(10,987
|
)
|
|
13,481
|
|
|
555
|
|
|
14,036
|
|
||||||
3.50% Senior Notes
|
|
12
|
|
|
—
|
|
|
12
|
|
|
12
|
|
|
—
|
|
|
12
|
|
||||||
5.375% Senior Notes
|
|
(505
|
)
|
|
—
|
|
|
(505
|
)
|
|
35
|
|
|
—
|
|
|
35
|
|
||||||
7.0% Junior Subordinated Debentures
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,096
|
)
|
|
—
|
|
|
(3,096
|
)
|
||||||
6.05% Subordinated Notes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(467
|
)
|
|
—
|
|
|
(467
|
)
|
||||||
Total (decrease) increase in borrowings expense
|
|
(12,901
|
)
|
|
1,421
|
|
|
(11,480
|
)
|
|
9,965
|
|
|
555
|
|
|
10,520
|
|
||||||
Increase in interest expense, net
|
|
76,956
|
|
|
59,930
|
|
|
136,886
|
|
|
13,655
|
|
|
17,495
|
|
|
31,150
|
|
||||||
Increase in net interest income
|
|
$
|
192,479
|
|
|
$
|
12,882
|
|
|
$
|
205,361
|
|
|
$
|
308,763
|
|
|
$
|
170,981
|
|
|
$
|
479,744
|
|
•
|
Interest income for 2019 increased by $342.2 million primarily due to:
|
◦
|
A $240.7 million increase in interest income from loans to $1.6 billion in 2019, compared to $1.4 billion in 2018. This increase was reflective of an increase in average loan balances of $4.3 billion and an increase in the overall yield on our loan portfolio of 5 basis points to 5.35 percent from 5.30 percent. Gross loan yields, excluding loan interest recoveries and loan fees, increased by 2 basis points to 4.79 percent from 4.77 percent, reflective of the benefit of interest rate increases in effect the first half of the year, partially offset by the strong growth of our lower yielding private equity/venture capital loan portfolio and interest rate decreases in the third and fourth quarters of 2019. Our private equity/venture capital portfolio represented 53.5 percent and 49.5 percent of our total gross loan portfolio at December 31, 2019 and 2018, respectively,
|
◦
|
A $61.2 million increase in interest income from our short-term investment securities to $96.4 million, compared to $35.2 million in 2018. The increase was due primarily to an increase of $3.1 billion in average interest earning cash and short-term investment securities balances and higher yields reflective of the benefit of interest rate increases in effect the first half of the year, partially offset by interest rate decreases in the third and fourth quarters of 2019, and
|
◦
|
A $40.3 million increase in interest income from our fixed income investment securities to $625.8 million in 2019, compared to $585.4 million in 2018. The increase was reflective of an increase in our fixed income securities yield of 22 basis points to 2.58 percent from 2.36 percent, partially offset by a decrease of $0.5 billion in average fixed income investment balances primarily due to a decrease in average HTM securities. The increase
|
◦
|
A $148.4 million increase in deposits interest expense, due primarily to an increase in interest paid on our interest-bearing money market deposits as a result of market rate adjustments and an increase of $7.8 billion in average interest-bearing deposits, partially offset by
|
◦
|
An $11.5 million decrease in borrowings interest expense, due primarily to a decrease in our average short-term borrowings balance during 2019 as a result of the increase in average deposit balances.
|
•
|
Interest income for 2018 increased by $510.9 million primarily due to:
|
◦
|
A $332.7 million increase in interest income from loans to $1.4 billion in 2018, compared to $1.0 billion in 2017. This increase was reflective of an increase in average loan balances of $4.5 billion and an increase in the overall yield on our loan portfolio of 45 basis points to 5.30 percent from 4.85 percent. Gross loan yields, excluding loan interest recoveries and loan fees, increased by 55 basis points to 4.77 percent from 4.22 percent, reflective of the benefit of interest rate increases, partially offset by the strong growth of our lower yielding private equity/ venture capital loan portfolio. Our private equity/venture capital portfolio represented 49.5 percent and 42.8 percent of our total gross loan portfolio at December 31, 2018 and 2017, respectively.
|
◦
|
A $164.5 million increase in interest income from our fixed income investment securities to $585.4 million in 2018, compared to $420.9 million in 2017. The increase was reflective of an increase of $2.4 billion in average fixed income investment balances as a result of strong deposit growth in 2018 and an increase in our fixed income securities yield of 48 basis points to 2.36 percent from 1.88 percent. The increase in our fixed income securities yield was primarily from higher reinvestment yields on maturing fixed income investments as well as higher yields on new purchases due to interest rate increases, and
|
◦
|
A $13.7 million increase in interest income from our Federal Reserve deposits to $35.2 million, compared to $21.5 million in 2017. The increase was due primarily to higher yields as a result of rate increases in 2018.
|
•
|
Interest expense for 2018 increased to $75.9 million, compared to $44.8 million for 2017, primarily due to:
|
◦
|
A $20.6 million increase in deposits interest expense, due primarily to an increase in interest paid on our interest-bearing money market deposits as a result of market rate adjustments, and
|
◦
|
A $10.5 million increase in borrowings interest expense, due primarily to an increase in our average short-term borrowings balance during 2018 to fund loan growth as a result of the timing of loan funding and deposit activities. The increase in interest expense from short-term borrowings was partially offset by a decrease in interest expense from long-term debt reflective of the repayment of our 6.05% Subordinated Notes and the redemption of our Junior Subordinated Debentures in 2017.
|
|
|
Year ended December 31,
|
|||||||||||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
|||||||||||||||||||||||||||
(Dollars in thousands)
|
|
Average
Balance
|
|
Interest
Income/
Expense
|
|
Yield/
Rate
|
|
Average
Balance
|
|
Interest
Income/
Expense
|
|
Yield/
Rate
|
|
Average
Balance
|
|
Interest
Income/
Expense
|
|
Yield/
Rate
|
|||||||||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities (1)
|
|
$
|
5,932,146
|
|
|
$
|
96,440
|
|
|
1.63
|
%
|
|
$
|
2,820,883
|
|
|
$
|
35,208
|
|
|
1.25
|
%
|
|
$
|
3,109,840
|
|
|
$
|
21,505
|
|
|
0.69
|
%
|
Investment Securities: (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Taxable
|
|
9,597,712
|
|
|
217,650
|
|
|
2.27
|
|
|
9,789,211
|
|
|
185,120
|
|
|
1.89
|
|
|
12,424,137
|
|
|
199,423
|
|
|
1.61
|
|
||||||
Held-to-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Taxable
|
|
13,041,160
|
|
|
351,201
|
|
|
2.69
|
|
|
13,727,745
|
|
|
356,485
|
|
|
2.60
|
|
|
9,732,869
|
|
|
212,710
|
|
|
2.19
|
|
||||||
Non-taxable (3)
|
|
1,631,182
|
|
|
56,901
|
|
|
3.49
|
|
|
1,270,101
|
|
|
43,817
|
|
|
3.45
|
|
|
251,741
|
|
|
8,790
|
|
|
3.49
|
|
||||||
Total loans, net of unearned income (4) (5)
|
|
29,916,207
|
|
|
1,599,165
|
|
|
5.35
|
|
|
25,630,520
|
|
|
1,358,480
|
|
|
5.30
|
|
|
21,159,394
|
|
|
1,025,788
|
|
|
4.85
|
|
||||||
Total interest-earning assets
|
|
60,118,407
|
|
|
2,321,357
|
|
|
3.86
|
|
|
53,238,460
|
|
|
1,979,110
|
|
|
3.71
|
|
|
46,677,981
|
|
|
1,468,216
|
|
|
3.15
|
|
||||||
Cash and due from banks
|
|
592,196
|
|
|
|
|
|
|
480,900
|
|
|
|
|
|
|
374,811
|
|
|
|
|
|
||||||||||||
Allowance for loan losses
|
|
(306,800
|
)
|
|
|
|
|
|
(282,489
|
)
|
|
|
|
|
|
(247,004
|
)
|
|
|
|
|
||||||||||||
Other assets (6)
|
|
2,807,827
|
|
|
|
|
|
|
1,792,189
|
|
|
|
|
|
|
1,574,484
|
|
|
|
|
|
||||||||||||
Total assets
|
|
$
|
63,211,630
|
|
|
|
|
|
|
$
|
55,229,060
|
|
|
|
|
|
|
$
|
48,380,272
|
|
|
|
|
|
|||||||||
Funding sources:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Interest-bearing checking and savings accounts
|
|
$
|
498,606
|
|
|
$
|
424
|
|
|
0.09
|
%
|
|
$
|
583,295
|
|
|
$
|
463
|
|
|
0.08
|
%
|
|
$
|
433,966
|
|
|
$
|
334
|
|
|
0.08
|
%
|
Money market deposits
|
|
13,721,076
|
|
|
152,901
|
|
|
1.11
|
|
|
6,609,873
|
|
|
27,713
|
|
|
0.42
|
|
|
5,743,083
|
|
|
7,771
|
|
|
0.14
|
|
||||||
Money market deposits in foreign offices
|
|
164,693
|
|
|
64
|
|
|
0.04
|
|
|
192,128
|
|
|
76
|
|
|
0.04
|
|
|
203,775
|
|
|
84
|
|
|
0.04
|
|
||||||
Time deposits
|
|
111,806
|
|
|
1,271
|
|
|
1.14
|
|
|
62,570
|
|
|
111
|
|
|
0.18
|
|
|
48,818
|
|
|
59
|
|
|
0.12
|
|
||||||
Sweep deposits in foreign offices
|
|
1,777,299
|
|
|
23,012
|
|
|
1.29
|
|
|
994,360
|
|
|
943
|
|
|
0.09
|
|
|
1,080,306
|
|
|
428
|
|
|
0.04
|
|
||||||
Total interest-bearing deposits
|
|
16,273,480
|
|
|
177,672
|
|
|
1.09
|
|
|
8,442,226
|
|
|
29,306
|
|
|
0.35
|
|
|
7,509,948
|
|
|
8,676
|
|
|
0.12
|
|
||||||
Short-term borrowings
|
|
144,545
|
|
|
3,592
|
|
|
2.49
|
|
|
643,886
|
|
|
14,579
|
|
|
2.26
|
|
|
48,505
|
|
|
543
|
|
|
1.12
|
|
||||||
3.50% Senior Notes
|
|
347,799
|
|
|
12,598
|
|
|
3.62
|
|
|
347,458
|
|
|
12,586
|
|
|
3.62
|
|
|
347,128
|
|
|
12,574
|
|
|
3.62
|
|
||||||
5.375% Senior Notes
|
|
337,646
|
|
|
18,945
|
|
|
5.61
|
|
|
348,480
|
|
|
19,450
|
|
|
5.58
|
|
|
347,862
|
|
|
19,415
|
|
|
5.58
|
|
||||||
7.0% Junior Subordinated Debentures
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
52,775
|
|
|
3,096
|
|
|
5.87
|
|
||||||
6.05% Subordinated Notes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,178
|
|
|
467
|
|
|
2.44
|
|
||||||
Total interest-bearing liabilities
|
|
17,103,470
|
|
|
212,807
|
|
|
1.24
|
|
|
9,782,050
|
|
|
75,921
|
|
|
0.78
|
|
|
8,325,396
|
|
|
44,771
|
|
|
0.54
|
|
||||||
Portion of noninterest-bearing funding sources
|
|
43,014,937
|
|
|
|
|
|
|
43,456,410
|
|
|
|
|
|
|
38,352,585
|
|
|
|
|
|
||||||||||||
Total funding sources
|
|
60,118,407
|
|
|
212,807
|
|
|
0.35
|
|
|
53,238,460
|
|
|
75,921
|
|
|
0.14
|
|
|
46,677,981
|
|
|
44,771
|
|
|
0.10
|
|
||||||
Noninterest-bearing funding sources:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Demand deposits
|
|
38,783,470
|
|
|
|
|
|
|
39,633,118
|
|
|
|
|
|
|
35,235,200
|
|
|
|
|
|
||||||||||||
Other liabilities
|
|
1,483,737
|
|
|
|
|
|
|
937,199
|
|
|
|
|
|
|
721,432
|
|
|
|
|
|
||||||||||||
Preferred stock
|
|
17,751
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
—
|
|
|
|
|
|
||||||||||||
SVBFG common stockholders’ equity
|
|
5,674,531
|
|
|
|
|
|
|
4,734,417
|
|
|
|
|
|
|
3,961,405
|
|
|
|
|
|
||||||||||||
Noncontrolling interests
|
|
148,671
|
|
|
|
|
|
|
142,276
|
|
|
|
|
|
|
136,839
|
|
|
|
|
|
||||||||||||
Portion used to fund interest-earning assets
|
|
(43,014,937
|
)
|
|
|
|
|
|
(43,456,410
|
)
|
|
|
|
|
|
(38,352,585
|
)
|
|
|
|
|
||||||||||||
Total liabilities and total equity
|
|
$
|
63,211,630
|
|
|
|
|
|
|
$
|
55,229,060
|
|
|
|
|
|
|
$
|
48,380,272
|
|
|
|
|
|
|||||||||
Net interest income and margin
|
|
|
|
$
|
2,108,550
|
|
|
3.51
|
%
|
|
|
|
$
|
1,903,189
|
|
|
3.57
|
%
|
|
|
|
$
|
1,423,445
|
|
|
3.05
|
%
|
||||||
Total deposits
|
|
$
|
55,056,950
|
|
|
|
|
|
|
$
|
48,075,344
|
|
|
|
|
|
|
$
|
42,745,148
|
|
|
|
|
|
|||||||||
Reconciliation to reported net interest income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjustments for taxable equivalent basis
|
|
|
|
(11,949
|
)
|
|
|
|
|
|
(9,201
|
)
|
|
|
|
|
|
(3,076
|
)
|
|
|
||||||||||||
Net interest income, as reported
|
|
|
|
$
|
2,096,601
|
|
|
|
|
|
|
$
|
1,893,988
|
|
|
|
|
|
|
$
|
1,420,369
|
|
|
|
|
(1)
|
Includes average interest-earning deposits in other financial institutions of $0.9 billion, $0.8 billion and $1.1 billion in 2019, 2018 and 2017, respectively. For 2019, 2018 and 2017, balances also include $4.1 billion, $1.6 billion and $1.9 billion, respectively, deposited at the FRB, earning interest at the Federal Funds target rate.
|
(2)
|
Yields on interest-earning investment securities do not give effect to changes in fair value that are reflected in other comprehensive income.
|
(3)
|
Interest income on non-taxable investment securities is presented on a fully taxable equivalent basis using the federal statutory income tax rate of 21.0 percent for 2019 and 2018 and 35.0 percent for 2017.
|
(4)
|
Nonaccrual loans are reflected in the average balances of loans.
|
(5)
|
Interest income includes loan fees of $167.6 million, $136.6 million and $128.1 million in 2019, 2018 and 2017, respectively.
|
(6)
|
Average investment securities of $1.1 billion, $0.8 billion, and $0.7 billion in 2019, 2018 and 2017, respectively, were classified as other assets as they were noninterest-earning assets. These investments primarily consisted of non-marketable and other equity securities.
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Allowance for loan losses, beginning balance
|
|
$
|
280,903
|
|
|
$
|
255,024
|
|
|
$
|
225,366
|
|
Provision for loan losses
|
|
94,183
|
|
|
84,292
|
|
|
85,939
|
|
|||
Gross loan charge-offs
|
|
(92,603
|
)
|
|
(67,917
|
)
|
|
(66,682
|
)
|
|||
Loan recoveries
|
|
21,038
|
|
|
11,636
|
|
|
8,538
|
|
|||
Foreign currency translation adjustments
|
|
1,403
|
|
|
(2,132
|
)
|
|
1,863
|
|
|||
Allowance for loan losses, ending balance
|
|
$
|
304,924
|
|
|
$
|
280,903
|
|
|
$
|
255,024
|
|
Allowance for unfunded credit commitments, beginning balance
|
|
55,183
|
|
|
51,770
|
|
|
45,265
|
|
|||
Provision for unfunded credit commitments
|
|
12,233
|
|
|
3,578
|
|
|
6,365
|
|
|||
Foreign currency translation adjustments
|
|
240
|
|
|
(165
|
)
|
|
140
|
|
|||
Allowance for unfunded credit commitments, ending balance (1)
|
|
$
|
67,656
|
|
|
$
|
55,183
|
|
|
$
|
51,770
|
|
Ratios and other information:
|
|
|
|
|
|
|
||||||
Provision for loan losses as a percentage of period-end total gross loans
|
|
0.28
|
%
|
|
0.30
|
%
|
|
0.37
|
%
|
|||
Gross loan charge-offs as a percentage of average total gross loans
|
|
0.31
|
|
|
0.26
|
|
|
0.31
|
|
|||
Net loan charge-offs as a percentage of average total gross loans
|
|
0.24
|
|
|
0.22
|
|
|
0.27
|
|
|||
Allowance for loan losses as a percentage of period-end total gross loans
|
|
0.91
|
|
|
0.99
|
|
|
1.10
|
|
|||
Provision for credit losses
|
|
$
|
106,416
|
|
|
$
|
87,870
|
|
|
$
|
92,304
|
|
Period-end total gross loans
|
|
33,327,704
|
|
|
28,511,312
|
|
|
23,254,153
|
|
|||
Average total gross loans
|
|
30,077,343
|
|
|
25,790,949
|
|
|
21,287,336
|
|
|
(1)
|
The “allowance for unfunded credit commitments” is included as a component of “Other liabilities.”
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
GAAP noninterest income
|
|
$
|
1,221,479
|
|
|
$
|
744,984
|
|
|
64.0
|
%
|
|
$
|
557,231
|
|
|
33.7
|
%
|
Less: income attributable to noncontrolling interests, including carried interest allocation
|
|
48,624
|
|
|
38,000
|
|
|
28.0
|
|
|
29,452
|
|
|
29.0
|
|
|||
Non-GAAP noninterest income, net of noncontrolling interests
|
|
$
|
1,172,855
|
|
|
$
|
706,984
|
|
|
65.9
|
|
|
$
|
527,779
|
|
|
34.0
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
GAAP noninterest income
|
|
$
|
1,221,479
|
|
|
$
|
744,984
|
|
|
64.0
|
%
|
|
$
|
557,231
|
|
|
33.7
|
%
|
Less: gains on investment securities, net
|
|
134,670
|
|
|
88,094
|
|
|
52.9
|
|
|
64,603
|
|
|
36.4
|
|
|||
Less: gains on equity warrant assets, net
|
|
138,078
|
|
|
89,142
|
|
|
54.9
|
|
|
54,555
|
|
|
63.4
|
|
|||
Less: other noninterest income
|
|
55,370
|
|
|
51,858
|
|
|
6.8
|
|
|
59,110
|
|
|
(12.3
|
)
|
|||
Non-GAAP core fee income plus investment banking revenue and commissions (1)
|
|
$
|
893,361
|
|
|
$
|
515,890
|
|
|
73.2
|
|
|
$
|
378,963
|
|
|
36.1
|
|
Less: investment banking revenue
|
|
195,177
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Less: commissions
|
|
56,346
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Non-GAAP core fee income (2)
|
|
$
|
641,838
|
|
|
$
|
515,890
|
|
|
24.4
|
|
|
$
|
378,963
|
|
|
36.1
|
|
|
(1)
|
Non-GAAP core fee income plus investment banking revenue and commissions represents noninterest income, but excludes certain line items where performance is typically subject to market or other conditions beyond our control and other noninterest income. Core fee income plus investment banking revenue and commissions is Non-GAAP core fee income (as defined in the subsequent footnote) with the addition of investment banking revenue and commissions.
|
(2)
|
Non-GAAP core fee income represents noninterest income, but excludes (i) certain line items where performance is typically subject to market or other conditions beyond our control, (ii) our investment banking revenue and commissions and (iii) other noninterest income. Non-GAAP core fee income includes client investment fees, foreign exchange fees, credit card fees, deposit service charges, lending related fees and letters of credit and standby letters of credit fees.
|
•
|
Gains of $37.9 million from our managed funds of funds portfolio, related primarily to net unrealized valuation increases in both private and public company investments held by the funds in the portfolio,
|
•
|
Gains of $33.1 million from our strategic and other investments portfolio, primarily driven by net unrealized valuation increases in both private and public company investments held in our strategic venture capital funds, and
|
•
|
Gains of $7.9 million from our managed direct venture funds, related primarily to net unrealized valuation increases in investments held by the funds in the portfolio.
|
•
|
Gains of $39.9 million from our strategic and other investments portfolio, primarily driven by net unrealized valuation increases in both private and public company investments held in our strategic venture capital funds,
|
•
|
Gains of $29.1 million from our managed funds of funds portfolio, related primarily to net unrealized valuation increases in both private and public company investments held by the funds in the portfolio, and
|
•
|
Losses of $25.2 million from our public equity securities portfolio primarily reflective of net losses on sales of shares of Roku, Inc. ("Roku"), from exercised warrants in 2017, which were sold in the first quarter of 2018.
|
(Dollars in thousands)
|
|
Managed
Funds of
Funds
|
|
Managed
Direct
Venture
Funds
|
|
Public Equity Securities (1)
|
|
Sales of AFS Debt
Securities (1)
|
|
Debt
Funds
|
|
Strategic
and Other
Investments
|
|
SVB Leerink
|
|
Total
|
||||||||||||||||
Year ended December 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
GAAP gains (losses) on investment securities, net
|
|
$
|
74,939
|
|
|
$
|
17,982
|
|
|
$
|
5,421
|
|
|
$
|
(3,905
|
)
|
|
$
|
1,647
|
|
|
$
|
33,101
|
|
|
$
|
5,485
|
|
|
$
|
134,670
|
|
Less: gains attributable to noncontrolling interests, including carried interest allocation
|
|
37,087
|
|
|
10,089
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,325
|
|
|
48,501
|
|
||||||||
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests
|
|
$
|
37,852
|
|
|
$
|
7,893
|
|
|
$
|
5,421
|
|
|
$
|
(3,905
|
)
|
|
$
|
1,647
|
|
|
$
|
33,101
|
|
|
$
|
4,160
|
|
|
$
|
86,169
|
|
Year ended December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
GAAP gains (losses) on investment securities, net
|
|
$
|
62,019
|
|
|
$
|
11,502
|
|
|
$
|
(25,158
|
)
|
|
$
|
(740
|
)
|
|
$
|
541
|
|
|
$
|
39,930
|
|
|
$
|
—
|
|
|
$
|
88,094
|
|
Less: gains attributable to noncontrolling interests, including carried interest allocation
|
|
32,938
|
|
|
5,245
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
38,183
|
|
||||||||
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests
|
|
$
|
29,081
|
|
|
$
|
6,257
|
|
|
$
|
(25,158
|
)
|
|
$
|
(740
|
)
|
|
$
|
541
|
|
|
$
|
39,930
|
|
|
$
|
—
|
|
|
$
|
49,911
|
|
Year ended December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
GAAP gains (losses) on investment securities, net
|
|
$
|
41,140
|
|
|
$
|
1,823
|
|
|
$
|
—
|
|
|
$
|
(5,189
|
)
|
|
$
|
8,950
|
|
|
$
|
17,879
|
|
|
$
|
—
|
|
|
$
|
64,603
|
|
Less: gains attributable to noncontrolling interests, including carried interest allocation
|
|
28,108
|
|
|
1,079
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
29,187
|
|
||||||||
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests
|
|
$
|
13,032
|
|
|
$
|
744
|
|
|
$
|
—
|
|
|
$
|
(5,189
|
)
|
|
$
|
8,950
|
|
|
$
|
17,879
|
|
|
$
|
—
|
|
|
$
|
35,416
|
|
|
(1)
|
Presentation for year-ended December 31, 2017 amounts are not determined in a manner consistent with the December 31, 2019 and 2018 presentation due to the adoption of ASU 2016-01.
|
•
|
Net gains of $107.2 million from the exercises of equity warrant assets in 2019, compared to net gains of $58.2 million in 2018, driven by increased IPO activity during 2019, and
|
•
|
Net gains of $34.4 million from changes in warrant valuations in 2019, compared to net gains of $36.9 million in 2018, driven by valuation increases in our private company warrant portfolio.
|
•
|
Net gains on $58.2 million from the exercises of equity warrant assets in 2018, compared to net gains of $48.3 million in 2017, driven by increased M&A and IPO activity during 2018, and
|
•
|
Net gains of $36.9 million from changes in warrant valuations in 2018, compared to net gains of $10.7 million in 2017, driven by valuation increases in our private company warrant portfolio and reflective of increased M&A activity during 2018.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Equity warrant assets (1):
|
|
|
|
|
|
|
|
|
|
|
||||||||
Gains on exercises, net
|
|
$
|
107,168
|
|
|
$
|
58,186
|
|
|
84.2
|
%
|
|
$
|
48,275
|
|
|
20.5
|
%
|
Terminations
|
|
(3,502
|
)
|
|
(5,964
|
)
|
|
(41.3
|
)
|
|
(4,422
|
)
|
|
34.9
|
|
|||
Changes in fair value, net
|
|
34,412
|
|
|
36,920
|
|
|
(6.8
|
)
|
|
10,702
|
|
|
NM
|
|
|||
Total gains on equity warrant assets, net
|
|
$
|
138,078
|
|
|
$
|
89,142
|
|
|
54.9
|
|
|
$
|
54,555
|
|
|
63.4
|
|
|
(1)
|
At December 31, 2019, we held warrants in 2,268 companies, compared to 2,095 companies at December 31, 2018 and 1,868 companies at December 31, 2017. The total value of our warrant portfolio was $165.5 million at December 31, 2019, $149.2 million at December 31, 2018, and $123.8 million at December 31, 2017. Warrants in 20 companies each had fair values greater than $1.0 million and collectively represented $57.6 million, or 34.8 percent, of the fair value of the total warrant portfolio at December
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Non-GAAP core fee income (1):
|
|
|
|
|
|
|
|
|
|
|
||||||||
Client investment fees
|
|
$
|
182,068
|
|
|
$
|
130,360
|
|
|
39.7
|
%
|
|
$
|
56,136
|
|
|
132.2
|
%
|
Foreign exchange fees
|
|
159,262
|
|
|
138,812
|
|
|
14.7
|
|
|
115,760
|
|
|
19.9
|
|
|||
Credit card fees
|
|
118,719
|
|
|
94,072
|
|
|
26.2
|
|
|
76,543
|
|
|
22.9
|
|
|||
Deposit service charges
|
|
89,200
|
|
|
76,097
|
|
|
17.2
|
|
|
58,715
|
|
|
29.6
|
|
|||
Lending related fees
|
|
49,920
|
|
|
41,949
|
|
|
19.0
|
|
|
43,265
|
|
|
(3.0
|
)
|
|||
Letters of credit and standby letters of credit fees
|
|
42,669
|
|
|
34,600
|
|
|
23.3
|
|
|
28,544
|
|
|
21.2
|
|
|||
Total non-GAAP core fee income (1)
|
|
$
|
641,838
|
|
|
$
|
515,890
|
|
|
24.4
|
|
|
$
|
378,963
|
|
|
36.1
|
|
Investment banking revenue
|
|
195,177
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Commissions
|
|
56,346
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Total non-GAAP core fee income plus investment banking revenue and commissions (2)
|
|
$
|
893,361
|
|
|
$
|
515,890
|
|
|
73.2
|
|
|
$
|
378,963
|
|
|
36.1
|
|
|
(1)
|
This non-GAAP core fee income represents noninterest income, but excludes (i) certain line items where performance is typically subject to market or other conditions beyond our control, (ii) our investment banking revenue and commissions and (iii) other noninterest income. See “Use of Non-GAAP Measures” above.
|
(2)
|
Non-GAAP core fee income plus investment banking revenue and commissions represents noninterest income, but excludes certain line items where performance is typically subject to market or other conditions beyond our control and other noninterest income. See “Use of Non-GAAP Measures” above.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Client investment fees by type:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Sweep money market fees
|
|
$
|
104,236
|
|
|
$
|
75,654
|
|
|
37.8
|
%
|
|
$
|
28,485
|
|
|
165.6
|
%
|
Asset management fees
|
|
28,665
|
|
|
23,882
|
|
|
20.0
|
|
|
16,831
|
|
|
41.9
|
|
|||
Repurchase agreement fees
|
|
49,167
|
|
|
30,824
|
|
|
59.5
|
|
|
10,820
|
|
|
184.9
|
|
|||
Total client investment fees
|
|
$
|
182,068
|
|
|
$
|
130,360
|
|
|
39.7
|
|
|
$
|
56,136
|
|
|
132.2
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in millions)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Sweep money market funds
|
|
$
|
40,667
|
|
|
$
|
32,232
|
|
|
26.2
|
%
|
|
$
|
19,718
|
|
|
63.5
|
%
|
Client investment assets under management (1)
|
|
41,887
|
|
|
34,754
|
|
|
20.5
|
|
|
25,417
|
|
|
36.7
|
|
|||
Repurchase agreements
|
|
9,079
|
|
|
8,086
|
|
|
12.3
|
|
|
6,390
|
|
|
26.5
|
|
|||
Total average client investment funds (2)
|
|
$
|
91,633
|
|
|
$
|
75,072
|
|
|
22.1
|
|
|
$
|
51,525
|
|
|
45.7
|
|
|
(1)
|
These funds represent investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.
|
(2)
|
Client investment funds are maintained at third-party financial institutions and are not recorded on our balance sheet.
|
|
|
December 31,
|
||||||||||||||||
(Dollars in millions)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Sweep money market funds
|
|
$
|
43,226
|
|
|
$
|
38,348
|
|
|
12.7
|
%
|
|
$
|
23,911
|
|
|
60.4
|
%
|
Client investment assets under management (1)
|
|
46,904
|
|
|
39,214
|
|
|
19.6
|
|
|
29,344
|
|
|
33.6
|
|
|||
Repurchase agreements
|
|
9,062
|
|
|
8,422
|
|
|
7.6
|
|
|
7,074
|
|
|
19.1
|
|
|||
Total period-end client investment funds (2)
|
|
$
|
99,192
|
|
|
$
|
85,984
|
|
|
15.4
|
|
|
$
|
60,329
|
|
|
42.5
|
|
|
(1)
|
These funds represent investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.
|
(2)
|
Client investment funds are maintained at third-party financial institutions and are not recorded on our balance sheet.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Foreign exchange fees by instrument type:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Spot contract commissions
|
|
$
|
145,915
|
|
|
$
|
127,459
|
|
|
14.5
|
%
|
|
$
|
104,344
|
|
|
22.2
|
%
|
Forward contract commissions
|
|
13,068
|
|
|
10,940
|
|
|
19.5
|
|
|
10,934
|
|
|
0.1
|
|
|||
Option premium fees
|
|
279
|
|
|
413
|
|
|
(32.4
|
)
|
|
482
|
|
|
(14.3
|
)
|
|||
Total foreign exchange fees
|
|
$
|
159,262
|
|
|
$
|
138,812
|
|
|
14.7
|
|
|
$
|
115,760
|
|
|
19.9
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Credit card fees by instrument type:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Card interchange fees, net
|
|
$
|
93,553
|
|
|
$
|
74,381
|
|
|
25.8
|
%
|
|
$
|
60,224
|
|
|
23.5
|
%
|
Merchant service fees
|
|
18,355
|
|
|
14,420
|
|
|
27.3
|
|
|
11,584
|
|
|
24.5
|
|
|||
Card service fees
|
|
6,811
|
|
|
5,271
|
|
|
29.2
|
|
|
4,735
|
|
|
11.3
|
|
|||
Total credit card fees
|
|
$
|
118,719
|
|
|
$
|
94,072
|
|
|
26.2
|
|
|
$
|
76,543
|
|
|
22.9
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Lending related fees by instrument type:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Unused commitment fees
|
|
$
|
34,829
|
|
|
$
|
32,452
|
|
|
7.3
|
%
|
|
$
|
34,110
|
|
|
(4.9
|
)%
|
Other
|
|
15,091
|
|
|
9,497
|
|
|
58.9
|
|
|
9,155
|
|
|
3.7
|
|
|||
Total lending related fees
|
|
$
|
49,920
|
|
|
$
|
41,949
|
|
|
19.0
|
|
|
$
|
43,265
|
|
|
(3.0
|
)
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Investment banking revenue:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Underwriting fees
|
|
$
|
153,306
|
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
%
|
Advisory fees
|
|
37,846
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Private placements and other
|
|
4,025
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Total investment banking revenue
|
|
$
|
195,177
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Other noninterest income by instrument type:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Fund management fees
|
|
$
|
32,522
|
|
|
$
|
23,016
|
|
|
41.3
|
%
|
|
$
|
21,214
|
|
|
8.5
|
%
|
Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)
|
|
345
|
|
|
666
|
|
|
(48.2
|
)
|
|
1,788
|
|
|
(62.8
|
)
|
|||
(Losses) gains on extinguishment of debt
|
|
(8,960
|
)
|
|
—
|
|
|
—
|
|
|
2,731
|
|
|
(100.0
|
)
|
|||
Other service revenue (2)
|
|
31,463
|
|
|
28,176
|
|
|
11.7
|
|
|
33,377
|
|
|
(15.6
|
)
|
|||
Total other noninterest income
|
|
$
|
55,370
|
|
|
$
|
51,858
|
|
|
6.8
|
|
|
$
|
59,110
|
|
|
(12.3
|
)
|
|
(1)
|
Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.
|
(2)
|
Includes dividends on FHLB/FRB stock, correspondent bank rebate income, incentive fees related to carried interest, valuation fee income and other fee income.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Compensation and benefits
|
|
$
|
989,734
|
|
|
$
|
726,980
|
|
|
36.1
|
%
|
|
$
|
606,402
|
|
|
19.9
|
%
|
Professional services
|
|
205,479
|
|
|
158,835
|
|
|
29.4
|
|
|
121,935
|
|
|
30.3
|
|
|||
Premises and equipment
|
|
96,770
|
|
|
77,918
|
|
|
24.2
|
|
|
71,753
|
|
|
8.6
|
|
|||
Net occupancy
|
|
69,279
|
|
|
54,753
|
|
|
26.5
|
|
|
48,397
|
|
|
13.1
|
|
|||
Business development and travel
|
|
68,912
|
|
|
48,180
|
|
|
43.0
|
|
|
41,978
|
|
|
14.8
|
|
|||
FDIC and state assessments
|
|
18,509
|
|
|
34,276
|
|
|
(46.0
|
)
|
|
35,069
|
|
|
(2.3
|
)
|
|||
Other
|
|
152,579
|
|
|
87,251
|
|
|
74.9
|
|
|
85,121
|
|
|
2.5
|
|
|||
Total noninterest expense
|
|
$
|
1,601,262
|
|
|
$
|
1,188,193
|
|
|
34.8
|
|
|
$
|
1,010,655
|
|
|
17.6
|
|
|
|
Year ended December 31,
|
||||||||||||||||
Non-GAAP core operating efficiency ratio (Dollars in thousands, except ratios)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
GAAP noninterest expense
|
|
$
|
1,601,262
|
|
|
$
|
1,188,193
|
|
|
34.8
|
%
|
|
$
|
1,010,655
|
|
|
17.6
|
%
|
Less: expense attributable to noncontrolling interests
|
|
835
|
|
|
522
|
|
|
60.0
|
|
|
813
|
|
|
(35.8
|
)
|
|||
Non-GAAP noninterest expense, net of noncontrolling interests
|
|
1,600,427
|
|
|
1,187,671
|
|
|
34.8
|
|
|
1,009,842
|
|
|
17.6
|
|
|||
Less: expense attributable to SVB Leerink
|
|
252,677
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Non-GAAP noninterest expense, net of noncontrolling interests and SVB Leerink
|
|
$
|
1,347,750
|
|
|
$
|
1,187,671
|
|
|
13.5
|
|
|
$
|
1,009,842
|
|
|
17.6
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
GAAP net interest income
|
|
$
|
2,096,601
|
|
|
$
|
1,893,988
|
|
|
10.7
|
|
|
$
|
1,420,369
|
|
|
33.3
|
|
Adjustments for taxable equivalent basis
|
|
11,949
|
|
|
9,201
|
|
|
29.9
|
|
|
3,076
|
|
|
199.1
|
|
|||
Non-GAAP taxable equivalent net interest income
|
|
2,108,550
|
|
|
1,903,189
|
|
|
10.8
|
|
|
1,423,445
|
|
|
33.7
|
|
|||
Less: income attributable to noncontrolling interests
|
|
72
|
|
|
30
|
|
|
140.0
|
|
|
33
|
|
|
(9.1
|
)
|
|||
Non-GAAP taxable equivalent net interest income, net of noncontrolling interests
|
|
2,108,478
|
|
|
1,903,159
|
|
|
10.8
|
|
|
1,423,412
|
|
|
33.7
|
|
|||
Less: net interest income attributable to SVB Leerink
|
|
1,252
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Non-GAAP taxable equivalent net interest income, net of noncontrolling interests and SVB Leerink
|
|
$
|
2,107,226
|
|
|
$
|
1,903,159
|
|
|
10.7
|
|
|
$
|
1,423,412
|
|
|
33.7
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
GAAP noninterest income
|
|
$
|
1,221,479
|
|
|
$
|
744,984
|
|
|
64.0
|
|
|
$
|
557,231
|
|
|
33.7
|
|
Less: income attributable to noncontrolling interests, including carried interest allocation
|
|
48,624
|
|
|
38,000
|
|
|
28.0
|
|
|
29,452
|
|
|
29.0
|
|
|||
Non-GAAP noninterest income, net of noncontrolling interests
|
|
1,172,855
|
|
|
706,984
|
|
|
65.9
|
|
|
527,779
|
|
|
34.0
|
|
|||
Less: non-GAAP net gains on investment securities, net of noncontrolling interests
|
|
86,169
|
|
|
49,911
|
|
|
72.6
|
|
|
35,416
|
|
|
40.9
|
|
|||
Less: net gains on equity warrant assets
|
|
138,078
|
|
|
89,142
|
|
|
54.9
|
|
|
54,555
|
|
|
63.4
|
|
|||
Less: investment banking revenue
|
|
195,177
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Less: commissions
|
|
56,346
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Non-GAAP noninterest income, net of noncontrolling interests and net of net gains on investment securities, net gains on equity warrant assets, investment banking revenue and commissions
|
|
$
|
697,085
|
|
|
$
|
567,931
|
|
|
22.7
|
|
|
$
|
437,808
|
|
|
29.7
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
GAAP total revenue
|
|
$
|
3,318,080
|
|
|
$
|
2,638,972
|
|
|
25.7
|
|
|
$
|
1,977,600
|
|
|
33.4
|
|
Non-GAAP taxable equivalent revenue, net of noncontrolling interests and SVB Leerink, net gains on investment securities, net gains on equity warrant assets, investment banking revenue and commissions
|
|
$
|
2,804,311
|
|
|
$
|
2,471,090
|
|
|
13.5
|
|
|
$
|
1,861,220
|
|
|
32.8
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
GAAP operating efficiency ratio
|
|
48.26
|
%
|
|
45.02
|
%
|
|
7.2
|
|
|
51.11
|
%
|
|
(11.9
|
)
|
|||
Non-GAAP core operating efficiency ratio (1)
|
|
48.06
|
|
|
48.06
|
|
|
—
|
|
|
54.26
|
|
|
(11.4
|
)
|
|
(1)
|
The non-GAAP core operating efficiency ratio is calculated by dividing noninterest expense after adjusting for noninterest expense attributable to SVB Leerink by total revenue after adjusting for net interest income attributable to SVB Leerink, net gains or losses on investment securities and equity warrant assets, investment banking revenue and commissions. Additionally, noninterest expense and total revenue are adjusted for income or losses and expenses attributable to noncontrolling interests and adjustments to net interest income for a taxable equivalent basis.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands, except employees)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Compensation and benefits:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Salaries and wages
|
|
$
|
436,500
|
|
|
$
|
324,971
|
|
|
34.3
|
%
|
|
$
|
277,148
|
|
|
17.3
|
%
|
Incentive compensation & ESOP
|
|
292,270
|
|
|
207,306
|
|
|
41.0
|
|
|
149,346
|
|
|
38.8
|
|
|||
Other employee incentives and benefits (1)
|
|
260,964
|
|
|
194,703
|
|
|
34.0
|
|
|
179,908
|
|
|
8.2
|
|
|||
Total compensation and benefits
|
|
$
|
989,734
|
|
|
$
|
726,980
|
|
|
36.1
|
|
|
$
|
606,402
|
|
|
19.9
|
|
Period-end full-time equivalent employees
|
|
3,564
|
|
|
2,900
|
|
|
22.9
|
|
|
2,438
|
|
|
18.9
|
|
|||
Average full-time equivalent employees
|
|
3,362
|
|
|
2,685
|
|
|
25.2
|
|
|
2,396
|
|
|
12.1
|
|
|
(1)
|
Other employee incentives and benefits includes employer payroll taxes, group health and life insurance, share-based compensation, 401(k), warrant incentive and retention plans, agency fees and other employee-related expenses.
|
•
|
An increase of $111.5 million in salaries and wages expense, reflective primarily of an increase in the number of average FTEs by 677 to 3,362 in 2019, compared to 2,685 in 2018, and annual pay raises. The increase in FTEs was primarily to support our overall growth as well as the acquisition of SVB Leerink which added 230 average FTEs in 2019,
|
•
|
An increase of $85.0 million in incentive compensation expense due primarily to the inclusion of SVB Leerink in our financial results for 2019, partially offset by lower incentive accruals compared to strong 2018 performance levels, and
|
•
|
An increase of $66.3 million in other employee compensation and benefits, related to various expenses, particularly the inclusion of SVB Leerink in our financial results for 2019, share-based compensation reflective of an increase in restricted stock compensation due to increased headcount in 2019, an increase in warrant incentive plan expense due to the increased cash liquidations on equity warrant assets in 2019 as compared to 2018 as well as an increase in employer payroll taxes and group health and life insurance reflective of our increased headcount in 2019.
|
•
|
An increase of $56.3 million in incentive compensation expense due primarily to our strong 2018 full-year performance and reflective of our improved ROE relative to our peers, which is one of our key plan performance metrics,
|
•
|
An increase of $47.8 million in salaries and wages expense, reflective primarily of an increase in the number of average FTEs by 289 to 2,685 in 2018, compared to 2,396 in 2017, and annual pay raises. The increase in FTE was primarily to support our overall growth, and
|
•
|
An increase of $14.8 million in other employee compensation and benefits, related to various expenses, particularly share-based compensation reflective of the increase in our stock price as well as employer payroll taxes and group health and life insurance reflective of our increased headcount in 2018. These increases were partially offset by a decrease in our warrant incentive plan expense in 2018 compared to 2017 primarily reflective of our exercise of Roku equity warrants in the fourth quarter of 2017 which resulted in a large accrual of warrant incentive compensation expense in 2017 and subsequent decline of Roku's common stock price, which was sold in 2018, resulting in a lower warrant incentive payout than previously accrued for.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Lending and other client related processing costs
|
|
$
|
28,491
|
|
|
$
|
24,237
|
|
|
17.6
|
%
|
|
$
|
23,768
|
|
|
2.0
|
%
|
Correspondent bank fees
|
|
14,503
|
|
|
13,713
|
|
|
5.8
|
|
|
12,976
|
|
|
5.7
|
|
|||
Investment banking activities
|
|
13,733
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Trade order execution costs
|
|
10,813
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Data processing services
|
|
12,536
|
|
|
10,811
|
|
|
16.0
|
|
|
10,251
|
|
|
5.5
|
|
|||
Telephone
|
|
9,861
|
|
|
9,404
|
|
|
4.9
|
|
|
10,647
|
|
|
(11.7
|
)
|
|||
Dues and publications
|
|
4,603
|
|
|
4,605
|
|
|
—
|
|
|
3,263
|
|
|
41.1
|
|
|||
Postage and supplies
|
|
3,198
|
|
|
2,799
|
|
|
14.3
|
|
|
2,797
|
|
|
0.1
|
|
|||
Other
|
|
54,841
|
|
|
21,682
|
|
|
152.9
|
|
|
21,419
|
|
|
1.2
|
|
|||
Total other noninterest expense
|
|
$
|
152,579
|
|
|
$
|
87,251
|
|
|
74.9
|
|
|
$
|
85,121
|
|
|
2.5
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Net interest income (1)
|
|
$
|
(72
|
)
|
|
$
|
(30
|
)
|
|
140.0
|
%
|
|
$
|
(33
|
)
|
|
(9.1
|
)%
|
Noninterest income (1)
|
|
(20,290
|
)
|
|
(22,342
|
)
|
|
(9.2
|
)
|
|
(25,789
|
)
|
|
(13.4
|
)
|
|||
Noninterest expense (1)
|
|
835
|
|
|
522
|
|
|
60.0
|
|
|
813
|
|
|
(35.8
|
)
|
|||
Carried interest allocation (2)
|
|
(28,334
|
)
|
|
(15,658
|
)
|
|
81.0
|
|
|
(3,663
|
)
|
|
NM
|
|
|||
Net income attributable to noncontrolling interests
|
|
$
|
(47,861
|
)
|
|
$
|
(37,508
|
)
|
|
27.6
|
|
|
$
|
(28,672
|
)
|
|
30.8
|
|
|
(1)
|
Represents noncontrolling interests’ share in net interest income, noninterest income and noninterest expense.
|
(2)
|
Represents the preferred allocation of income (or change in income) earned by us as the general partner of certain consolidated funds.
|
•
|
Net gains on investment securities (including carried interest allocation) attributable to noncontrolling interests of $48.5 million ($20.2 million excluding carried interest allocation) primarily from our managed funds of funds and our managed direct venture funds portfolios, related primarily to net unrealized valuation increases in both private and public company investments held by the funds in the portfolios, and
|
•
|
Noninterest expense of $0.8 million, primarily related to management fees paid by the noncontrolling interests to our subsidiaries that serve as the general partner.
|
•
|
Net gains on investment securities (including carried interest allocation) attributable to noncontrolling interests of $38.2 million ($22.5 million excluding carried interest allocation) primarily from our managed funds of funds portfolio, related primarily to net unrealized valuation increases in both private and public company investments held by the funds in the portfolio, and
|
•
|
Noninterest expense of $0.5 million, primarily related to management fees paid by the noncontrolling interests to our subsidiaries that serve as the general partner.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Net interest income
|
|
$
|
1,850,391
|
|
|
$
|
1,623,488
|
|
|
14.0
|
%
|
|
$
|
1,274,366
|
|
|
27.4
|
%
|
Provision for loan losses
|
|
(91,814
|
)
|
|
(80,953
|
)
|
|
13.4
|
|
|
(81,553
|
)
|
|
(0.7
|
)
|
|||
Noninterest income
|
|
637,922
|
|
|
520,302
|
|
|
22.6
|
|
|
392,101
|
|
|
32.7
|
|
|||
Noninterest expense
|
|
(874,854
|
)
|
|
(793,159
|
)
|
|
10.3
|
|
|
(707,666
|
)
|
|
12.1
|
|
|||
Income before income tax expense
|
|
$
|
1,521,645
|
|
|
$
|
1,269,678
|
|
|
19.8
|
|
|
$
|
877,248
|
|
|
44.7
|
|
Total average loans, net of unearned income
|
|
$
|
26,031,284
|
|
|
$
|
22,354,305
|
|
|
16.4
|
|
|
$
|
18,479,793
|
|
|
21.0
|
|
Total average assets
|
|
56,043,321
|
|
|
48,854,416
|
|
|
14.7
|
|
|
43,704,667
|
|
|
11.8
|
|
|||
Total average deposits
|
|
53,053,665
|
|
|
46,039,570
|
|
|
15.2
|
|
|
41,043,731
|
|
|
12.2
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Net interest income
|
|
$
|
51,022
|
|
|
$
|
64,902
|
|
|
(21.4
|
)%
|
|
$
|
58,131
|
|
|
11.6
|
%
|
Provision for loan losses
|
|
(2,369
|
)
|
|
(3,339
|
)
|
|
(29.1
|
)
|
|
(4,386
|
)
|
|
(23.9
|
)
|
|||
Noninterest income
|
|
3,366
|
|
|
2,281
|
|
|
47.6
|
|
|
2,175
|
|
|
4.9
|
|
|||
Noninterest expense
|
|
(40,151
|
)
|
|
(25,064
|
)
|
|
60.2
|
|
|
(17,693
|
)
|
|
41.7
|
|
|||
Income before income tax expense
|
|
$
|
11,868
|
|
|
$
|
38,780
|
|
|
(69.4
|
)
|
|
$
|
38,227
|
|
|
1.4
|
|
Total average loans, net of unearned income
|
|
$
|
3,341,188
|
|
|
$
|
2,850,271
|
|
|
17.2
|
|
|
$
|
2,423,078
|
|
|
17.6
|
|
Total average assets
|
|
3,371,052
|
|
|
2,871,743
|
|
|
17.4
|
|
|
2,445,220
|
|
|
17.4
|
|
|||
Total average deposits
|
|
1,524,232
|
|
|
1,502,308
|
|
|
1.5
|
|
|
1,303,542
|
|
|
15.2
|
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Net interest income
|
|
$
|
38
|
|
|
$
|
23
|
|
|
65.2
|
%
|
|
$
|
48
|
|
|
(52.1
|
)%
|
Noninterest income
|
|
122,394
|
|
|
101,181
|
|
|
21.0
|
|
|
58,992
|
|
|
71.5
|
|
|||
Noninterest expense
|
|
(30,798
|
)
|
|
(22,792
|
)
|
|
35.1
|
|
|
(19,340
|
)
|
|
17.8
|
|
|||
Income before income tax expense
|
|
$
|
91,634
|
|
|
$
|
78,412
|
|
|
16.9
|
|
|
$
|
39,700
|
|
|
97.5
|
|
Total average assets
|
|
$
|
405,152
|
|
|
$
|
380,543
|
|
|
6.5
|
|
|
$
|
325,939
|
|
|
16.8
|
|
•
|
Net gains on investment securities of $82.2 million in 2019, compared to net gains of $69.8 million in 2018. The net gains on investment securities of $82.2 million in 2019 were related to net unrealized valuation increases in both private and public company investments held in our strategic venture capital funds as well as in our managed funds of funds portfolio driven by IPO and M&A activity in 2019, and
|
•
|
Fund management fees of $26.9 million for 2019, compared to $23.0 million in 2018.
|
•
|
Net gains on investment securities of $69.8 million in 2018, compared to net gains of $35.8 million in 2017. The net gains on investment securities of $69.8 million in 2018 were related to net unrealized valuation increases in both private and public company investments held in our strategic venture capital funds as well as in our managed funds of funds portfolio driven by IPO and M&A activity in 2018, and
|
•
|
Fund management fees of $23.0 million for 2018, compared to $21.2 million in 2017.
|
|
|
Year ended December 31,
|
||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change 2019/2018
|
|
2017
|
|
% Change 2018/2017
|
||||||||
Net interest income
|
|
$
|
1,252
|
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
%
|
Noninterest income
|
|
264,516
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Noninterest expense
|
|
(252,678
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Income before income tax expense
|
|
$
|
13,090
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
Total average assets
|
|
$
|
397,650
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
|
December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Available-for-sale securities, at fair value:
|
|
|
|
|
|
|
||||||
U.S. Treasury securities
|
|
$
|
6,894,010
|
|
|
$
|
4,738,258
|
|
|
$
|
6,840,502
|
|
U.S. agency debentures
|
|
99,547
|
|
|
1,084,117
|
|
|
1,567,128
|
|
|||
Foreign government debt securities
|
|
9,038
|
|
|
5,812
|
|
|
—
|
|
|||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
||||||
Agency-issued mortgage-backed securities
|
|
4,148,791
|
|
|
—
|
|
|
—
|
|
|||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,538,343
|
|
|
1,880,218
|
|
|
2,267,035
|
|
|||
Agency-issued collateralized mortgage obligations—variable rate
|
|
—
|
|
|
81,638
|
|
|
373,730
|
|
|||
Agency-issued commercial mortgage-backed securities
|
|
1,325,190
|
|
|
—
|
|
|
—
|
|
|||
Equity securities
|
|
—
|
|
|
—
|
|
|
72,269
|
|
|||
Total available-for-sale securities
|
|
14,014,919
|
|
|
7,790,043
|
|
|
11,120,664
|
|
|||
Held-to-maturity securities, at amortized cost:
|
|
|
|
|
|
|
||||||
U.S. agency debentures
|
|
518,728
|
|
|
640,990
|
|
|
659,979
|
|
|||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
||||||
Agency-issued mortgage-backed securities
|
|
6,992,009
|
|
|
8,103,638
|
|
|
6,304,969
|
|
|||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,608,032
|
|
|
2,183,204
|
|
|
2,829,979
|
|
|||
Agency-issued collateralized mortgage obligations—variable rate
|
|
178,611
|
|
|
214,483
|
|
|
255,782
|
|
|||
Agency-issued commercial mortgage-backed securities
|
|
2,759,615
|
|
|
2,769,706
|
|
|
1,868,985
|
|
|||
Municipal bonds and notes
|
|
1,785,951
|
|
|
1,575,421
|
|
|
743,761
|
|
|||
Total held-to-maturity securities
|
|
13,842,946
|
|
|
15,487,442
|
|
|
12,663,455
|
|
|||
Non-marketable and other equity securities:
|
|
|
|
|
|
|
||||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
||||||
Consolidated venture capital and private equity fund investments
|
|
87,180
|
|
|
118,333
|
|
|
128,111
|
|
|||
Unconsolidated venture capital and private equity fund investments
|
|
178,217
|
|
|
201,098
|
|
|
98,548
|
|
|||
Other investments without a readily determinable fair value
|
|
55,255
|
|
|
25,668
|
|
|
27,680
|
|
|||
Other equity securities in public companies (fair value accounting)
|
|
59,200
|
|
|
20,398
|
|
|
310
|
|
|||
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
||||||
Venture capital and private equity fund investments
|
|
215,367
|
|
|
129,485
|
|
|
89,809
|
|
|||
Debt funds
|
|
7,271
|
|
|
5,826
|
|
|
21,183
|
|
|||
Other investments
|
|
152,863
|
|
|
121,721
|
|
|
111,198
|
|
|||
Investments in qualified affordable housing projects, net
|
|
458,476
|
|
|
318,575
|
|
|
174,214
|
|
|||
Total non-marketable and other equity securities
|
|
1,213,829
|
|
|
941,104
|
|
|
651,053
|
|
|||
Total investment securities
|
|
$
|
29,071,694
|
|
|
$
|
24,218,589
|
|
|
$
|
24,435,172
|
|
|
|
December 31, 2019
|
|||||||||||||||||||||||||||||||||
|
|
Total
|
|
One Year
or Less
|
|
After One Year to
Five Years
|
|
After Five Years to
Ten Years
|
|
After
Ten Years
|
|||||||||||||||||||||||||
(Dollars in thousands)
|
|
Carrying
Value
|
|
Weighted
Average
Yield
|
|
Carrying
Value
|
|
Weighted
Average Yield |
|
Carrying
Value
|
|
Weighted
Average Yield |
|
Carrying
Value
|
|
Weighted
Average Yield |
|
Carrying
Value
|
|
Weighted
Average Yield |
|||||||||||||||
U.S. Treasury securities
|
|
$
|
6,894,010
|
|
|
1.99
|
%
|
|
$
|
1,835,971
|
|
|
1.78
|
%
|
|
$
|
1,890,778
|
|
|
2.27
|
%
|
|
$
|
3,167,261
|
|
|
1.96
|
%
|
|
$
|
—
|
|
|
—
|
%
|
U.S. agency debentures
|
|
99,547
|
|
|
2.28
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
99,547
|
|
|
2.28
|
|
|
—
|
|
|
—
|
|
|||||
Foreign government debt securities
|
|
9,038
|
|
|
(0.64
|
)
|
|
9,038
|
|
|
(0.64
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agency-issued mortgage backed securities
|
|
4,148,791
|
|
|
2.82
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,148,791
|
|
|
2.82
|
|
|||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
1,538,343
|
|
|
2.58
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,858
|
|
|
3.22
|
|
|
1,536,485
|
|
|
2.58
|
|
|||||
Agency-issued commercial mortgage-backed securities
|
|
1,325,190
|
|
|
2.35
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
743,874
|
|
|
2.25
|
|
|
581,316
|
|
|
2.48
|
|
|||||
Total
|
|
$
|
14,014,919
|
|
|
2.34
|
|
|
$
|
1,845,009
|
|
|
1.77
|
|
|
$
|
1,890,778
|
|
|
2.27
|
|
|
$
|
4,012,540
|
|
|
2.02
|
|
|
$
|
6,266,592
|
|
|
2.73
|
|
|
|
December 31, 2019
|
|||||||||||||||||||||||||||||||||
|
|
Total
|
|
One Year
or Less
|
|
After One Year to
Five Years
|
|
After Five Years to
Ten Years
|
|
After
Ten Years
|
|||||||||||||||||||||||||
(Dollars in thousands)
|
|
Amortized Cost
|
|
Weighted
Average Yield |
|
Amortized Cost
|
|
Weighted
Average Yield |
|
Amortized Cost
|
|
Weighted
Average Yield |
|
Amortized Cost
|
|
Weighted
Average Yield |
|
Amortized Cost
|
|
Weighted
Average Yield |
|||||||||||||||
U.S. agency debentures
|
|
$
|
518,728
|
|
|
2.65
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
123,100
|
|
|
2.61
|
%
|
|
$
|
395,628
|
|
|
2.66
|
%
|
|
$
|
—
|
|
|
—
|
%
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agency-issued mortgage-backed securities
|
|
6,992,009
|
|
|
2.90
|
|
|
2,066
|
|
|
2.73
|
|
|
76,759
|
|
|
2.05
|
|
|
726,422
|
|
|
2.47
|
|
|
6,186,762
|
|
|
2.96
|
|
|||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
1,608,032
|
|
|
1.78
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
624,128
|
|
|
1.64
|
|
|
983,904
|
|
|
1.87
|
|
|||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
178,611
|
|
|
0.74
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
178,611
|
|
|
0.74
|
|
|||||
Agency-issued commercial mortgage-backed securities
|
|
2,759,615
|
|
|
3.03
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
102,633
|
|
|
3.56
|
|
|
2,656,982
|
|
|
3.01
|
|
|||||
Municipal bonds and notes
|
|
1,785,951
|
|
|
3.57
|
|
|
13,973
|
|
|
1.91
|
|
|
83,368
|
|
|
2.18
|
|
|
387,278
|
|
|
2.89
|
|
|
1,301,332
|
|
|
3.88
|
|
|||||
Total
|
|
$
|
13,842,946
|
|
|
2.84
|
|
|
$
|
16,039
|
|
|
2.02
|
|
|
$
|
283,227
|
|
|
2.33
|
|
|
$
|
2,236,089
|
|
|
2.40
|
|
|
$
|
11,307,591
|
|
|
2.95
|
|
|
|
December 31,
|
||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||||||||
(Dollars in thousands)
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
||||||||||||
Non-marketable and other equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Consolidated venture capital and private equity fund investments (1)
|
|
$
|
87,180
|
|
|
$
|
22,482
|
|
|
$
|
118,333
|
|
|
$
|
30,235
|
|
|
$
|
128,111
|
|
|
$
|
33,044
|
|
Unconsolidated venture capital and private equity fund investments (2)
|
|
178,217
|
|
|
178,217
|
|
|
201,098
|
|
|
201,098
|
|
|
98,548
|
|
|
98,548
|
|
||||||
Other investments without a readily determinable fair value (3)
|
|
55,255
|
|
|
55,255
|
|
|
25,668
|
|
|
25,668
|
|
|
27,680
|
|
|
27,680
|
|
||||||
Other equity securities in public companies (fair value accounting) (4)
|
|
59,200
|
|
|
59,056
|
|
|
20,398
|
|
|
20,098
|
|
|
310
|
|
|
103
|
|
||||||
Non-marketable securities (equity method accounting) (5):
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Venture capital and private equity fund investments
|
|
215,367
|
|
|
131,403
|
|
|
129,485
|
|
|
82,921
|
|
|
89,809
|
|
|
64,675
|
|
||||||
Debt funds
|
|
7,271
|
|
|
7,271
|
|
|
5,826
|
|
|
5,826
|
|
|
21,183
|
|
|
21,183
|
|
||||||
Other investments
|
|
152,863
|
|
|
152,863
|
|
|
121,721
|
|
|
121,721
|
|
|
111,198
|
|
|
111,198
|
|
||||||
Investments in qualified affordable housing projects, net
|
|
458,476
|
|
|
458,476
|
|
|
318,575
|
|
|
318,575
|
|
|
174,214
|
|
|
174,214
|
|
||||||
Total non-marketable and other equity securities
|
|
$
|
1,213,829
|
|
|
$
|
1,065,023
|
|
|
$
|
941,104
|
|
|
$
|
806,142
|
|
|
$
|
651,053
|
|
|
$
|
530,645
|
|
|
(1)
|
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and amounts attributable to SVBFG for each fund at December 31, 2019, 2018 and 2017:
|
|
|
December 31,
|
||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||||||||
(Dollars in thousands)
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG |
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG |
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG |
||||||||||||
Strategic Investors Fund, LP
|
|
$
|
5,729
|
|
|
$
|
720
|
|
|
$
|
12,452
|
|
|
$
|
1,564
|
|
|
$
|
14,673
|
|
|
$
|
1,843
|
|
Capital Preferred Return Fund, LP
|
|
45,341
|
|
|
9,772
|
|
|
53,957
|
|
|
11,629
|
|
|
54,147
|
|
|
11,670
|
|
||||||
Growth Partners, LP
|
|
35,976
|
|
|
11,976
|
|
|
50,845
|
|
|
16,927
|
|
|
58,372
|
|
|
19,432
|
|
||||||
CP I, LP
|
|
134
|
|
|
14
|
|
|
1,079
|
|
|
115
|
|
|
919
|
|
|
99
|
|
||||||
Total consolidated venture capital and private equity fund investments
|
|
$
|
87,180
|
|
|
$
|
22,482
|
|
|
$
|
118,333
|
|
|
$
|
30,235
|
|
|
$
|
128,111
|
|
|
$
|
33,044
|
|
(2)
|
The carrying values represented investments in 205 and 213 funds (primarily venture capital funds) at December 31, 2019 and December 31, 2018, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. Effective January 1, 2018, we adopted ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities which eliminated the concept of cost method accounting. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment and significant fund transactions or market events during the reporting period. We recorded a cumulative adjustment to opening retained earnings on January 1, 2018 for the difference between fair value and cost for these fund investments. The estimated fair values and carrying values of these venture capital and private equity fund investments were $178.2 million and $201.1 million as of December 31, 2019 and 2018, respectively. As of December 31, 2017, these investments were carried at cost and had a carrying value of $98.5 million.
|
(3)
|
Effective January 1, 2018, we adopted ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities, which eliminated the concept of cost method accounting. On a prospective basis, we report our other investments in the line item "Other investments without a readily determinable fair value." These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted. For further details on the carrying value of these investments refer to Note 9—“Investment Securities" of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report.
|
(4)
|
Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Effective January 1, 2018 we adopted ASU 2016-01 Recognition and Measurement of Financial Assets and Financial Liabilities, which requires equity securities to be measured at fair value with changes in the fair value recognized through net income. Prior to January 1, 2018, we reported equity securities in public companies that we held as a result of exercising public equity warrant assets in available-for-sale securities. These equity securities are reported in non-marketable and other equity securities.
|
(5)
|
The following table shows the carrying value and our ownership percentage of each investment at December 31, 2019, 2018 and 2017 (equity method accounting):
|
|
|
December 31, 2019
|
|
December 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||
(Dollars in thousands)
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
||||||||||||
Venture capital and private equity fund investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Strategic Investors Fund II, LP
|
|
$
|
3,612
|
|
|
$
|
3,387
|
|
|
$
|
4,670
|
|
|
$
|
4,366
|
|
|
$
|
6,342
|
|
|
$
|
5,971
|
|
Strategic Investors Fund III, LP
|
|
15,668
|
|
|
12,701
|
|
|
17,396
|
|
|
14,059
|
|
|
18,758
|
|
|
15,211
|
|
||||||
Strategic Investors Fund IV, LP
|
|
27,064
|
|
|
22,780
|
|
|
28,974
|
|
|
24,388
|
|
|
25,551
|
|
|
21,739
|
|
||||||
Strategic Investors Fund V funds
|
|
46,830
|
|
|
24,586
|
|
|
28,189
|
|
|
14,799
|
|
|
16,856
|
|
|
8,849
|
|
||||||
CP II, LP (i)
|
|
5,907
|
|
|
3,567
|
|
|
7,122
|
|
|
4,308
|
|
|
6,700
|
|
|
4,056
|
|
||||||
Other venture capital and private equity fund investments
|
|
116,286
|
|
|
64,382
|
|
|
43,134
|
|
|
21,001
|
|
|
15,602
|
|
|
8,849
|
|
||||||
Total venture capital and private equity fund investments
|
|
$
|
215,367
|
|
|
$
|
131,403
|
|
|
$
|
129,485
|
|
|
$
|
82,921
|
|
|
$
|
89,809
|
|
|
$
|
64,675
|
|
Debt funds:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Gold Hill Capital 2008, LP (ii)
|
|
$
|
5,525
|
|
|
$
|
5,525
|
|
|
$
|
3,901
|
|
|
$
|
3,901
|
|
|
$
|
18,690
|
|
|
$
|
18,690
|
|
Other debt funds
|
|
1,746
|
|
|
1,746
|
|
|
1,925
|
|
|
1,925
|
|
|
2,493
|
|
|
2,493
|
|
||||||
Total debt funds
|
|
$
|
7,271
|
|
|
$
|
7,271
|
|
|
$
|
5,826
|
|
|
$
|
5,826
|
|
|
$
|
21,183
|
|
|
$
|
21,183
|
|
Other investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
SPD Silicon Valley Bank Co., Ltd.
|
|
$
|
74,190
|
|
|
$
|
74,190
|
|
|
$
|
76,412
|
|
|
$
|
76,412
|
|
|
$
|
75,337
|
|
|
$
|
75,337
|
|
Other investments
|
|
78,673
|
|
|
78,673
|
|
|
45,309
|
|
|
45,309
|
|
|
35,861
|
|
|
35,861
|
|
||||||
Total other investments
|
|
$
|
152,863
|
|
|
$
|
152,863
|
|
|
$
|
121,721
|
|
|
$
|
121,721
|
|
|
$
|
111,198
|
|
|
$
|
111,198
|
|
|
(i)
|
Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.
|
(ii)
|
Our ownership includes direct ownership interest of 11.5 percent in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.
|
|
|
December 31,
|
||||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet (1)
|
|
$
|
6,199,548
|
|
|
$
|
6,154,755
|
|
|
$
|
6,172,531
|
|
|
$
|
5,627,031
|
|
|
$
|
5,437,915
|
|
Hardware (1)
|
|
1,371,159
|
|
|
1,234,557
|
|
|
1,193,599
|
|
|
1,180,398
|
|
|
1,071,528
|
|
|||||
Private equity/venture capital
|
|
17,801,324
|
|
|
14,110,560
|
|
|
9,952,377
|
|
|
7,691,148
|
|
|
5,467,577
|
|
|||||
Life science/healthcare (1)
|
|
2,368,048
|
|
|
2,385,612
|
|
|
1,808,827
|
|
|
1,853,004
|
|
|
1,710,642
|
|
|||||
Premium wine
|
|
267,487
|
|
|
249,266
|
|
|
204,105
|
|
|
200,156
|
|
|
201,175
|
|
|||||
Other (1)
|
|
420,555
|
|
|
321,978
|
|
|
365,724
|
|
|
393,551
|
|
|
312,278
|
|
|||||
Total commercial loans
|
|
28,428,121
|
|
|
24,456,728
|
|
|
19,697,163
|
|
|
16,945,288
|
|
|
14,201,115
|
|
|||||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Premium wine (2)
|
|
820,730
|
|
|
710,397
|
|
|
669,053
|
|
|
678,166
|
|
|
646,120
|
|
|||||
Consumer loans (3)
|
|
3,286,737
|
|
|
2,612,971
|
|
|
2,300,506
|
|
|
1,926,968
|
|
|
1,544,440
|
|
|||||
Other
|
|
38,880
|
|
|
40,435
|
|
|
42,068
|
|
|
43,487
|
|
|
44,830
|
|
|||||
Total real estate secured loans
|
|
4,146,347
|
|
|
3,363,803
|
|
|
3,011,627
|
|
|
2,648,621
|
|
|
2,235,390
|
|
|||||
Construction loans (4)
|
|
100,219
|
|
|
97,077
|
|
|
68,546
|
|
|
64,671
|
|
|
78,682
|
|
|||||
Consumer loans
|
|
489,949
|
|
|
420,672
|
|
|
328,980
|
|
|
241,364
|
|
|
226,883
|
|
|||||
Total loans, net of unearned income (5)(6)
|
|
$
|
33,164,636
|
|
|
$
|
28,338,280
|
|
|
$
|
23,106,316
|
|
|
$
|
19,899,944
|
|
|
$
|
16,742,070
|
|
|
(1)
|
Due to the diverse nature of energy and resource innovation products and services, for our loan-related reporting purposes, ERI-related loans are reported under our software/internet, hardware, life science/healthcare and other commercial loan categories, as applicable.
|
(2)
|
Included in our premium wine portfolio are gross construction loans of $83 million, $99 million, $100 million, $110 million and $121 million at December 31, 2019, 2018, 2017, 2016 and 2015, respectively.
|
(3)
|
Consumer loans secured by real estate at December 31, 2019, 2018, 2017, 2016 and 2015 were comprised of the following:
|
|
|
December 31,
|
||||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Loans for personal residence
|
|
$
|
2,829,880
|
|
|
$
|
2,251,292
|
|
|
$
|
1,995,840
|
|
|
$
|
1,655,349
|
|
|
$
|
1,312,818
|
|
Loans to eligible employees
|
|
401,396
|
|
|
290,194
|
|
|
243,118
|
|
|
199,291
|
|
|
156,001
|
|
|||||
Home equity lines of credit
|
|
55,461
|
|
|
71,485
|
|
|
61,548
|
|
|
72,328
|
|
|
75,621
|
|
|||||
Consumer loans secured by real estate
|
|
$
|
3,286,737
|
|
|
$
|
2,612,971
|
|
|
$
|
2,300,506
|
|
|
$
|
1,926,968
|
|
|
$
|
1,544,440
|
|
(4)
|
Construction loans consist of qualified affordable housing project loans made to fulfill our responsibilities under the Community Reinvestment Act and are primarily secured by real estate.
|
(5)
|
Unearned income, net of deferred costs, was $163 million, $173 million, $148 million, $125 million and $115 million in 2019, 2018, 2017, 2016 and 2015, respectively.
|
(6)
|
Included within our total loan portfolio are credit card loans of $395 million, $335 million, $270 million, $224 million, and $177 million at December 31, 2019, 2018, 2017, 2016 and 2015, respectively, and primarily represent corporate credit cards.
|
|
|
December 31,
|
||||||||||||
|
|
2019
|
|
2018
|
||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage
|
|
Amount
|
|
Percentage
|
||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||
Software/internet
|
|
$
|
6,255,866
|
|
|
18.8
|
%
|
|
$
|
6,209,978
|
|
|
21.8
|
%
|
Hardware
|
|
1,381,025
|
|
|
4.1
|
|
|
1,245,800
|
|
|
4.4
|
|
||
Private equity/venture capital
|
|
17,817,390
|
|
|
53.5
|
|
|
14,118,132
|
|
|
49.5
|
|
||
Life science/healthcare
|
|
2,427,680
|
|
|
7.2
|
|
|
2,461,076
|
|
|
8.6
|
|
||
Premium wine
|
|
267,739
|
|
|
0.8
|
|
|
249,316
|
|
|
0.9
|
|
||
Other
|
|
442,469
|
|
|
1.3
|
|
|
346,747
|
|
|
1.2
|
|
||
Commercial loans
|
|
28,592,169
|
|
|
85.7
|
|
|
24,631,049
|
|
|
86.4
|
|
||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
||||||
Premium wine
|
|
821,837
|
|
|
2.5
|
|
|
711,237
|
|
|
2.5
|
|
||
Consumer loans
|
|
3,283,445
|
|
|
9.9
|
|
|
2,609,645
|
|
|
9.2
|
|
||
Other
|
|
38,997
|
|
|
0.1
|
|
|
40,627
|
|
|
0.1
|
|
||
Real estate secured loans
|
|
4,144,279
|
|
|
12.5
|
|
|
3,361,509
|
|
|
11.8
|
|
||
Construction loans
|
|
100,978
|
|
|
0.3
|
|
|
98,034
|
|
|
0.3
|
|
||
Consumer loans
|
|
490,278
|
|
|
1.5
|
|
|
420,720
|
|
|
1.5
|
|
||
Total gross loans
|
|
$
|
33,327,704
|
|
|
100.0
|
%
|
|
$
|
28,511,312
|
|
|
100.0
|
%
|
|
|
December 31, 2019
|
||||||||||||||||||||||
(Dollars in thousands)
|
|
Less than
Five Million
|
|
Five to Ten
Million
|
|
Ten to Twenty
Million
|
|
Twenty to Thirty Million
|
|
Thirty Million
or More
|
|
Total
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
1,565,277
|
|
|
$
|
893,496
|
|
|
$
|
1,419,850
|
|
|
$
|
1,065,751
|
|
|
$
|
1,311,492
|
|
|
$
|
6,255,866
|
|
Hardware
|
|
331,064
|
|
|
103,903
|
|
|
323,595
|
|
|
221,529
|
|
|
400,934
|
|
|
1,381,025
|
|
||||||
Private equity/venture capital
|
|
1,051,650
|
|
|
1,101,597
|
|
|
2,575,482
|
|
|
2,029,547
|
|
|
11,059,114
|
|
|
17,817,390
|
|
||||||
Life science/healthcare
|
|
346,573
|
|
|
372,821
|
|
|
626,389
|
|
|
429,419
|
|
|
652,478
|
|
|
2,427,680
|
|
||||||
Premium wine
|
|
76,133
|
|
|
55,046
|
|
|
49,180
|
|
|
57,036
|
|
|
30,344
|
|
|
267,739
|
|
||||||
Other
|
|
375,862
|
|
|
6,149
|
|
|
26,709
|
|
|
—
|
|
|
33,749
|
|
|
442,469
|
|
||||||
Commercial loans
|
|
3,746,559
|
|
|
2,533,012
|
|
|
5,021,205
|
|
|
3,803,282
|
|
|
13,488,111
|
|
|
28,592,169
|
|
||||||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Premium wine
|
|
173,090
|
|
|
212,343
|
|
|
232,706
|
|
|
91,433
|
|
|
112,265
|
|
|
821,837
|
|
||||||
Consumer loans
|
|
2,716,617
|
|
|
295,045
|
|
|
169,102
|
|
|
20,180
|
|
|
82,501
|
|
|
3,283,445
|
|
||||||
Other
|
|
7,244
|
|
|
—
|
|
|
31,753
|
|
|
—
|
|
|
—
|
|
|
38,997
|
|
||||||
Real estate secured loans
|
|
2,896,951
|
|
|
507,388
|
|
|
433,561
|
|
|
111,613
|
|
|
194,766
|
|
|
4,144,279
|
|
||||||
Construction loans
|
|
5,382
|
|
|
22,670
|
|
|
24,675
|
|
|
48,251
|
|
|
—
|
|
|
100,978
|
|
||||||
Consumer loans
|
|
209,765
|
|
|
82,225
|
|
|
41,428
|
|
|
73,133
|
|
|
83,727
|
|
|
490,278
|
|
||||||
Total gross loans
|
|
$
|
6,858,657
|
|
|
$
|
3,145,295
|
|
|
$
|
5,520,869
|
|
|
$
|
4,036,279
|
|
|
$
|
13,766,604
|
|
|
$
|
33,327,704
|
|
|
|
December 31, 2018
|
||||||||||||||||||||||
(Dollars in thousands)
|
|
Less than
Five Million
|
|
Five to Ten
Million
|
|
Ten to Twenty
Million
|
|
Twenty to Thirty Million
|
|
Thirty Million
or More
|
|
Total
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
1,515,096
|
|
|
$
|
918,647
|
|
|
$
|
1,520,634
|
|
|
$
|
1,221,250
|
|
|
$
|
1,034,351
|
|
|
$
|
6,209,978
|
|
Hardware
|
|
292,022
|
|
|
152,061
|
|
|
196,763
|
|
|
386,288
|
|
|
218,666
|
|
|
1,245,800
|
|
||||||
Private equity/venture capital
|
|
836,894
|
|
|
1,012,605
|
|
|
2,120,918
|
|
|
2,135,279
|
|
|
8,012,436
|
|
|
14,118,132
|
|
||||||
Life science/healthcare
|
|
273,075
|
|
|
477,046
|
|
|
645,895
|
|
|
410,127
|
|
|
654,933
|
|
|
2,461,076
|
|
||||||
Premium wine
|
|
70,573
|
|
|
55,852
|
|
|
48,656
|
|
|
65,035
|
|
|
9,200
|
|
|
249,316
|
|
||||||
Other
|
|
246,011
|
|
|
18,921
|
|
|
10,911
|
|
|
70,904
|
|
|
—
|
|
|
346,747
|
|
||||||
Commercial loans
|
|
3,233,671
|
|
|
2,635,132
|
|
|
4,543,777
|
|
|
4,288,883
|
|
|
9,929,586
|
|
|
24,631,049
|
|
||||||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Premium wine
|
|
168,130
|
|
|
173,882
|
|
|
263,093
|
|
|
83,945
|
|
|
22,187
|
|
|
711,237
|
|
||||||
Consumer loans
|
|
2,258,479
|
|
|
239,400
|
|
|
111,766
|
|
|
—
|
|
|
—
|
|
|
2,609,645
|
|
||||||
Other
|
|
7,506
|
|
|
—
|
|
|
33,121
|
|
|
—
|
|
|
—
|
|
|
40,627
|
|
||||||
Real estate secured loans
|
|
2,434,115
|
|
|
413,282
|
|
|
407,980
|
|
|
83,945
|
|
|
22,187
|
|
|
3,361,509
|
|
||||||
Construction loans
|
|
7,076
|
|
|
15,064
|
|
|
75,894
|
|
|
—
|
|
|
—
|
|
|
98,034
|
|
||||||
Consumer loans
|
|
148,391
|
|
|
55,401
|
|
|
51,409
|
|
|
93,690
|
|
|
71,829
|
|
|
420,720
|
|
||||||
Total gross loans
|
|
$
|
5,823,253
|
|
|
$
|
3,118,879
|
|
|
$
|
5,079,060
|
|
|
$
|
4,466,518
|
|
|
$
|
10,023,602
|
|
|
$
|
28,511,312
|
|
|
|
Remaining Contractual Maturity of Gross Loans
|
||||||||||||||
(Dollars in thousands)
|
|
One Year or Less
|
|
After One Year and Through Five Years
|
|
After Five Years
|
|
Total
|
||||||||
Fixed-rate loans:
|
|
|
|
|
|
|
|
|
||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
Software/internet
|
|
$
|
338,416
|
|
|
$
|
194,091
|
|
|
$
|
6
|
|
|
$
|
532,513
|
|
Hardware
|
|
40,381
|
|
|
15,374
|
|
|
—
|
|
|
55,755
|
|
||||
Private equity/venture capital
|
|
13,173
|
|
|
43,710
|
|
|
4,800
|
|
|
61,683
|
|
||||
Life science/healthcare
|
|
69,265
|
|
|
84,065
|
|
|
75
|
|
|
153,405
|
|
||||
Premium wine
|
|
2,313
|
|
|
10,376
|
|
|
7,726
|
|
|
20,415
|
|
||||
Other
|
|
387,359
|
|
|
612
|
|
|
—
|
|
|
387,971
|
|
||||
Total commercial loans
|
|
850,907
|
|
|
348,228
|
|
|
12,607
|
|
|
1,211,742
|
|
||||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
||||||||
Premium wine
|
|
49,545
|
|
|
174,329
|
|
|
498,097
|
|
|
721,971
|
|
||||
Consumer loans
|
|
—
|
|
|
9,014
|
|
|
344,920
|
|
|
353,934
|
|
||||
Other
|
|
—
|
|
|
21,494
|
|
|
17,503
|
|
|
38,997
|
|
||||
Total real estate secured loans
|
|
49,545
|
|
|
204,837
|
|
|
860,520
|
|
|
1,114,902
|
|
||||
Construction loans
|
|
90,290
|
|
|
4,864
|
|
|
5,805
|
|
|
100,959
|
|
||||
Consumer loans
|
|
829
|
|
|
6,111
|
|
|
2,683
|
|
|
9,623
|
|
||||
Total fixed-rate loans
|
|
$
|
991,571
|
|
|
$
|
564,040
|
|
|
$
|
881,615
|
|
|
$
|
2,437,226
|
|
|
|
|
|
|
|
|
|
|
||||||||
Variable-rate loans:
|
|
|
|
|
|
|
|
|
||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
Software/internet
|
|
$
|
1,369,995
|
|
|
$
|
4,268,125
|
|
|
$
|
85,233
|
|
|
$
|
5,723,353
|
|
Hardware
|
|
278,227
|
|
|
947,156
|
|
|
99,887
|
|
|
1,325,270
|
|
||||
Private equity/venture capital
|
|
17,359,728
|
|
|
345,226
|
|
|
50,753
|
|
|
17,755,707
|
|
||||
Life science/healthcare
|
|
128,182
|
|
|
2,117,839
|
|
|
28,254
|
|
|
2,274,275
|
|
||||
Premium wine
|
|
121,568
|
|
|
121,558
|
|
|
4,198
|
|
|
247,324
|
|
||||
Other
|
|
8,096
|
|
|
46,402
|
|
|
—
|
|
|
54,498
|
|
||||
Total commercial loans
|
|
19,265,796
|
|
|
7,846,306
|
|
|
268,325
|
|
|
27,380,427
|
|
||||
Real estate secured loans:
|
|
|
|
|
|
|
|
|
||||||||
Premium wine
|
|
1,555
|
|
|
59,037
|
|
|
39,274
|
|
|
99,866
|
|
||||
Consumer loans
|
|
7,399
|
|
|
17,076
|
|
|
2,905,036
|
|
|
2,929,511
|
|
||||
Other
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total real estate secured loans
|
|
8,954
|
|
|
76,113
|
|
|
2,944,310
|
|
|
3,029,377
|
|
||||
Construction loans
|
|
19
|
|
|
—
|
|
|
—
|
|
|
19
|
|
||||
Consumer loans
|
|
140,312
|
|
|
153,589
|
|
|
186,754
|
|
|
480,655
|
|
||||
Total variable-rate loans
|
|
19,415,081
|
|
|
8,076,008
|
|
|
3,399,389
|
|
|
30,890,478
|
|
||||
Total gross loans
|
|
$
|
20,406,652
|
|
|
$
|
8,640,048
|
|
|
$
|
4,281,004
|
|
|
$
|
33,327,704
|
|
|
|
Year ended December 31,
|
||||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Allowance for loan losses, beginning balance
|
|
$
|
280,903
|
|
|
$
|
255,024
|
|
|
$
|
225,366
|
|
|
$
|
217,613
|
|
|
$
|
165,359
|
|
Charge-offs:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet
|
|
(46,930
|
)
|
|
(42,315
|
)
|
|
(45,012
|
)
|
|
(68,784
|
)
|
|
(33,246
|
)
|
|||||
Hardware
|
|
(10,056
|
)
|
|
(16,148
|
)
|
|
(10,414
|
)
|
|
(13,233
|
)
|
|
(5,145
|
)
|
|||||
Venture capital/private equity
|
|
(2,047
|
)
|
|
(112
|
)
|
|
(323
|
)
|
|
—
|
|
|
—
|
|
|||||
Life science/healthcare
|
|
(31,950
|
)
|
|
(6,662
|
)
|
|
(8,210
|
)
|
|
(9,693
|
)
|
|
(7,291
|
)
|
|||||
Premium wine
|
|
(174
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Other
|
|
(415
|
)
|
|
(2,391
|
)
|
|
(1,156
|
)
|
|
(5,045
|
)
|
|
(4,990
|
)
|
|||||
Total commercial loans
|
|
(91,572
|
)
|
|
(67,628
|
)
|
|
(65,115
|
)
|
|
(96,755
|
)
|
|
(50,672
|
)
|
|||||
Consumer loans
|
|
(1,031
|
)
|
|
(289
|
)
|
|
(1,567
|
)
|
|
(102
|
)
|
|
(296
|
)
|
|||||
Total charge-offs
|
|
(92,603
|
)
|
|
(67,917
|
)
|
|
(66,682
|
)
|
|
(96,857
|
)
|
|
(50,968
|
)
|
|||||
Recoveries:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet
|
|
11,363
|
|
|
5,664
|
|
|
4,649
|
|
|
7,278
|
|
|
1,621
|
|
|||||
Hardware
|
|
7,069
|
|
|
1,849
|
|
|
487
|
|
|
1,667
|
|
|
3,332
|
|
|||||
Venture capital/private equity
|
|
2,047
|
|
|
13
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Life science/healthcare
|
|
267
|
|
|
348
|
|
|
189
|
|
|
1,129
|
|
|
277
|
|
|||||
Premium wine
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|||||
Other
|
|
36
|
|
|
3,275
|
|
|
1,850
|
|
|
1,880
|
|
|
809
|
|
|||||
Total commercial loans
|
|
20,782
|
|
|
11,149
|
|
|
7,175
|
|
|
11,954
|
|
|
6,046
|
|
|||||
Consumer loans
|
|
256
|
|
|
487
|
|
|
1,363
|
|
|
258
|
|
|
163
|
|
|||||
Total recoveries
|
|
21,038
|
|
|
11,636
|
|
|
8,538
|
|
|
12,212
|
|
|
6,209
|
|
|||||
Provision for loan losses
|
|
94,183
|
|
|
84,292
|
|
|
85,939
|
|
|
95,697
|
|
|
97,629
|
|
|||||
Foreign currency translation adjustments
|
|
1,403
|
|
|
(2,132
|
)
|
|
1,863
|
|
|
(3,299
|
)
|
|
(616
|
)
|
|||||
Allowance for loan losses, ending balance
|
|
$
|
304,924
|
|
|
$
|
280,903
|
|
|
$
|
255,024
|
|
|
$
|
225,366
|
|
|
$
|
217,613
|
|
|
|
December 31,
|
|||||||||||||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||||||||||||
(Dollars in thousands)
|
|
ALL Amount
|
|
Percent of Total Loans (1)
|
|
ALL Amount
|
|
Percent of Total Loans (1)
|
|
ALL Amount
|
|
Percent of Total Loans (1)
|
|
ALL Amount
|
|
Percent of Total Loans (1)
|
|
ALL Amount
|
|
Percent of Total Loans (1)
|
|||||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Software/internet
|
|
$
|
100,223
|
|
|
18.8
|
%
|
|
$
|
103,567
|
|
|
21.8
|
%
|
|
$
|
96,104
|
|
|
26.8
|
%
|
|
$
|
97,388
|
|
|
28.3
|
%
|
|
$
|
103,045
|
|
|
32.5
|
%
|
Hardware
|
|
19,644
|
|
|
4.1
|
|
|
19,725
|
|
|
4.4
|
|
|
27,614
|
|
|
5.2
|
|
|
31,166
|
|
|
5.9
|
|
|
23,085
|
|
|
6.4
|
|
|||||
Private equity/venture capital
|
|
115,805
|
|
|
53.5
|
|
|
98,581
|
|
|
49.5
|
|
|
82,468
|
|
|
42.8
|
|
|
50,299
|
|
|
38.7
|
|
|
35,282
|
|
|
32.7
|
|
|||||
Life science/healthcare
|
|
39,245
|
|
|
7.2
|
|
|
32,180
|
|
|
8.6
|
|
|
24,924
|
|
|
8.0
|
|
|
25,446
|
|
|
9.3
|
|
|
36,576
|
|
|
10.2
|
|
|||||
Premium wine
|
|
5,148
|
|
|
3.3
|
|
|
3,355
|
|
|
3.4
|
|
|
3,532
|
|
|
3.8
|
|
|
4,115
|
|
|
4.5
|
|
|
5,205
|
|
|
5.1
|
|
|||||
Other
|
|
3,353
|
|
|
1.7
|
|
|
3,558
|
|
|
1.7
|
|
|
3,941
|
|
|
2.1
|
|
|
4,768
|
|
|
2.5
|
|
|
4,252
|
|
|
2.6
|
|
|||||
Total commercial loans
|
|
283,418
|
|
|
88.6
|
|
|
260,966
|
|
|
89.4
|
|
|
238,583
|
|
|
88.7
|
|
|
213,182
|
|
|
89.2
|
|
|
207,445
|
|
|
89.5
|
|
|||||
Consumer loans
|
|
21,506
|
|
|
11.4
|
|
|
19,937
|
|
|
10.6
|
|
|
16,441
|
|
|
11.3
|
|
|
12,184
|
|
|
10.8
|
|
|
10,168
|
|
|
10.5
|
|
|||||
Total
|
|
$
|
304,924
|
|
|
100.0
|
%
|
|
$
|
280,903
|
|
|
100.0
|
%
|
|
$
|
255,024
|
|
|
100.0
|
%
|
|
$
|
225,366
|
|
|
100.0
|
%
|
|
$
|
217,613
|
|
|
100.0
|
%
|
|
(1)
|
Represents loan balances as a percentage of total gross loans at each respective year-end.
|
|
|
December 31,
|
||||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Gross nonperforming, past due, and restructured loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Nonaccrual loans
|
|
$
|
102,669
|
|
|
$
|
94,142
|
|
|
$
|
119,259
|
|
|
$
|
118,979
|
|
|
$
|
123,392
|
|
Loans past due 90 days or more still accruing interest
|
|
3,515
|
|
|
1,964
|
|
|
191
|
|
|
33
|
|
|
—
|
|
|||||
Total nonperforming loans
|
|
106,184
|
|
|
96,106
|
|
|
119,450
|
|
|
119,012
|
|
|
123,392
|
|
|||||
OREO and other foreclosed assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total nonperforming assets
|
|
$
|
106,184
|
|
|
$
|
96,106
|
|
|
$
|
119,450
|
|
|
$
|
119,012
|
|
|
$
|
123,392
|
|
Performing TDRs
|
|
$
|
31,990
|
|
|
$
|
31,639
|
|
|
$
|
71,468
|
|
|
$
|
33,732
|
|
|
$
|
10,635
|
|
Nonperforming loans as a percentage of total gross loans
|
|
0.32
|
%
|
|
0.34
|
%
|
|
0.51
|
%
|
|
0.59
|
%
|
|
0.73
|
%
|
|||||
Nonperforming assets as a percentage of total assets
|
|
0.15
|
|
|
0.17
|
|
|
0.23
|
|
|
0.27
|
|
|
0.28
|
|
|||||
Allowance for loan losses
|
|
$
|
304,924
|
|
|
$
|
280,903
|
|
|
$
|
255,024
|
|
|
$
|
225,366
|
|
|
$
|
217,613
|
|
As a percentage of total gross loans
|
|
0.91
|
%
|
|
0.99
|
%
|
|
1.10
|
%
|
|
1.13
|
%
|
|
1.29
|
%
|
|||||
As a percentage of total gross nonperforming loans
|
|
287.17
|
|
|
292.28
|
|
|
213.50
|
|
|
189.36
|
|
|
176.36
|
|
|||||
Allowance for loan losses for nonaccrual loans
|
|
$
|
44,859
|
|
|
$
|
37,941
|
|
|
$
|
41,793
|
|
|
$
|
37,277
|
|
|
$
|
51,844
|
|
As a percentage of total gross loans
|
|
0.13
|
%
|
|
0.13
|
%
|
|
0.18
|
%
|
|
0.19
|
%
|
|
0.31
|
%
|
|||||
As a percentage of total gross nonperforming loans
|
|
42.25
|
|
|
39.48
|
|
|
34.99
|
|
|
31.32
|
|
|
42.02
|
|
|||||
Allowance for loan losses for total gross performing loans
|
|
$
|
260,065
|
|
|
$
|
242,962
|
|
|
$
|
213,231
|
|
|
$
|
188,089
|
|
|
$
|
165,769
|
|
As a percentage of total gross loans
|
|
0.78
|
%
|
|
0.85
|
%
|
|
0.92
|
%
|
|
0.94
|
%
|
|
0.98
|
%
|
|||||
As a percentage of total gross performing loans
|
|
0.78
|
|
|
0.86
|
|
|
0.92
|
|
|
0.94
|
|
|
0.99
|
|
|||||
Total gross loans
|
|
$
|
33,327,704
|
|
|
$
|
28,511,312
|
|
|
$
|
23,254,153
|
|
|
$
|
20,024,662
|
|
|
$
|
16,857,131
|
|
Total gross performing loans
|
|
33,221,520
|
|
|
28,415,206
|
|
|
23,134,703
|
|
|
19,905,650
|
|
|
16,733,739
|
|
|||||
Allowance for unfunded credit commitments (1)
|
|
67,656
|
|
|
55,183
|
|
|
51,770
|
|
|
45,265
|
|
|
34,415
|
|
|||||
As a percentage of total unfunded credit commitments
|
|
0.28
|
%
|
|
0.29
|
%
|
|
0.30
|
%
|
|
0.27
|
%
|
|
0.22
|
%
|
|||||
Total unfunded credit commitments (2)
|
|
$
|
24,521,920
|
|
|
$
|
18,913,021
|
|
|
$
|
17,462,537
|
|
|
$
|
16,743,196
|
|
|
$
|
15,614,359
|
|
|
(1)
|
The “allowance for unfunded credit commitments” is included as a component of other liabilities and any provision is included in the "Provision for credit losses" in the statement of income. See “Provision for Credit Losses” for a discussion of the changes to the allowance.
|
(2)
|
Includes unfunded loan commitments and letters of credit.
|
|
|
December 31,
|
||||||||||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet
|
|
$
|
67,155
|
|
|
$
|
66,781
|
|
|
$
|
78,860
|
|
|
$
|
76,605
|
|
|
$
|
77,545
|
|
Hardware
|
|
2,143
|
|
|
1,256
|
|
|
16,185
|
|
|
6,581
|
|
|
430
|
|
|||||
Private equity/venture capital
|
|
—
|
|
|
3,700
|
|
|
658
|
|
|
—
|
|
|
—
|
|
|||||
Life science/healthcare
|
|
26,401
|
|
|
17,791
|
|
|
20,520
|
|
|
31,783
|
|
|
44,107
|
|
|||||
Premium wine
|
|
205
|
|
|
284
|
|
|
401
|
|
|
491
|
|
|
1,167
|
|
|||||
Other
|
|
1,285
|
|
|
411
|
|
|
32
|
|
|
403
|
|
|
—
|
|
|||||
Total commercial loans
|
|
97,189
|
|
|
90,223
|
|
|
116,656
|
|
|
115,863
|
|
|
123,249
|
|
|||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Real estate secured loans
|
|
5,480
|
|
|
3,919
|
|
|
2,181
|
|
|
1,504
|
|
|
143
|
|
|||||
Other consumer loans
|
|
—
|
|
|
—
|
|
|
422
|
|
|
1,612
|
|
|
—
|
|
|||||
Total consumer loans
|
|
5,480
|
|
|
3,919
|
|
|
2,603
|
|
|
3,116
|
|
|
143
|
|
|||||
Total nonaccrual loans
|
|
$
|
102,669
|
|
|
$
|
94,142
|
|
|
$
|
119,259
|
|
|
$
|
118,979
|
|
|
$
|
123,392
|
|
|
|
Year ended December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Balance, beginning of period
|
|
$
|
94,142
|
|
|
$
|
119,259
|
|
Additions
|
|
165,827
|
|
|
85,499
|
|
||
Paydowns
|
|
(101,994
|
)
|
|
(66,660
|
)
|
||
Charge-offs
|
|
(55,224
|
)
|
|
(43,857
|
)
|
||
Other reductions
|
|
(82
|
)
|
|
(99
|
)
|
||
Balance, end of period
|
|
$
|
102,669
|
|
|
$
|
94,142
|
|
|
|
December 31,
|
|||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change
|
|||||
Derivative assets (1)
|
|
$
|
332,814
|
|
|
$
|
258,139
|
|
|
28.9
|
%
|
Foreign exchange spot contract assets, gross
|
|
810,275
|
|
|
152,268
|
|
|
NM
|
|
||
Accrued interest receivable
|
|
216,962
|
|
|
197,927
|
|
|
9.6
|
|
||
Net deferred tax assets
|
|
28,433
|
|
|
65,433
|
|
|
(56.5
|
)
|
||
FHLB and Federal Reserve Bank stock
|
|
60,258
|
|
|
58,878
|
|
|
2.3
|
|
||
Accounts receivable
|
|
47,663
|
|
|
55,807
|
|
|
(14.6
|
)
|
||
Other assets
|
|
248,828
|
|
|
162,809
|
|
|
52.8
|
|
||
Total accrued interest receivable and other assets
|
|
$
|
1,745,233
|
|
|
$
|
951,261
|
|
|
83.5
|
|
|
(1)
|
See “Derivatives” section below.
|
|
|
December 31,
|
|||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change
|
|||||
Assets:
|
|
|
|
|
|
|
|||||
Equity warrant assets
|
|
$
|
165,473
|
|
|
$
|
149,238
|
|
|
10.9
|
%
|
Foreign exchange forward and option contracts
|
|
115,854
|
|
|
100,402
|
|
|
15.4
|
|
||
Client interest rate derivatives
|
|
28,811
|
|
|
8,499
|
|
|
NM
|
|
||
Interest rate swaps
|
|
22,676
|
|
|
—
|
|
|
—
|
|
||
Total derivatives assets
|
|
$
|
332,814
|
|
|
$
|
258,139
|
|
|
28.9
|
|
Liabilities:
|
|
|
|
|
|
|
|||||
Foreign exchange forward and option contracts
|
|
$
|
98,207
|
|
|
$
|
88,559
|
|
|
10.9
|
|
Client interest rate derivatives
|
|
14,154
|
|
|
9,491
|
|
|
49.1
|
|
||
Interest rate swaps
|
|
25,623
|
|
|
—
|
|
|
—
|
|
||
Total derivatives liabilities
|
|
$
|
137,984
|
|
|
$
|
98,050
|
|
|
40.7
|
|
|
|
|
Year ended December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Balance, beginning of period
|
|
$
|
149,238
|
|
|
$
|
123,763
|
|
New equity warrant assets
|
|
16,103
|
|
|
18,021
|
|
||
Non-cash increases in fair value
|
|
34,412
|
|
|
36,920
|
|
||
Exercised equity warrant assets
|
|
(30,778
|
)
|
|
(23,502
|
)
|
||
Terminated equity warrant assets
|
|
(3,502
|
)
|
|
(5,964
|
)
|
||
Balance, end of period
|
|
$
|
165,473
|
|
|
$
|
149,238
|
|
|
|
December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Noninterest-bearing demand
|
|
$
|
40,841,570
|
|
|
$
|
39,103,422
|
|
|
$
|
36,655,497
|
|
Interest-bearing checking and savings accounts
|
|
568,256
|
|
|
648,468
|
|
|
556,121
|
|
|||
Money market
|
|
17,749,736
|
|
|
7,498,205
|
|
|
5,975,220
|
|
|||
Money market deposits in foreign offices
|
|
352,437
|
|
|
152,781
|
|
|
111,201
|
|
|||
Sweep deposits in foreign offices
|
|
2,057,715
|
|
|
1,875,298
|
|
|
908,890
|
|
|||
Time
|
|
188,093
|
|
|
50,726
|
|
|
47,146
|
|
|||
Total deposits
|
|
$
|
61,757,807
|
|
|
$
|
49,328,900
|
|
|
$
|
44,254,075
|
|
|
|
December 31, 2019
|
||||||||||||||||||
(Dollars in thousands)
|
|
Three months
or less
|
|
More than
three months
to six months
|
|
More than six
months to
twelve months
|
|
More than
twelve months
|
|
Total
|
||||||||||
Time deposits, $100,000 and over
|
|
$
|
155,533
|
|
|
$
|
1,558
|
|
|
$
|
24,514
|
|
|
$
|
3,105
|
|
|
$
|
184,710
|
|
Other time deposits
|
|
2,114
|
|
|
635
|
|
|
634
|
|
|
—
|
|
|
3,383
|
|
|||||
Total time deposits
|
|
$
|
157,647
|
|
|
$
|
2,193
|
|
|
$
|
25,148
|
|
|
$
|
3,105
|
|
|
$
|
188,093
|
|
|
|
December 31,
|
|||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
|||||||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
|||||||||
Short-term FHLB advances
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
300,000
|
|
|
2.54
|
%
|
|
$
|
700,000
|
|
|
1.37
|
%
|
Federal funds purchased
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
330,000
|
|
|
1.45
|
|
|||
Securities sold under agreement to repurchase
|
|
—
|
|
|
—
|
|
|
319,414
|
|
|
2.70
|
|
|
—
|
|
|
—
|
|
|||
Other short-term borrowings
|
|
17,430
|
|
|
1.55
|
|
|
11,998
|
|
|
2.39
|
|
|
3,730
|
|
|
1.33
|
|
|||
Total short-term borrowings
|
|
$
|
17,430
|
|
|
1.55
|
|
|
$
|
631,412
|
|
|
2.62
|
|
|
$
|
1,033,730
|
|
|
1.39
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Average daily balances:
|
|
|
|
|
|
|
||||||
Short-term FHLB advances
|
|
$
|
63,836
|
|
|
$
|
424,384
|
|
|
$
|
36,712
|
|
Federal Funds purchased (1)
|
|
25,959
|
|
|
44,164
|
|
|
7,529
|
|
|||
Securities sold under agreements to repurchase
|
|
36,716
|
|
|
164,938
|
|
|
—
|
|
|||
Other short-term borrowings (2)
|
|
19,034
|
|
|
10,400
|
|
|
4,264
|
|
|||
Total average short-term borrowings
|
|
$
|
145,545
|
|
|
$
|
643,886
|
|
|
$
|
48,505
|
|
Weighted average interest rate during the year:
|
|
|
|
|
|
|
||||||
Short-term FHLB advances
|
|
2.57
|
%
|
|
2.24
|
%
|
|
1.02
|
%
|
|||
Federal Funds purchased
|
|
2.45
|
|
|
2.10
|
|
|
1.36
|
|
|||
Securities sold under agreements to repurchase
|
|
2.65
|
|
|
2.37
|
|
|
—
|
|
|||
Other short-term borrowings
|
|
1.92
|
|
|
2.28
|
|
|
1.55
|
|
|||
Maximum month-end balances:
|
|
|
|
|
|
|
||||||
Short-term FHLB advances
|
|
$
|
400,000
|
|
|
$
|
2,250,000
|
|
|
$
|
700,000
|
|
Federal Funds purchased
|
|
265,000
|
|
|
490,000
|
|
|
330,000
|
|
|||
Securities sold under agreements to repurchase
|
|
196,000
|
|
|
394,592
|
|
|
—
|
|
|||
Other short-term borrowings
|
|
30,246
|
|
|
19,770
|
|
|
8,470
|
|
|
(1)
|
As part of our liquidity risk management practices, we periodically test availability and access to overnight borrowings in the Federal Funds market. These balances represent short-term borrowings.
|
(2)
|
Represents cash collateral received from certain counterparties in relation to market value exposures of derivative contracts in our favor.
|
|
|
Principal value at December 31, 2019
|
|
December 31,
|
||||||||||||
(Dollars in thousands)
|
|
|
2019
|
|
2018
|
|
2017
|
|||||||||
3.50% Senior Notes
|
|
$
|
350,000
|
|
|
$
|
347,987
|
|
|
$
|
347,639
|
|
|
$
|
347,303
|
|
5.375% Senior Notes
|
|
—
|
|
|
—
|
|
|
348,826
|
|
|
348,189
|
|
||||
Total long-term debt
|
|
$
|
350,000
|
|
|
$
|
347,987
|
|
|
$
|
696,465
|
|
|
$
|
695,492
|
|
|
|
December 31,
|
||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
% Change
|
||||
Foreign exchange spot contract liabilities, gross
|
|
$
|
888,360
|
|
|
$
|
170,355
|
|
|
NM
|
Accrued compensation
|
|
354,393
|
|
|
224,405
|
|
|
57.9
|
||
Derivative liabilities (1)
|
|
137,984
|
|
|
98,050
|
|
|
40.7
|
||
Allowance for unfunded credit commitments
|
|
67,656
|
|
|
55,183
|
|
|
22.6
|
||
Other liabilities
|
|
593,359
|
|
|
458,366
|
|
|
29.5
|
||
Total other liabilities
|
|
$
|
2,041,752
|
|
|
$
|
1,006,359
|
|
|
102.9
|
|
(1)
|
See “Derivatives” section above.
|
|
|
December 31,
|
|
Required Minimum (1)
|
|
Well Capitalized Minimum
|
|||||||||
|
|
2019
|
|
2018
|
|
2017
|
|
|
|||||||
SVB Financial:
|
|
|
|
|
|
|
|
|
|
|
|||||
CET 1 risk-based capital ratio (2)
|
|
12.58
|
%
|
|
13.41
|
%
|
|
12.78
|
%
|
|
7.0
|
%
|
|
N/A
|
|
Tier 1 risk-based capital ratio
|
|
13.43
|
|
|
13.58
|
|
|
12.97
|
|
|
8.5
|
|
|
6.0
|
|
Total risk-based capital ratio
|
|
14.23
|
|
|
14.45
|
|
|
13.96
|
|
|
10.5
|
|
|
10.0
|
|
Tier 1 leverage ratio (2)
|
|
9.06
|
|
|
9.06
|
|
|
8.34
|
|
|
4.0
|
|
|
N/A
|
|
Tangible common equity to tangible assets ratio (3)(4)
|
|
8.39
|
|
|
8.99
|
|
|
8.16
|
|
|
N/A
|
|
|
N/A
|
|
Tangible common equity to risk-weighted assets ratio (3)(4)
|
|
12.76
|
|
|
13.28
|
|
|
12.77
|
|
|
N/A
|
|
|
N/A
|
|
Bank:
|
|
|
|
|
|
|
|
|
|
|
|||||
CET 1 risk-based capital ratio
|
|
11.12
|
%
|
|
12.41
|
%
|
|
12.06
|
%
|
|
7.0
|
%
|
|
6.5
|
%
|
Tier 1 risk-based capital ratio
|
|
11.12
|
|
|
12.41
|
|
|
12.06
|
|
|
8.5
|
|
|
8.0
|
|
Total risk-based capital ratio
|
|
11.96
|
|
|
13.32
|
|
|
13.04
|
|
|
10.5
|
|
|
10.0
|
|
Tier 1 leverage ratio
|
|
7.30
|
|
|
8.10
|
|
|
7.56
|
|
|
4.0
|
|
|
5.0
|
|
Tangible common equity to tangible assets ratio (3)(4)
|
|
7.24
|
|
|
8.13
|
|
|
7.47
|
|
|
N/A
|
|
|
N/A
|
|
Tangible common equity to risk-weighted assets ratio (3)(4)
|
|
11.31
|
|
|
12.28
|
|
|
11.98
|
|
|
N/A
|
|
|
N/A
|
|
|
(1)
|
Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in 2.5% CET1 capital conservation buffer under the Capital Rules.
|
(2)
|
"Well-Capitalized Minimum" CET 1 risk-based capital and Tier 1 leverage ratios are not formally defined under applicable banking regulations for bank holding companies.
|
(3)
|
See below for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.
|
(4)
|
The FRB has not issued any minimum guidelines for the tangible common equity to tangible assets ratio or the tangible common equity to risk-weighted assets ratio, however, we believe these ratios provide meaningful supplemental information regarding our capital levels and are therefore provided above.
|
Non-GAAP tangible common equity and tangible assets
(Dollars in thousands, except ratios)
|
|
SVB Financial
|
||||||||||||||||||
|
December 31,
2019 |
|
December 31,
2018 |
|
December 31,
2017 |
|
December 31,
2016 |
|
December 31,
2015 |
|||||||||||
GAAP SVBFG stockholders’ equity
|
|
$
|
6,470,307
|
|
|
$
|
5,116,209
|
|
|
$
|
4,179,795
|
|
|
$
|
3,642,554
|
|
|
$
|
3,198,134
|
|
Less: preferred stock
|
|
340,138
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Less: intangible assets
|
|
187,240
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Tangible common equity
|
|
$
|
5,942,929
|
|
|
$
|
5,116,209
|
|
|
$
|
4,179,795
|
|
|
$
|
3,642,554
|
|
|
$
|
3,198,134
|
|
GAAP total assets
|
|
$
|
71,004,903
|
|
|
$
|
56,927,979
|
|
|
$
|
51,214,467
|
|
|
$
|
44,683,660
|
|
|
$
|
44,686,703
|
|
Less: intangible assets
|
|
187,240
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Tangible assets
|
|
$
|
70,817,663
|
|
|
$
|
56,927,979
|
|
|
$
|
51,214,467
|
|
|
$
|
44,683,660
|
|
|
$
|
44,686,703
|
|
Risk-weighted assets
|
|
$
|
46,577,485
|
|
|
$
|
38,527,853
|
|
|
$
|
32,736,959
|
|
|
$
|
28,248,750
|
|
|
$
|
25,919,594
|
|
Non-GAAP tangible common equity to tangible assets
|
|
8.39
|
%
|
|
8.99
|
%
|
|
8.16
|
%
|
|
8.15
|
%
|
|
7.16
|
%
|
|||||
Non-GAAP tangible common equity to risk-weighted assets
|
|
12.76
|
|
|
13.28
|
|
|
12.77
|
|
|
12.89
|
|
|
12.34
|
|
Non-GAAP tangible common equity and tangible assets
(Dollars in thousands, except ratios)
|
|
Bank
|
||||||||||||||||||
|
December 31,
2019 |
|
December 31,
2018 |
|
December 31,
2017 |
|
December 31,
2016 |
|
December 31,
2015 |
|||||||||||
Tangible common equity
|
|
$
|
5,034,095
|
|
|
$
|
4,554,814
|
|
|
$
|
3,762,542
|
|
|
$
|
3,423,427
|
|
|
$
|
3,059,045
|
|
Tangible assets
|
|
$
|
69,563,817
|
|
|
$
|
56,047,134
|
|
|
$
|
50,383,774
|
|
|
$
|
44,059,340
|
|
|
$
|
44,045,967
|
|
Risk-weighted assets
|
|
$
|
44,502,150
|
|
|
$
|
37,104,080
|
|
|
$
|
31,403,489
|
|
|
$
|
26,856,850
|
|
|
$
|
24,301,043
|
|
Non-GAAP tangible common equity to tangible assets
|
|
7.24
|
%
|
|
8.13
|
%
|
|
7.47
|
%
|
|
7.77
|
%
|
|
6.95
|
%
|
|||||
Non-GAAP tangible common equity to risk-weighted assets
|
|
11.31
|
|
|
12.28
|
|
|
11.98
|
|
|
12.75
|
|
|
12.59
|
|
|
|
Amount of Commitments Expiring per Period
|
||||||||||||||||||
(Dollars in thousands)
|
|
Total
|
|
Less than 1 year
|
|
1-3 years
|
|
4-5 years
|
|
After 5 years
|
||||||||||
Commercial commitments:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Loan commitments available for funding
|
|
$
|
21,743,359
|
|
|
$
|
16,983,484
|
|
|
$
|
3,039,575
|
|
|
$
|
1,170,986
|
|
|
$
|
549,314
|
|
Standby letters of credit
|
|
2,771,441
|
|
|
2,672,616
|
|
|
87,023
|
|
|
8,148
|
|
|
3,654
|
|
|||||
Commercial letters of credit
|
|
7,120
|
|
|
7,120
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total unfunded credit commitments
|
|
$
|
24,521,920
|
|
|
$
|
19,663,220
|
|
|
$
|
3,126,598
|
|
|
$
|
1,179,134
|
|
|
$
|
552,968
|
|
|
|
Payments Due By Period
|
||||||||||||||||||
(Dollars in thousands)
|
|
Total
|
|
Less than 1 year
|
|
1-3 years
|
|
4-5 years
|
|
After 5 years
|
||||||||||
SVBFG contractual obligations:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Deposits (1) (2)
|
|
$
|
61,757,807
|
|
|
$
|
61,757,807
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Borrowings (2)
|
|
365,417
|
|
|
17,430
|
|
|
—
|
|
|
—
|
|
|
347,987
|
|
|||||
Non-cancelable operating leases
|
|
240,787
|
|
|
44,791
|
|
|
80,352
|
|
|
63,516
|
|
|
52,128
|
|
|||||
Commitments to qualified affordable housing projects
|
|
302,031
|
|
|
128,494
|
|
|
158,186
|
|
|
3,921
|
|
|
11,430
|
|
|||||
Other obligations
|
|
10,470
|
|
|
7,952
|
|
|
2,518
|
|
|
—
|
|
|
—
|
|
|||||
Total obligations attributable to SVBFG
|
|
$
|
62,676,512
|
|
|
$
|
61,956,474
|
|
|
$
|
241,056
|
|
|
$
|
67,437
|
|
|
$
|
411,545
|
|
|
(1)
|
Includes time deposits and deposits with no defined maturity, such as noninterest-bearing demand, interest-bearing checking, savings, money market and sweep accounts.
|
(2)
|
Amounts exclude contractual interest.
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Average cash and cash equivalents
|
|
$
|
6,524,342
|
|
|
$
|
3,301,783
|
|
|
$
|
3,484,651
|
|
Percentage of total average assets
|
|
10.3
|
%
|
|
6.0
|
%
|
|
7.2
|
%
|
|||
Net cash provided by operating activities
|
|
$
|
1,164,129
|
|
|
$
|
933,562
|
|
|
$
|
646,865
|
|
Net cash used for investing activities
|
|
(9,371,882
|
)
|
|
(4,800,375
|
)
|
|
(5,970,496
|
)
|
|||
Net cash provided by financing activities
|
|
11,417,997
|
|
|
4,515,277
|
|
|
5,700,956
|
|
|||
Net increase in cash and cash equivalents
|
|
$
|
3,210,244
|
|
|
$
|
648,464
|
|
|
$
|
377,325
|
|
ITEM 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
Change in interest rates (bps)
(Dollars in thousands)
|
|
Estimated
|
|
Estimated Increase/(Decrease) In EVE
|
|
Estimated
|
|
Estimated Increase/
(Decrease) In NII
|
||||||||||||||
|
EVE
|
|
Amount
|
|
Percent
|
|
NII (1)
|
|
Amount
|
|
Percent
|
|||||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
+200
|
|
$
|
9,930,270
|
|
|
$
|
(253,659
|
)
|
|
(2.5
|
)%
|
|
$
|
2,528,158
|
|
|
$
|
421,358
|
|
|
20.0
|
%
|
+100
|
|
10,056,711
|
|
|
(127,218
|
)
|
|
(1.2
|
)
|
|
2,314,686
|
|
|
207,886
|
|
|
9.9
|
|
||||
—
|
|
10,183,929
|
|
|
—
|
|
|
—
|
|
|
2,106,800
|
|
|
—
|
|
|
—
|
|
||||
-100
|
|
10,138,558
|
|
|
(45,371
|
)
|
|
(0.4
|
)
|
|
1,927,801
|
|
|
(178,999
|
)
|
|
(8.5
|
)
|
||||
-200
|
|
10,000,585
|
|
|
(183,344
|
)
|
|
(1.8
|
)
|
|
1,760,283
|
|
|
(346,517
|
)
|
|
(16.4
|
)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
+200
|
|
$
|
9,348,408
|
|
|
$
|
504,405
|
|
|
5.7
|
%
|
|
$
|
2,583,577
|
|
|
$
|
499,257
|
|
|
24.0
|
%
|
+100
|
|
9,090,781
|
|
|
246,778
|
|
|
2.8
|
|
|
2,334,040
|
|
|
249,720
|
|
|
12.0
|
|
||||
—
|
|
8,844,003
|
|
|
—
|
|
|
—
|
|
|
2,084,320
|
|
|
—
|
|
|
—
|
|
||||
-100
|
|
8,470,501
|
|
|
(373,502
|
)
|
|
(4.2
|
)
|
|
1,840,190
|
|
|
(244,130
|
)
|
|
(11.7
|
)
|
||||
-200
|
|
7,590,973
|
|
|
(1,253,030
|
)
|
|
(14.2
|
)
|
|
1,543,150
|
|
|
(541,170
|
)
|
|
(26.0
|
)
|
|
(1)
|
Estimated NII sensitivity for December 31, 2018 has been revised from prior period presentations to reflect updated assumptions.
|
•
|
evaluating that the Company’s methodology is sufficiently structured, transparent, and repeatable for compliance with U.S. generally accepted accounting principles,
|
•
|
evaluating the methodology used to determine the loss emergence and historical observation periods used in the quantitative loss estimate,
|
•
|
evaluating the methodology used to determine the qualitative factors and the effect of those factors on the collectively evaluated ALL and AUCC compared with relevant credit risk factors and consistency with credit trends, and
|
•
|
testing individual loan grades for a selection of commercial loans by evaluating the financial performance of the borrower and underlying collateral, as applicable.
|
|
|
December 31,
|
||||||
(Dollars in thousands, except par value and share data)
|
|
2019
|
|
2018
|
||||
Assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
6,781,783
|
|
|
$
|
3,571,539
|
|
Available-for-sale securities, at fair value (cost of $13,894,348 and $7,862,311, respectively)
|
|
14,014,919
|
|
|
7,790,043
|
|
||
Held-to-maturity securities, at cost (fair value of $14,115,272 and $15,188,236, respectively)
|
|
13,842,946
|
|
|
15,487,442
|
|
||
Non-marketable and other equity securities
|
|
1,213,829
|
|
|
941,104
|
|
||
Total investment securities
|
|
29,071,694
|
|
|
24,218,589
|
|
||
Loans, net of unearned income
|
|
33,164,636
|
|
|
28,338,280
|
|
||
Allowance for loan losses
|
|
(304,924
|
)
|
|
(280,903
|
)
|
||
Net loans
|
|
32,859,712
|
|
|
28,057,377
|
|
||
Premises and equipment, net of accumulated depreciation and amortization
|
|
161,876
|
|
|
129,213
|
|
||
Goodwill
|
|
137,823
|
|
|
—
|
|
||
Other intangible assets, net
|
|
49,417
|
|
|
—
|
|
||
Lease right-of-use assets
|
|
197,365
|
|
|
—
|
|
||
Accrued interest receivable and other assets
|
|
1,745,233
|
|
|
951,261
|
|
||
Total assets
|
|
$
|
71,004,903
|
|
|
$
|
56,927,979
|
|
Liabilities and total equity
|
|
|
|
|
||||
Liabilities:
|
|
|
|
|
||||
Noninterest-bearing demand deposits
|
|
$
|
40,841,570
|
|
|
$
|
39,103,422
|
|
Interest-bearing deposits
|
|
20,916,237
|
|
|
10,225,478
|
|
||
Total deposits
|
|
61,757,807
|
|
|
49,328,900
|
|
||
Short-term borrowings
|
|
17,430
|
|
|
631,412
|
|
||
Lease liabilities
|
|
218,847
|
|
|
—
|
|
||
Other liabilities
|
|
2,041,752
|
|
|
1,006,359
|
|
||
Long-term debt
|
|
347,987
|
|
|
696,465
|
|
||
Total liabilities
|
|
64,383,823
|
|
|
51,663,136
|
|
||
Commitments and contingencies (Note 22 and Note 28)
|
|
|
|
|
|
|||
SVBFG stockholders’ equity:
|
|
|
|
|
||||
Preferred stock, $0.001 par value, 20,000,000 shares authorized; 350,000 shares and no shares issued and outstanding, respectively
|
|
340,138
|
|
|
—
|
|
||
Common stock, $0.001 par value, 150,000,000 shares authorized; 51,655,607 shares and 52,586,498 shares issued and outstanding, respectively
|
|
52
|
|
|
53
|
|
||
Additional paid-in capital
|
|
1,470,071
|
|
|
1,378,438
|
|
||
Retained earnings
|
|
4,575,601
|
|
|
3,791,838
|
|
||
Accumulated other comprehensive income (loss)
|
|
84,445
|
|
|
(54,120
|
)
|
||
Total SVBFG stockholders’ equity
|
|
6,470,307
|
|
|
5,116,209
|
|
||
Noncontrolling interests
|
|
150,773
|
|
|
148,634
|
|
||
Total equity
|
|
6,621,080
|
|
|
5,264,843
|
|
||
Total liabilities and total equity
|
|
$
|
71,004,903
|
|
|
$
|
56,927,979
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands, except per share amounts)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Interest income:
|
|
|
|
|
|
|
||||||
Loans
|
|
$
|
1,599,165
|
|
|
$
|
1,358,480
|
|
|
$
|
1,025,788
|
|
Investment securities:
|
|
|
|
|
|
|
||||||
Taxable
|
|
568,851
|
|
|
541,605
|
|
|
412,133
|
|
|||
Non-taxable
|
|
44,952
|
|
|
34,616
|
|
|
5,714
|
|
|||
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities
|
|
96,440
|
|
|
35,208
|
|
|
21,505
|
|
|||
Total interest income
|
|
2,309,408
|
|
|
1,969,909
|
|
|
1,465,140
|
|
|||
Interest expense:
|
|
|
|
|
|
|
||||||
Deposits
|
|
177,672
|
|
|
29,306
|
|
|
8,676
|
|
|||
Borrowings
|
|
35,135
|
|
|
46,615
|
|
|
36,095
|
|
|||
Total interest expense
|
|
212,807
|
|
|
75,921
|
|
|
44,771
|
|
|||
Net interest income
|
|
2,096,601
|
|
|
1,893,988
|
|
|
1,420,369
|
|
|||
Provision for credit losses
|
|
106,416
|
|
|
87,870
|
|
|
92,304
|
|
|||
Net interest income after provision for credit losses
|
|
1,990,185
|
|
|
1,806,118
|
|
|
1,328,065
|
|
|||
Noninterest income:
|
|
|
|
|
|
|
||||||
Gains on investment securities, net
|
|
134,670
|
|
|
88,094
|
|
|
64,603
|
|
|||
Gains on equity warrant assets, net
|
|
138,078
|
|
|
89,142
|
|
|
54,555
|
|
|||
Client investment fees
|
|
182,068
|
|
|
130,360
|
|
|
56,136
|
|
|||
Foreign exchange fees
|
|
159,262
|
|
|
138,812
|
|
|
115,760
|
|
|||
Credit card fees
|
|
118,719
|
|
|
94,072
|
|
|
76,543
|
|
|||
Deposit service charges
|
|
89,200
|
|
|
76,097
|
|
|
58,715
|
|
|||
Lending related fees
|
|
49,920
|
|
|
41,949
|
|
|
43,265
|
|
|||
Letters of credit and standby letters of credit fees
|
|
42,669
|
|
|
34,600
|
|
|
28,544
|
|
|||
Investment banking revenue
|
|
195,177
|
|
|
—
|
|
|
—
|
|
|||
Commissions
|
|
56,346
|
|
|
—
|
|
|
—
|
|
|||
Other
|
|
55,370
|
|
|
51,858
|
|
|
59,110
|
|
|||
Total noninterest income
|
|
1,221,479
|
|
|
744,984
|
|
|
557,231
|
|
|||
Noninterest expense:
|
|
|
|
|
|
|
||||||
Compensation and benefits
|
|
989,734
|
|
|
726,980
|
|
|
606,402
|
|
|||
Professional services
|
|
205,479
|
|
|
158,835
|
|
|
121,935
|
|
|||
Premises and equipment
|
|
96,770
|
|
|
77,918
|
|
|
71,753
|
|
|||
Net occupancy
|
|
69,279
|
|
|
54,753
|
|
|
48,397
|
|
|||
Business development and travel
|
|
68,912
|
|
|
48,180
|
|
|
41,978
|
|
|||
FDIC and state assessments
|
|
18,509
|
|
|
34,276
|
|
|
35,069
|
|
|||
Other
|
|
152,579
|
|
|
87,251
|
|
|
85,121
|
|
|||
Total noninterest expense
|
|
1,601,262
|
|
|
1,188,193
|
|
|
1,010,655
|
|
|||
Income before income tax expense
|
|
1,610,402
|
|
|
1,362,909
|
|
|
874,641
|
|
|||
Income tax expense
|
|
425,685
|
|
|
351,561
|
|
|
355,463
|
|
|||
Net income before noncontrolling interests
|
|
1,184,717
|
|
|
1,011,348
|
|
|
519,178
|
|
|||
Net income attributable to noncontrolling interests
|
|
(47,861
|
)
|
|
(37,508
|
)
|
|
(28,672
|
)
|
|||
Net income available to common stockholders
|
|
$
|
1,136,856
|
|
|
$
|
973,840
|
|
|
$
|
490,506
|
|
Earnings per common share—basic
|
|
$
|
21.90
|
|
|
$
|
18.35
|
|
|
$
|
9.33
|
|
Earnings per common share—diluted
|
|
21.73
|
|
|
18.11
|
|
|
9.20
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Net income before noncontrolling interests
|
|
$
|
1,184,717
|
|
|
$
|
1,011,348
|
|
|
$
|
519,178
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
||||||
Change in foreign currency cumulative translation gains and losses:
|
|
|
|
|
|
|
||||||
Foreign currency translation gains (losses)
|
|
3,208
|
|
|
(5,999
|
)
|
|
6,355
|
|
|||
Related tax (expense) benefit
|
|
(889
|
)
|
|
1,669
|
|
|
(2,587
|
)
|
|||
Change in unrealized gains and losses on available-for-sale securities:
|
|
|
|
|
|
|
||||||
Unrealized holding gains (losses)
|
|
189,813
|
|
|
(22,348
|
)
|
|
(47,161
|
)
|
|||
Related tax (expense) benefit
|
|
(52,697
|
)
|
|
6,315
|
|
|
19,282
|
|
|||
Reclassification adjustment for losses included in net
income
|
|
3,905
|
|
|
740
|
|
|
5,189
|
|
|||
Related tax benefit
|
|
(1,087
|
)
|
|
(205
|
)
|
|
(2,098
|
)
|
|||
Reclassification of unrealized gains on equity securities to retained earnings for ASU 2016-01
|
|
—
|
|
|
(40,316
|
)
|
|
—
|
|
|||
Related tax expense
|
|
—
|
|
|
11,145
|
|
|
—
|
|
|||
Amortization of unrealized gains on securities transferred from
available-for-sale to held-to-maturity
|
|
(2,158
|
)
|
|
(4,607
|
)
|
|
(6,475
|
)
|
|||
Related tax benefit
|
|
600
|
|
|
1,277
|
|
|
2,593
|
|
|||
Reclassification of stranded tax effect to retained earnings for ASU 2018-02
|
|
—
|
|
|
(319
|
)
|
|
—
|
|
|||
Change in unrealized gains and losses on cash flow hedges:
|
|
|
|
|
|
|
||||||
Unrealized losses
|
|
(8,305
|
)
|
|
—
|
|
|
—
|
|
|||
Related tax benefit
|
|
2,306
|
|
|
—
|
|
|
—
|
|
|||
Reclassification adjustment for losses included in net income
|
|
5,358
|
|
|
—
|
|
|
—
|
|
|||
Related tax benefit
|
|
(1,489
|
)
|
|
—
|
|
|
—
|
|
|||
Other comprehensive income (loss), net of tax
|
|
138,565
|
|
|
(52,648
|
)
|
|
(24,902
|
)
|
|||
Comprehensive income
|
|
1,323,282
|
|
|
958,700
|
|
|
494,276
|
|
|||
Comprehensive income attributable to noncontrolling interests
|
|
(47,861
|
)
|
|
(37,508
|
)
|
|
(28,672
|
)
|
|||
Comprehensive income attributable to SVBFG
|
|
$
|
1,275,421
|
|
|
$
|
921,192
|
|
|
$
|
465,604
|
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-in Capital
|
|
Retained Earnings
|
|
Accumulated Other
Comprehensive Income (Loss)
|
|
Total SVBFG
Stockholders’ Equity
|
|
Noncontrolling Interests
|
|
Total Equity
|
|||||||||||||||||||
(Dollars in thousands, except share data)
|
|
|
Shares
|
|
Amount
|
|
|
|
|
|
|
||||||||||||||||||||||||
Balance at December 31, 2016
|
|
$
|
—
|
|
|
52,254,074
|
|
|
$
|
52
|
|
|
$
|
1,242,741
|
|
|
$
|
2,376,331
|
|
|
$
|
23,430
|
|
|
$
|
3,642,554
|
|
|
$
|
134,483
|
|
|
$
|
3,777,037
|
|
Common stock issued under employee benefit plans, net of restricted stock cancellations
|
|
—
|
|
|
570,276
|
|
|
1
|
|
|
24,908
|
|
|
—
|
|
|
—
|
|
|
24,909
|
|
|
—
|
|
|
24,909
|
|
||||||||
Common stock issued under ESOP
|
|
—
|
|
|
10,838
|
|
|
—
|
|
|
2,094
|
|
|
—
|
|
|
—
|
|
|
2,094
|
|
|
—
|
|
|
2,094
|
|
||||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
490,506
|
|
|
—
|
|
|
490,506
|
|
|
28,672
|
|
|
519,178
|
|
||||||||
Capital calls and distributions, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(23,535
|
)
|
|
(23,535
|
)
|
||||||||
Net change in unrealized gains and losses on AFS securities, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(24,788
|
)
|
|
(24,788
|
)
|
|
—
|
|
|
(24,788
|
)
|
||||||||
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,882
|
)
|
|
(3,882
|
)
|
|
—
|
|
|
(3,882
|
)
|
||||||||
Foreign currency translation adjustments, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,768
|
|
|
3,768
|
|
|
—
|
|
|
3,768
|
|
||||||||
Share-based compensation, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
44,634
|
|
|
—
|
|
|
—
|
|
|
44,634
|
|
|
—
|
|
|
44,634
|
|
||||||||
Balance at December 31, 2017
|
|
$
|
—
|
|
|
52,835,188
|
|
|
$
|
53
|
|
|
$
|
1,314,377
|
|
|
$
|
2,866,837
|
|
|
$
|
(1,472
|
)
|
|
$
|
4,179,795
|
|
|
$
|
139,620
|
|
|
$
|
4,319,415
|
|
Cumulative adjustment for ASU 2014-09, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,802
|
)
|
|
—
|
|
|
(5,802
|
)
|
|
—
|
|
|
(5,802
|
)
|
||||||||
Cumulative adjustment for ASU 2016-01, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
103,766
|
|
|
(29,171
|
)
|
|
74,595
|
|
|
—
|
|
|
74,595
|
|
||||||||
Reclassification of stranded tax effect for ASU 2018-02
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
319
|
|
|
(319
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Common stock issued under employee benefit plans, net of restricted stock cancellations
|
|
—
|
|
|
456,845
|
|
|
1
|
|
|
15,809
|
|
|
—
|
|
|
—
|
|
|
15,810
|
|
|
—
|
|
|
15,810
|
|
||||||||
Common stock issued under ESOP
|
|
—
|
|
|
9,672
|
|
|
—
|
|
|
2,577
|
|
|
—
|
|
|
—
|
|
|
2,577
|
|
|
—
|
|
|
2,577
|
|
||||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
973,840
|
|
|
—
|
|
|
973,840
|
|
|
37,508
|
|
|
1,011,348
|
|
||||||||
Capital calls and distributions, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(28,494
|
)
|
|
(28,494
|
)
|
||||||||
Net change in unrealized gains and losses on AFS securities, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(15,498
|
)
|
|
(15,498
|
)
|
|
—
|
|
|
(15,498
|
)
|
||||||||
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,330
|
)
|
|
(3,330
|
)
|
|
—
|
|
|
(3,330
|
)
|
||||||||
Foreign currency translation adjustments, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,330
|
)
|
|
(4,330
|
)
|
|
—
|
|
|
(4,330
|
)
|
||||||||
Share-based compensation, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
45,675
|
|
|
—
|
|
|
—
|
|
|
45,675
|
|
|
—
|
|
|
45,675
|
|
||||||||
Common stock repurchases
|
|
—
|
|
|
(715,207
|
)
|
|
(1
|
)
|
|
—
|
|
|
(147,122
|
)
|
|
—
|
|
|
(147,123
|
)
|
|
—
|
|
|
(147,123
|
)
|
||||||||
Balance at December 31, 2018
|
|
$
|
—
|
|
|
52,586,498
|
|
|
$
|
53
|
|
|
$
|
1,378,438
|
|
|
$
|
3,791,838
|
|
|
$
|
(54,120
|
)
|
|
$
|
5,116,209
|
|
|
$
|
148,634
|
|
|
$
|
5,264,843
|
|
Cumulative adjustment for the adoption of premium amortization on purchased callable debt securities (ASU 2017-08) (1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(583
|
)
|
|
—
|
|
|
(583
|
)
|
|
—
|
|
|
(583
|
)
|
||||||||
Acquisition of SVB Leerink
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,256
|
|
|
5,256
|
|
||||||||
Common stock issued under employee benefit plans, net of restricted stock cancellations
|
|
—
|
|
|
586,877
|
|
|
—
|
|
|
21,312
|
|
|
—
|
|
|
—
|
|
|
21,312
|
|
|
—
|
|
|
21,312
|
|
||||||||
Common stock issued under ESOP
|
|
—
|
|
|
14,442
|
|
|
—
|
|
|
3,506
|
|
|
—
|
|
|
—
|
|
|
3,506
|
|
|
—
|
|
|
3,506
|
|
||||||||
Issuance of Series A Preferred Stock
|
|
340,138
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
340,138
|
|
|
—
|
|
|
340,138
|
|
||||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,136,856
|
|
|
—
|
|
|
1,136,856
|
|
|
47,861
|
|
|
1,184,717
|
|
||||||||
Capital calls and distributions, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(50,978
|
)
|
|
(50,978
|
)
|
||||||||
Net change in unrealized gains and losses on AFS securities, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
139,934
|
|
|
139,934
|
|
|
—
|
|
|
139,934
|
|
||||||||
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,558
|
)
|
|
(1,558
|
)
|
|
—
|
|
|
(1,558
|
)
|
||||||||
Foreign currency translation adjustments, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,319
|
|
|
2,319
|
|
|
—
|
|
|
2,319
|
|
||||||||
Net change in unrealized gains and losses on cash flow hedges, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,130
|
)
|
|
(2,130
|
)
|
|
—
|
|
|
(2,130
|
)
|
||||||||
Share-based compensation, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
66,815
|
|
|
—
|
|
|
—
|
|
|
66,815
|
|
|
—
|
|
|
66,815
|
|
||||||||
Common stock repurchases
|
|
—
|
|
|
(1,532,210
|
)
|
|
(1
|
)
|
|
—
|
|
|
(352,510
|
)
|
|
—
|
|
|
(352,511
|
)
|
|
—
|
|
|
(352,511
|
)
|
||||||||
Balance at December 31, 2019
|
|
$
|
340,138
|
|
|
51,655,607
|
|
|
$
|
52
|
|
|
$
|
1,470,071
|
|
|
$
|
4,575,601
|
|
|
$
|
84,445
|
|
|
$
|
6,470,307
|
|
|
$
|
150,773
|
|
|
$
|
6,621,080
|
|
|
(1)
|
See Note 2- "Summary of Significant Accounting Policies" of the "Notes to Consolidated Financial Statements" under Part II, Item 8 of this report for additional details.
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
|
||||||
Net income before noncontrolling interests
|
|
$
|
1,184,717
|
|
|
$
|
1,011,348
|
|
|
$
|
519,178
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
||||||
Provision for credit losses
|
|
106,416
|
|
|
87,870
|
|
|
92,304
|
|
|||
Change in fair value of equity warrant assets, net of proceeds from exercises
|
|
2,240
|
|
|
(24,417
|
)
|
|
(11,862
|
)
|
|||
Changes in fair values of derivatives, net
|
|
(18,506
|
)
|
|
(11,043
|
)
|
|
14,261
|
|
|||
Gains on investment securities, net
|
|
(134,670
|
)
|
|
(88,094
|
)
|
|
(45,547
|
)
|
|||
Distributions of earnings from non-marketable and other equity securities
|
|
95,131
|
|
|
72,015
|
|
|
45,867
|
|
|||
Depreciation and amortization
|
|
82,717
|
|
|
57,906
|
|
|
56,123
|
|
|||
Amortization of premiums and discounts on investment securities, net
|
|
15,513
|
|
|
(28
|
)
|
|
2,530
|
|
|||
Amortization of share-based compensation
|
|
66,815
|
|
|
45,675
|
|
|
36,900
|
|
|||
Amortization of deferred loan fees
|
|
(155,429
|
)
|
|
(128,077
|
)
|
|
(111,738
|
)
|
|||
Deferred income tax (benefit) expense
|
|
(3,072
|
)
|
|
(21,061
|
)
|
|
25,187
|
|
|||
Excess tax benefit from exercise of stock options and vesting of restricted shares
|
|
(9,588
|
)
|
|
(17,989
|
)
|
|
(18,014
|
)
|
|||
Losses from the write-off of premises and equipment
|
|
5,219
|
|
|
7,278
|
|
|
—
|
|
|||
Other losses (gains)
|
|
8,959
|
|
|
—
|
|
|
(3,308
|
)
|
|||
Changes in other assets and liabilities:
|
|
|
|
|
|
|
||||||
Accrued interest receivable and payable, net
|
|
(24,189
|
)
|
|
(55,834
|
)
|
|
(31,372
|
)
|
|||
Accounts receivable and payable, net
|
|
(17,019
|
)
|
|
(23,020
|
)
|
|
3,481
|
|
|||
Income tax receivable and payable, net
|
|
(11,630
|
)
|
|
(5,820
|
)
|
|
46,168
|
|
|||
Accrued compensation
|
|
(15,253
|
)
|
|
56,874
|
|
|
31,689
|
|
|||
Foreign exchange spot contracts, net
|
|
59,998
|
|
|
24,018
|
|
|
(20,891
|
)
|
|||
Other, net
|
|
(74,240
|
)
|
|
(54,039
|
)
|
|
15,909
|
|
|||
Net cash provided by operating activities
|
|
1,164,129
|
|
|
933,562
|
|
|
646,865
|
|
|||
Cash flows from investing activities:
|
|
|
|
|
|
|
||||||
Purchases of available-for-sale securities
|
|
(9,872,095
|
)
|
|
(668,264
|
)
|
|
(2,420,741
|
)
|
|||
Proceeds from sales of available-for-sale securities
|
|
2,189,087
|
|
|
474,482
|
|
|
580,871
|
|
|||
Proceeds from maturities and paydowns of available-for-sale securities
|
|
1,643,357
|
|
|
3,436,064
|
|
|
3,339,574
|
|
|||
Purchases of held-to-maturity securities
|
|
(492,502
|
)
|
|
(4,726,595
|
)
|
|
(5,967,223
|
)
|
|||
Proceeds from maturities and paydowns of held-to-maturity securities
|
|
2,124,513
|
|
|
1,891,761
|
|
|
1,708,001
|
|
|||
Purchases of non-marketable and other equity securities
|
|
(136,186
|
)
|
|
(81,574
|
)
|
|
(44,047
|
)
|
|||
Proceeds from sales and distributions of capital of non-marketable and other equity securities
|
|
113,526
|
|
|
95,025
|
|
|
51,052
|
|
|||
Net increase in loans
|
|
(4,773,775
|
)
|
|
(5,175,409
|
)
|
|
(3,170,099
|
)
|
|||
Purchases of premises and equipment
|
|
(65,479
|
)
|
|
(45,865
|
)
|
|
(50,884
|
)
|
|||
Proceeds from sale of equity valuation services business
|
|
—
|
|
|
—
|
|
|
3,000
|
|
|||
Acquisition of SVB Leerink
|
|
(102,328
|
)
|
|
—
|
|
|
—
|
|
|||
Net cash used for investing activities
|
|
(9,371,882
|
)
|
|
(4,800,375
|
)
|
|
(5,970,496
|
)
|
|||
Cash flows from financing activities:
|
|
|
|
|
|
|
||||||
Net increase in deposits
|
|
12,428,907
|
|
|
5,074,825
|
|
|
5,274,207
|
|
|||
Net (decrease) increase in short-term borrowings
|
|
(613,982
|
)
|
|
(402,318
|
)
|
|
521,062
|
|
|||
Principal payments of long-term debt
|
|
(358,395
|
)
|
|
—
|
|
|
(97,781
|
)
|
|||
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests
|
|
(50,978
|
)
|
|
(28,494
|
)
|
|
(23,535
|
)
|
|||
Net proceeds from the issuance of preferred stock
|
|
340,138
|
|
|
—
|
|
|
—
|
|
|||
Common stock repurchase
|
|
(352,511
|
)
|
|
(147,123
|
)
|
|
—
|
|
|||
Proceeds from issuance of common stock, ESPP and ESOP
|
|
24,818
|
|
|
18,387
|
|
|
27,003
|
|
|||
Net cash provided by financing activities
|
|
11,417,997
|
|
|
4,515,277
|
|
|
5,700,956
|
|
|||
Net increase in cash and cash equivalents
|
|
3,210,244
|
|
|
648,464
|
|
|
377,325
|
|
|||
Cash and cash equivalents at beginning of period
|
|
3,571,539
|
|
|
2,923,075
|
|
|
2,545,750
|
|
|||
Cash and cash equivalents at end of period
|
|
$
|
6,781,783
|
|
|
$
|
3,571,539
|
|
|
$
|
2,923,075
|
|
Supplemental disclosures:
|
|
|
|
|
|
|
||||||
Cash paid during the period for:
|
|
|
|
|
|
|
||||||
Interest
|
|
$
|
217,961
|
|
|
$
|
75,601
|
|
|
$
|
45,592
|
|
Income taxes
|
|
422,346
|
|
|
376,425
|
|
|
277,823
|
|
|||
Noncash items during the period:
|
|
|
|
|
|
|
||||||
Changes in unrealized gains and losses on available-for-sale securities, net of tax
|
|
$
|
139,934
|
|
|
$
|
(15,498
|
)
|
|
$
|
(24,788
|
)
|
Distributions of stock from investments
|
|
8,917
|
|
|
5,277
|
|
|
6,807
|
|
1.
|
Nature of Business
|
2.
|
Summary of Significant Accounting Policies
|
•
|
The length of time and the extent to which the fair value has been less than the amortized cost basis (severity and duration);
|
•
|
Adverse conditions specifically related to the security, an industry or geographic area; for example, changes in the financial condition of the issuer of the security, or in the case of an asset-backed debt security, changes in the financial condition of the underlying loan obligors. Examples of those changes include any of the following:
|
◦
|
Changes in technology;
|
◦
|
The discontinuance of a segment of the business that may affect the future earnings potential of the issuer or underlying loan obligors of the security; and
|
◦
|
Changes in the quality of the credit enhancement.
|
•
|
The historical and implied volatility of the fair value of the security;
|
•
|
The payment structure of the debt security and the likelihood of the issuer being able to make payments that increase in the future;
|
•
|
Failure of the issuer of the security to make scheduled interest or principal payments;
|
•
|
Any changes to the rating of the security by a rating agency; and
|
•
|
Recoveries or additional declines in fair value after the balance sheet date.
|
•
|
Funds of funds, which make investments in venture capital and private equity funds, and
|
•
|
Direct venture funds, which make equity investments in privately held companies.
|
Limited partnership
|
|
Company Direct and Indirect Ownership in Limited Partnership
|
|
Managed funds of funds
|
|
|
|
Strategic Investors Fund, LP
|
|
12.6
|
%
|
Capital Preferred Return Fund, LP
|
|
20.0
|
|
Growth Partners, LP
|
|
33.0
|
|
Managed direct venture funds
|
|
|
|
CP I, LP
|
|
10.7
|
|
•
|
Equity securities, such as preferred or common stock in privately-held companies in which we hold a voting interest of at least 20 percent, or in which we have the ability to exercise significant influence over the investees' operating and financial policies through board involvement or other influence, are accounted for under the equity method,
|
•
|
Investments in limited partnerships in which we hold voting interests of more than 5 percent, or in which we have the ability to exercise significant influence over the partnerships' operating and financial policies, are accounted for using the equity method, and
|
•
|
Our China Joint Venture partnership, for which we have 50 percent ownership, is accounted for under the equity method.
|
•
|
Changes in lending policies and procedures, including underwriting standards and collections, and charge-off and recovery practices;
|
•
|
Changes in national and local economic business conditions, including the market and economic condition of our clients' industry sectors;
|
•
|
Changes in the nature of our loan portfolio;
|
•
|
Changes in experience, ability, and depth of lending management and staff;
|
•
|
Changes in the trend of the volume and severity of past due and classified loans;
|
•
|
Changes in the trend of the volume of nonaccrual loans, troubled debt restructurings and other loan modifications;
|
•
|
Reserve floor for portfolio segments that would not draw a minimum reserve based on the lack of historical loan loss experience;
|
•
|
Reserve for large funded loan exposure;
|
•
|
Reserve for performing impaired loan exposure; and
|
•
|
Other factors as determined by management from time to time.
|
Leasehold improvements
|
|
Lesser of lease term or asset life
|
Furniture and equipment
|
|
7 years
|
Computer software
|
|
3-7 years
|
Computer hardware
|
|
3-5 years
|
•
|
An underlying asset value, which is estimated based on current information available in valuation reports, including any information regarding subsequent rounds of funding or performance of a company.
|
•
|
Stated strike price, which can be adjusted for certain warrants upon the occurrence of subsequent funding rounds or other future events.
|
•
|
Price volatility or risk associated with possible changes in the warrant price. The volatility assumption is based on historical price volatility of publicly traded companies within indices similar in nature to the underlying client companies issuing the warrant. The actual volatility input is based on the mean and median volatility for an individual public company within an index for the past 16 quarters, from which an average volatility was derived.
|
•
|
Actual data on terminations and exercises of our warrants are utilized as the basis for determining the expected remaining life of the warrants in each financial reporting period. Warrants may be exercised in the event of acquisitions, mergers or IPOs, and cancelled due to events such as bankruptcies, restructuring activities or additional financings. These events cause the expected remaining life assumption to be shorter than the contractual term of the warrants.
|
•
|
The risk-free interest rate is derived from the Treasury yield curve and is calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant.
|
•
|
Other adjustments, including a marketability discount, are estimated based on management's judgment about the general industry environment.
|
•
|
Number of shares and contingencies associated with obtaining warrant positions such as the funding of associated loans.
|
3.
|
Business Combination
|
(Dollars in thousands)
|
|
January 4, 2019
|
||
Cash paid
|
|
$
|
265,601
|
|
Replacement award liabilities (1)
|
|
7,629
|
|
|
Total purchase consideration
|
|
$
|
273,230
|
|
Fair value of net assets acquired
|
|
135,407
|
|
|
Goodwill
|
|
$
|
137,823
|
|
|
(1)
|
The replacement award liabilities recognized as part of the total purchase consideration and the post-combination expenses of $9.1 million related to share-based replacement awards will be paid out in cash in accordance with SVB Leerink's original grant date vesting schedules.
|
(Dollars in thousands)
|
|
January 4, 2019
|
||
Assets acquired:
|
|
|
||
Cash and cash equivalents
|
|
$
|
163,273
|
|
Investment securities
|
|
33,644
|
|
|
Accounts receivable
|
|
36,538
|
|
|
Intangible assets
|
|
60,900
|
|
|
Other assets
|
|
35,128
|
|
|
Total assets acquired
|
|
329,483
|
|
|
Liabilities assumed:
|
|
|
||
Accrued compensation
|
|
137,206
|
|
|
Due to broker-dealers
|
|
18,483
|
|
|
Other liabilities
|
|
33,131
|
|
|
Noncontrolling interests
|
|
5,256
|
|
|
Total liabilities assumed
|
|
194,076
|
|
|
Fair value of net assets acquired
|
|
$
|
135,407
|
|
(Dollars in thousands)
|
|
Estimated Fair Value
|
|
Weighted Average Estimated Useful Life - in Years
|
||
Other intangible assets:
|
|
|
|
|
||
Customer relationships
|
|
$
|
42,000
|
|
|
11.0
|
Other
|
|
18,900
|
|
|
9.9
|
|
Total other intangible assets
|
|
$
|
60,900
|
|
|
|
(Dollars in thousands)
|
|
Year ended December 31, 2019
|
||
Net interest income
|
|
$
|
1,252
|
|
Noninterest income
|
|
265,841
|
|
|
Noninterest expense
|
|
252,678
|
|
|
Income before income tax expense
|
|
14,415
|
|
|
Income tax expense
|
|
3,566
|
|
|
Net income attributable to noncontrolling interests
|
|
1,325
|
|
|
Net income available to common stockholders
|
|
$
|
9,524
|
|
(Dollars in thousands)
|
|
Year ended December 31, 2019
|
||
Professional fees
|
|
$
|
919
|
|
Other
|
|
396
|
|
|
Total acquisition-related expenses
|
|
$
|
1,315
|
|
4.
|
Stockholders' Equity and EPS
|
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
Income Statement Location
|
|
2019
|
|
2018
|
|
2017
|
||||||
Reclassification adjustment for losses on available-for-sale securities included in net income
|
|
Gains on investment securities, net
|
|
$
|
3,905
|
|
|
$
|
740
|
|
|
$
|
5,189
|
|
Related tax benefit
|
|
Income tax expense
|
|
(1,087
|
)
|
|
(205
|
)
|
|
(2,098
|
)
|
|||
Reclassification adjustment for losses on cash flow hedges included in net income
|
|
Net interest income
|
|
5,358
|
|
|
—
|
|
|
—
|
|
|||
Related tax benefit
|
|
Income tax expense
|
|
(1,489
|
)
|
|
—
|
|
|
—
|
|
|||
Total reclassification adjustment for losses included in net income, net of tax
|
|
|
|
$
|
6,687
|
|
|
$
|
535
|
|
|
$
|
3,091
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Balance, beginning of period, net of tax
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Net decrease in fair value, net of tax
|
|
(5,999
|
)
|
|
—
|
|
|
—
|
|
|||
Net realized loss reclassified to net income, net of tax
|
|
3,869
|
|
|
—
|
|
|
—
|
|
|||
Balance, end of period, net of tax
|
|
$
|
(2,130
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars and shares in thousands, except per share amounts)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Numerator:
|
|
|
|
|
|
|
||||||
Net income available to common stockholders
|
|
$
|
1,136,856
|
|
|
$
|
973,840
|
|
|
$
|
490,506
|
|
Denominator:
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding—basic
|
|
51,915
|
|
|
53,078
|
|
|
52,588
|
|
|||
Weighted average effect of dilutive securities:
|
|
|
|
|
|
|
||||||
Stock options and ESPP
|
|
227
|
|
|
377
|
|
|
385
|
|
|||
Restricted stock units
|
|
169
|
|
|
317
|
|
|
333
|
|
|||
Weighted average common shares outstanding—diluted
|
|
52,311
|
|
|
53,772
|
|
|
53,306
|
|
|||
Earnings per common share:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
21.90
|
|
|
$
|
18.35
|
|
|
$
|
9.33
|
|
Diluted
|
|
21.73
|
|
|
18.11
|
|
|
9.20
|
|
|
|
Year ended December 31,
|
|||||||
(Shares in thousands)
|
|
2019
|
|
2018
|
|
2017
|
|||
Stock options
|
|
167
|
|
|
59
|
|
|
73
|
|
Restricted stock units
|
|
250
|
|
|
85
|
|
|
1
|
|
Total
|
|
417
|
|
|
144
|
|
|
74
|
|
Series
|
|
Description
|
|
Amount outstanding (in millions)
|
|
Carrying value
(in millions)
|
|
Shares issued and outstanding
|
|
Par Value
|
|
Ownership interest per depository share
|
|
Liquidation preference per depository share
|
|
2019 dividends paid per depository share
|
||||||||||
Series A
|
|
5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock
|
|
$
|
350
|
|
|
$
|
340.1
|
|
|
350,000
|
|
$
|
0.001
|
|
|
1/40th
|
|
$
|
25
|
|
|
$
|
—
|
|
5.
|
Share-Based Compensation
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Share-based compensation expense
|
|
$
|
66,815
|
|
|
$
|
45,675
|
|
|
$
|
36,900
|
|
Income tax benefit related to share-based compensation expense
|
|
(16,152
|
)
|
|
(10,997
|
)
|
|
(12,845
|
)
|
|||
Capitalized compensation costs
|
|
1,517
|
|
|
1,466
|
|
|
1,071
|
|
(Dollars in thousands)
|
|
Unrecognized
Expense
|
|
Weighted Average Expected Recognition Period - in Years
|
||
Stock options
|
|
$
|
14,313
|
|
|
2.52
|
Restricted stock awards/units
|
|
101,310
|
|
|
2.66
|
|
Total unrecognized share-based compensation expense
|
|
$
|
115,623
|
|
|
|
Equity Incentive Plan Awards
|
|
2019
|
|
2018
|
|
2017
|
||||||
Weighted average expected term of options - in years
|
|
4.6
|
|
|
4.8
|
|
|
4.9
|
|
|||
Weighted average expected volatility of the Company's underlying common stock
|
|
35.5
|
%
|
|
34.7
|
%
|
|
33.7
|
%
|
|||
Risk-free interest rate
|
|
2.26
|
|
|
2.82
|
|
|
1.81
|
|
|||
Expected dividend yield
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Weighted average grant date fair value - stock options
|
|
$
|
83.50
|
|
|
$
|
105.81
|
|
|
$
|
57.81
|
|
Weighted average grant date fair value - restricted stock units
|
|
243.65
|
|
|
294.50
|
|
|
181.23
|
|
ESPP
|
|
2019
|
|
2018
|
|
2017
|
||||||
Expected term in years
|
|
0.5
|
|
|
0.5
|
|
|
0.5
|
|
|||
Weighted average expected volatility of the Company's underlying common stock
|
|
38.1
|
%
|
|
32.2
|
%
|
|
31.2
|
%
|
|||
Risk-free interest rate
|
|
2.40
|
|
|
1.79
|
|
|
0.80
|
|
|||
Expected dividend yield
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Weighted average grant date fair value
|
|
$
|
52.90
|
|
|
$
|
62.76
|
|
|
$
|
41.70
|
|
|
|
Options
|
|
Weighted
Average
Exercise Price
|
|
Weighted Average Remaining Contractual Life - in Years
|
|
Aggregate Intrinsic Value of
In-The-Money Options
|
|||||
Outstanding at December 31, 2018
|
|
679,659
|
|
|
$
|
137.19
|
|
|
|
|
|
||
Granted
|
|
126,945
|
|
|
249.15
|
|
|
|
|
|
|||
Exercised
|
|
(154,897
|
)
|
|
86.96
|
|
|
|
|
|
|||
Forfeited
|
|
(25,580
|
)
|
|
213.26
|
|
|
|
|
|
|||
Expired
|
|
(720
|
)
|
|
64.37
|
|
|
|
|
|
|||
Outstanding at December 31, 2019
|
|
625,407
|
|
|
169.33
|
|
|
3.63
|
|
$
|
55,364,613
|
|
|
Vested and expected to vest at December 31, 2019
|
|
609,849
|
|
|
167.31
|
|
|
3.58
|
|
55,128,404
|
|
||
Exercisable at December 31, 2019
|
|
361,503
|
|
|
124.70
|
|
|
2.35
|
|
46,760,360
|
|
|
|
Outstanding Options
|
|
Exercisable Options
|
||||||||||||
Range of Exercise Prices
|
|
Shares
|
|
Weighted Average Remaining Contractual Life - in Years
|
|
Weighted Average Exercise Price
|
|
Shares
|
|
Weighted Average Exercise Price
|
||||||
$71.11 - 105.14
|
|
55,724
|
|
|
0.43
|
|
$
|
73.67
|
|
|
55,724
|
|
|
$
|
73.67
|
|
105.15 - 105.84
|
|
114,449
|
|
|
3.33
|
|
105.18
|
|
|
79,188
|
|
|
105.18
|
|
||
105.85 - 108.59
|
|
99,936
|
|
|
1.33
|
|
107.94
|
|
|
99,936
|
|
|
107.94
|
|
||
108.60 - 149.65
|
|
67,573
|
|
|
2.26
|
|
129.13
|
|
|
67,573
|
|
|
129.13
|
|
||
149.66 - 180.62
|
|
80,583
|
|
|
4.34
|
|
178.07
|
|
|
37,320
|
|
|
178.04
|
|
||
180.63 - 247.01
|
|
11,966
|
|
|
6.18
|
|
226.22
|
|
|
1,578
|
|
|
210.73
|
|
||
247.02 - 255.58
|
|
117,265
|
|
|
6.33
|
|
250.43
|
|
|
—
|
|
|
—
|
|
||
255.59 - 315.12
|
|
75,647
|
|
|
5.33
|
|
305.18
|
|
|
19,617
|
|
|
304.39
|
|
||
315.13 - 324.77
|
|
2,264
|
|
|
5.60
|
|
324.77
|
|
|
567
|
|
|
324.77
|
|
||
Total
|
|
625,407
|
|
|
3.63
|
|
169.33
|
|
|
361,503
|
|
|
124.70
|
|
|
|
Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
Nonvested at December 31, 2018
|
|
597,296
|
|
|
$
|
194.48
|
|
Granted (1)
|
|
543,938
|
|
|
243.65
|
|
|
Vested
|
|
(227,707
|
)
|
|
154.96
|
|
|
Forfeited
|
|
(65,555
|
)
|
|
195.69
|
|
|
Nonvested at December 31, 2019
|
|
847,972
|
|
|
236.54
|
|
|
(1)
|
On February 1, 2019, we granted 125,160 restricted stock awards to SVB Leerink employees at a market price of $238.28 under the retention plan previously announced on November 13, 2018. The restricted stock awards will vest over a five-year period.
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Total intrinsic value of stock options exercised
|
|
$
|
23,088
|
|
|
$
|
40,681
|
|
|
$
|
36,173
|
|
Total grant date fair value of stock options vested
|
|
5,735
|
|
|
5,823
|
|
|
6,094
|
|
|||
Total intrinsic value of restricted stock vested
|
|
56,101
|
|
|
63,917
|
|
|
40,925
|
|
|||
Total grant date fair value of restricted stock vested
|
|
35,191
|
|
|
28,813
|
|
|
23,383
|
|
6.
|
Variable Interest Entities
|
(Dollars in thousands)
|
|
Consolidated VIEs
|
|
Unconsolidated VIEs
|
|
Maximum Exposure to Loss in Unconsolidated VIEs
|
||||||
December 31, 2019:
|
|
|
|
|
|
|
||||||
Assets:
|
|
|
|
|
|
|
||||||
Cash and cash equivalents
|
|
$
|
7,629
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Non-marketable and other equity securities (1)
|
|
270,057
|
|
|
689,360
|
|
|
689,360
|
|
|||
Accrued interest receivable and other assets
|
|
1,117
|
|
|
—
|
|
|
—
|
|
|||
Total assets
|
|
$
|
278,803
|
|
|
$
|
689,360
|
|
|
$
|
689,360
|
|
Liabilities:
|
|
|
|
|
|
|
||||||
Other liabilities (1)
|
|
2,854
|
|
|
302,031
|
|
|
—
|
|
|||
Total liabilities
|
|
$
|
2,854
|
|
|
$
|
302,031
|
|
|
$
|
—
|
|
December 31, 2018:
|
|
|
|
|
|
|
||||||
Assets:
|
|
|
|
|
|
|
||||||
Cash and cash equivalents
|
|
$
|
9,058
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Non-marketable and other equity securities (1)
|
|
221,646
|
|
|
568,272
|
|
|
568,272
|
|
|||
Accrued interest receivable and other assets
|
|
228
|
|
|
—
|
|
|
—
|
|
|||
Total assets
|
|
$
|
230,932
|
|
|
$
|
568,272
|
|
|
$
|
568,272
|
|
Liabilities:
|
|
|
|
|
|
|
||||||
Other liabilities (1)
|
|
919
|
|
|
205,685
|
|
|
—
|
|
|||
Total liabilities
|
|
$
|
919
|
|
|
$
|
205,685
|
|
|
$
|
—
|
|
|
(1)
|
Included in our unconsolidated non-marketable and other equity securities portfolio at December 31, 2019 and December 31, 2018 are investments in qualified affordable housing projects of $458.5 million and $318.6 million, respectively, and related other liabilities consisting of unfunded commitments of $302.0 million and $205.7 million, respectively.
|
7.
|
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock
|
|
|
Year ended December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Average required reserve balances at FRB San Francisco
|
|
$
|
315,784
|
|
|
$
|
455,866
|
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
FHLB stock holdings
|
|
$
|
17,250
|
|
|
$
|
17,250
|
|
FRB stock holdings
|
|
43,008
|
|
|
41,628
|
|
8.
|
Cash and Cash Equivalents
|
(Dollars in thousands)
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Cash and due from banks (1)
|
|
$
|
6,492,443
|
|
|
$
|
3,444,971
|
|
Securities purchased under agreements to resell (2)
|
|
289,340
|
|
|
123,611
|
|
||
Other short-term investment securities
|
|
—
|
|
|
2,957
|
|
||
Total cash and cash equivalents
|
|
$
|
6,781,783
|
|
|
$
|
3,571,539
|
|
|
(1)
|
At December 31, 2019 and 2018, $3.7 billion and $1.7 billion, respectively, of our cash and due from banks was deposited at the FRB and was earning interest at the Federal Funds target rate, and interest-earning deposits in other financial institutions were $2.1 billion and $1.2 billion, respectively.
|
(2)
|
At December 31, 2019 and 2018, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $295 million and $126 million, respectively. None of these securities were sold or repledged as of December 31, 2019 and 2018.
|
|
|
Year ended December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Average securities purchased under agreements to resell
|
|
$
|
166,205
|
|
|
$
|
132,938
|
|
Maximum amount outstanding at any month-end during the year
|
|
613,247
|
|
|
375,180
|
|
9.
|
Investment Securities
|
|
|
December 31, 2019
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost |
|
Unrealized
Gains |
|
Unrealized
Losses |
|
Carrying
Value |
||||||||
Available-for-sale securities, at fair value:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
6,815,874
|
|
|
$
|
82,267
|
|
|
$
|
(4,131
|
)
|
|
6,894,010
|
|
|
U.S. agency debentures
|
|
100,000
|
|
|
—
|
|
|
(453
|
)
|
|
99,547
|
|
||||
Foreign government debt securities
|
|
9,037
|
|
|
1
|
|
|
—
|
|
|
9,038
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued mortgage-backed securities
|
|
4,109,372
|
|
|
39,438
|
|
|
(19
|
)
|
|
4,148,791
|
|
||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,520,414
|
|
|
17,929
|
|
|
—
|
|
|
1,538,343
|
|
||||
Agency-issued commercial mortgage-backed securities
|
|
1,339,651
|
|
|
1,078
|
|
|
(15,539
|
)
|
|
1,325,190
|
|
||||
Total available-for-sale securities
|
|
$
|
13,894,348
|
|
|
$
|
140,713
|
|
|
$
|
(20,142
|
)
|
|
$
|
14,014,919
|
|
|
|
December 31, 2018
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Carrying
Value
|
||||||||
Available-for-sale securities, at fair value:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
4,762,182
|
|
|
$
|
11,638
|
|
|
$
|
(35,562
|
)
|
|
$
|
4,738,258
|
|
U.S. agency debentures
|
|
1,090,426
|
|
|
61
|
|
|
(6,370
|
)
|
|
1,084,117
|
|
||||
Foreign government debt securities
|
|
5,815
|
|
|
—
|
|
|
(3
|
)
|
|
5,812
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,922,618
|
|
|
—
|
|
|
(42,400
|
)
|
|
1,880,218
|
|
||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
81,270
|
|
|
383
|
|
|
(15
|
)
|
|
81,638
|
|
||||
Total available-for-sale securities
|
|
$
|
7,862,311
|
|
|
$
|
12,082
|
|
|
$
|
(84,350
|
)
|
|
$
|
7,790,043
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Sales proceeds
|
|
$
|
2,189,087
|
|
|
$
|
474,482
|
|
|
$
|
580,871
|
|
Net realized gains and losses:
|
|
|
|
|
|
|
||||||
Gross realized gains
|
|
1,250
|
|
|
127
|
|
|
5,113
|
|
|||
Gross realized losses
|
|
(5,155
|
)
|
|
(867
|
)
|
|
(10,302
|
)
|
|||
Net realized losses
|
|
$
|
(3,905
|
)
|
|
$
|
(740
|
)
|
|
$
|
(5,189
|
)
|
|
|
December 31, 2019
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer (1)
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury securities
|
|
$
|
971,572
|
|
|
$
|
(3,996
|
)
|
|
$
|
449,850
|
|
|
$
|
(135
|
)
|
|
$
|
1,421,422
|
|
|
$
|
(4,131
|
)
|
U.S. agency debentures
|
|
99,547
|
|
|
(453
|
)
|
|
—
|
|
|
—
|
|
|
99,547
|
|
|
(453
|
)
|
||||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued mortgage-backed securities
|
|
4,014
|
|
|
(19
|
)
|
|
—
|
|
|
—
|
|
|
4,014
|
|
|
(19
|
)
|
||||||
Agency-issued commercial mortgage-backed securities
|
|
1,027,232
|
|
|
(15,539
|
)
|
|
—
|
|
|
—
|
|
|
1,027,232
|
|
|
(15,539
|
)
|
||||||
Total temporarily impaired securities (1)
|
|
$
|
2,102,365
|
|
|
$
|
(20,007
|
)
|
|
$
|
449,850
|
|
|
$
|
(135
|
)
|
|
$
|
2,552,215
|
|
|
$
|
(20,142
|
)
|
|
(1)
|
As of December 31, 2019, we identified a total of 58 investments that were in unrealized loss positions, of which 12 investments totaling $0.4 billion with unrealized losses of $0.1 million have been in an impaired position for a period of time greater than 12 months. As of December 31, 2019, we do not intend to sell any of our impaired securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis. Based on our analysis as of December 31, 2019, we deem all impairments to be temporary, and therefore changes in value for our temporarily impaired securities as of the same date are included in other comprehensive income. Market valuations and impairment analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis.
|
|
|
December 31, 2018
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer (1)
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury securities
|
|
$
|
494,287
|
|
|
$
|
(3,785
|
)
|
|
$
|
3,568,119
|
|
|
$
|
(31,777
|
)
|
|
$
|
4,062,406
|
|
|
$
|
(35,562
|
)
|
U.S. agency debentures
|
|
443,790
|
|
|
(1,602
|
)
|
|
591,216
|
|
|
(4,768
|
)
|
|
1,035,006
|
|
|
(6,370
|
)
|
||||||
Foreign government debt securities
|
|
5,812
|
|
|
(3
|
)
|
|
—
|
|
|
—
|
|
|
5,812
|
|
|
(3
|
)
|
||||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
13,430
|
|
|
(22
|
)
|
|
1,866,788
|
|
|
(42,378
|
)
|
|
1,880,218
|
|
|
(42,400
|
)
|
||||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
—
|
|
|
—
|
|
|
13,516
|
|
|
(15
|
)
|
|
13,516
|
|
|
(15
|
)
|
||||||
Total temporarily impaired securities (1)
|
|
$
|
957,319
|
|
|
$
|
(5,412
|
)
|
|
$
|
6,039,639
|
|
|
$
|
(78,938
|
)
|
|
$
|
6,996,958
|
|
|
$
|
(84,350
|
)
|
|
(1)
|
As of December 31, 2018, we identified a total of 200 investments that were in unrealized loss positions, of which 162 investments totaling $6.0 billion with unrealized losses of $78.9 million have been in an impaired position for a period of time greater than 12 months.
|
|
|
December 31, 2019
|
||||||||||||||||||
(Dollars in thousands)
|
|
Total
|
|
One Year
or Less |
|
After One
Year to Five Years |
|
After Five
Years to Ten Years |
|
After
Ten Years |
||||||||||
U.S. Treasury securities
|
|
$
|
6,894,010
|
|
|
$
|
1,835,971
|
|
|
$
|
1,890,778
|
|
|
$
|
3,167,261
|
|
|
$
|
—
|
|
U.S. agency debentures
|
|
99,547
|
|
|
—
|
|
|
—
|
|
|
99,547
|
|
|
—
|
|
|||||
Foreign government debt securities
|
|
9,038
|
|
|
9,038
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Agency-issued collateralized mortgage-backed securities
|
|
4,148,791
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,148,791
|
|
|||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,538,343
|
|
|
—
|
|
|
—
|
|
|
1,858
|
|
|
1,536,485
|
|
|||||
Agency -issued commercial mortgage-backed securities
|
|
1,325,190
|
|
|
—
|
|
|
—
|
|
|
743,874
|
|
|
581,316
|
|
|||||
Total
|
|
$
|
14,014,919
|
|
|
$
|
1,845,009
|
|
|
$
|
1,890,778
|
|
|
$
|
4,012,540
|
|
|
$
|
6,266,592
|
|
|
|
December 31, 2019
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair Value
|
||||||||
Held-to-maturity securities, at cost:
|
|
|
|
|
|
|
|
|
||||||||
U.S. agency debentures (1)
|
|
$
|
518,728
|
|
|
$
|
6,640
|
|
|
$
|
(668
|
)
|
|
$
|
524,700
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued mortgage-backed securities
|
|
6,992,009
|
|
|
142,209
|
|
|
(2,066
|
)
|
|
7,132,152
|
|
||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
1,608,032
|
|
|
592
|
|
|
(8,502
|
)
|
|
1,600,122
|
|
||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
178,611
|
|
|
94
|
|
|
(259
|
)
|
|
178,446
|
|
||||
Agency-issued commercial mortgage-backed securities
|
|
2,759,615
|
|
|
56,914
|
|
|
(4,508
|
)
|
|
2,812,021
|
|
||||
Municipal bonds and notes
|
|
1,785,951
|
|
|
83,314
|
|
|
(1,434
|
)
|
|
1,867,831
|
|
||||
Total held-to-maturity securities
|
|
$
|
13,842,946
|
|
|
$
|
289,763
|
|
|
$
|
(17,437
|
)
|
|
$
|
14,115,272
|
|
|
(1)
|
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
|
|
|
December 31, 2018
|
||||||||||||||
(Dollars in thousands)
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair Value
|
||||||||
Held-to-maturity securities, at cost:
|
|
|
|
|
|
|
|
|
||||||||
U.S. agency debentures (1)
|
|
$
|
640,990
|
|
|
$
|
2,148
|
|
|
$
|
(4,850
|
)
|
|
$
|
638,288
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued mortgage-backed securities
|
|
8,103,638
|
|
|
5,011
|
|
|
(157,767
|
)
|
|
7,950,882
|
|
||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
2,183,204
|
|
|
—
|
|
|
(62,272
|
)
|
|
2,120,932
|
|
||||
Agency-issued collateralized mortgage obligations—variable rate
|
|
214,483
|
|
|
608
|
|
|
(14
|
)
|
|
215,077
|
|
||||
Agency-issued commercial mortgage-backed securities
|
|
2,769,706
|
|
|
6,969
|
|
|
(64,374
|
)
|
|
2,712,301
|
|
||||
Municipal bonds and notes
|
|
1,575,421
|
|
|
2,304
|
|
|
(26,969
|
)
|
|
1,550,756
|
|
||||
Total held-to-maturity securities
|
|
$
|
15,487,442
|
|
|
$
|
17,040
|
|
|
$
|
(316,246
|
)
|
|
$
|
15,188,236
|
|
|
(1)
|
Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
|
|
|
December 31, 2019
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer (1)
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
Held-to-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. agency debentures
|
|
$
|
125,304
|
|
|
$
|
(668
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
125,304
|
|
|
$
|
(668
|
)
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued mortgage-backed securities
|
|
132,042
|
|
|
(420
|
)
|
|
181,585
|
|
|
(1,646
|
)
|
|
313,627
|
|
|
(2,066
|
)
|
||||||
Agency-issued collateralized mortgage
obligations—fixed rate
|
|
350,868
|
|
|
(1,131
|
)
|
|
872,527
|
|
|
(7,371
|
)
|
|
1,223,395
|
|
|
(8,502
|
)
|
||||||
Agency-issued collateralized mortgage
obligations—variable rate
|
|
143,265
|
|
|
(256
|
)
|
|
4,615
|
|
|
(3
|
)
|
|
147,880
|
|
|
(259
|
)
|
||||||
Agency-issued commercial mortgage-backed
securities
|
|
307,087
|
|
|
(1,818
|
)
|
|
310,229
|
|
|
(2,690
|
)
|
|
617,316
|
|
|
(4,508
|
)
|
||||||
Municipal bonds and notes
|
|
160,414
|
|
|
(1,434
|
)
|
|
—
|
|
|
—
|
|
|
160,414
|
|
|
(1,434
|
)
|
||||||
Total temporarily impaired securities (1)
|
|
$
|
1,218,980
|
|
|
$
|
(5,727
|
)
|
|
$
|
1,368,956
|
|
|
$
|
(11,710
|
)
|
|
$
|
2,587,936
|
|
|
$
|
(17,437
|
)
|
|
(1)
|
As of December 31, 2019, we identified a total of 266 investments that were in unrealized loss positions, of which 143 investments totaling $1.4 billion with unrealized losses of $11.7 million have been in an impaired position for a period of time greater than 12 months. As of December 31, 2019, we do not intend to sell any of our impaired securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis, which is consistent with our classification of these securities. Based on our analysis as of December 31, 2019, we deem all impairments to be temporary. Market valuations and impairment analyses on assets in the HTM securities portfolio are reviewed and monitored on a quarterly basis.
|
|
|
December 31, 2018
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer (1)
|
|
Total
|
||||||||||||||||||
(Dollars in thousands)
|
|
Fair Value of
Investments |
|
Unrealized
Losses |
|
Fair Value of
Investments |
|
Unrealized
Losses |
|
Fair Value of
Investments |
|
Unrealized
Losses |
||||||||||||
Held-to-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. agency debentures
|
|
$
|
291,432
|
|
|
$
|
(2,915
|
)
|
|
$
|
66,624
|
|
|
$
|
(1,935
|
)
|
|
$
|
358,056
|
|
|
$
|
(4,850
|
)
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency-issued mortgage-backed securities
|
|
2,493,156
|
|
|
(34,956
|
)
|
|
3,972,690
|
|
|
(122,811
|
)
|
|
6,465,846
|
|
|
(157,767
|
)
|
||||||
Agency-issued collateralized mortgage obligations—fixed rate
|
|
16,952
|
|
|
(109
|
)
|
|
2,103,980
|
|
|
(62,163
|
)
|
|
2,120,932
|
|
|
(62,272
|
)
|
||||||
Agency-issued collateralized mortgage
obligations—variable rate
|
|
3,364
|
|
|
(1
|
)
|
|
8,101
|
|
|
(13
|
)
|
|
11,465
|
|
|
(14
|
)
|
||||||
Agency-issued commercial mortgage-backed securities
|
|
177,697
|
|
|
(1,580
|
)
|
|
1,600,277
|
|
|
(62,794
|
)
|
|
1,777,974
|
|
|
(64,374
|
)
|
||||||
Municipal bonds and notes
|
|
868,751
|
|
|
(17,075
|
)
|
|
340,413
|
|
|
(9,894
|
)
|
|
1,209,164
|
|
|
(26,969
|
)
|
||||||
Total temporarily impaired securities (1)
|
|
$
|
3,851,352
|
|
|
$
|
(56,636
|
)
|
|
$
|
8,092,085
|
|
|
$
|
(259,610
|
)
|
|
$
|
11,943,437
|
|
|
$
|
(316,246
|
)
|
|
(1)
|
As of December 31, 2018, we identified a total of 1,244 investments that were in unrealized loss positions, of which 695 investments totaling $8.1 billion with unrealized losses of $259.6 million have been in an impaired position for a period of time greater than 12 months.
|
|
|
December 31, 2019
|
||||||||||||||||||||||||||||||||||||||
|
|
Total
|
|
One Year
or Less
|
|
After One Year to
Five Years
|
|
After Five Years to
Ten Years
|
|
After
Ten Years
|
||||||||||||||||||||||||||||||
(Dollars in thousands)
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||||||||||||||
U.S. agency debentures
|
|
$
|
518,728
|
|
|
$
|
524,700
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
123,100
|
|
|
$
|
123,969
|
|
|
$
|
395,628
|
|
|
$
|
400,731
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Agency-issued mortgage-backed securities
|
|
6,992,009
|
|
|
7,132,152
|
|
|
2,066
|
|
|
2,117
|
|
|
76,759
|
|
|
76,956
|
|
|
726,422
|
|
|
725,854
|
|
|
6,186,762
|
|
|
6,327,225
|
|
||||||||||
Agency-issued collateralized mortgage obligations - fixed rate
|
|
1,608,032
|
|
|
1,600,122
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
624,128
|
|
|
619,180
|
|
|
983,904
|
|
|
980,942
|
|
||||||||||
Agency-issued collateralized mortgage obligations - variable rate
|
|
178,611
|
|
|
178,446
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
178,611
|
|
|
178,446
|
|
||||||||||
Agency-issued commercial mortgage-backed securities
|
|
2,759,615
|
|
|
2,812,021
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
102,633
|
|
|
110,836
|
|
|
2,656,982
|
|
|
2,701,185
|
|
||||||||||
Municipal bonds and notes
|
|
1,785,951
|
|
|
1,867,831
|
|
|
13,973
|
|
|
13,984
|
|
|
83,368
|
|
|
84,773
|
|
|
387,278
|
|
|
403,736
|
|
|
1,301,332
|
|
|
1,365,338
|
|
||||||||||
Total
|
|
$
|
13,842,946
|
|
|
$
|
14,115,272
|
|
|
$
|
16,039
|
|
|
$
|
16,101
|
|
|
$
|
283,227
|
|
|
$
|
285,698
|
|
|
$
|
2,236,089
|
|
|
$
|
2,260,337
|
|
|
$
|
11,307,591
|
|
|
$
|
11,553,136
|
|
(Dollars in thousands)
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Non-marketable and other equity securities:
|
|
|
|
|
||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
||||
Consolidated venture capital and private equity fund investments (1)
|
|
$
|
87,180
|
|
|
$
|
118,333
|
|
Unconsolidated venture capital and private equity fund investments (2)
|
|
178,217
|
|
|
201,098
|
|
||
Other investments without a readily determinable fair value (3)
|
|
55,255
|
|
|
25,668
|
|
||
Other equity securities in public companies (fair value accounting) (4)
|
|
59,200
|
|
|
20,398
|
|
||
Non-marketable securities (equity method accounting) (5):
|
|
|
|
|
||||
Venture capital and private equity fund investments
|
|
215,367
|
|
|
129,485
|
|
||
Debt funds
|
|
7,271
|
|
|
5,826
|
|
||
Other investments
|
|
152,863
|
|
|
121,721
|
|
||
Investments in qualified affordable housing projects, net (6)
|
|
458,476
|
|
|
318,575
|
|
||
Total non-marketable and other equity securities
|
|
$
|
1,213,829
|
|
|
$
|
941,104
|
|
|
(1)
|
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at December 31, 2019 and 2018 (fair value accounting):
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
Strategic Investors Fund, LP
|
|
$
|
5,729
|
|
|
12.6
|
%
|
|
$
|
12,452
|
|
|
12.6
|
%
|
Capital Preferred Return Fund, LP
|
|
45,341
|
|
|
20.0
|
|
|
53,957
|
|
|
20.0
|
|
||
Growth Partners, LP
|
|
35,976
|
|
|
33.0
|
|
|
50,845
|
|
|
33.0
|
|
||
CP I, LP
|
|
134
|
|
|
10.7
|
|
|
1,079
|
|
|
10.7
|
|
||
Total consolidated venture capital and private equity fund investments
|
|
$
|
87,180
|
|
|
|
|
$
|
118,333
|
|
|
|
(2)
|
The carrying value represents investments in 205 and 213 funds (primarily venture capital funds) at December 31, 2019 and December 31, 2018, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30th for our December 31st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.
|
(3)
|
These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.
|
(Dollars in thousands)
|
|
Year ended December 31, 2019
|
|
Cumulative Adjustments
|
||||
Measurement alternative:
|
|
|
|
|
||||
Carrying value at December 31, 2019
|
|
$
|
55,255
|
|
|
|
||
Carrying value adjustments:
|
|
|
|
|
||||
Impairment
|
|
$
|
(460
|
)
|
|
$
|
(460
|
)
|
Upward changes for observable prices
|
|
1,929
|
|
|
2,348
|
|
||
Downward changes for observable prices
|
|
(3,511
|
)
|
|
(5,030
|
)
|
(4)
|
Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets, direct equity investments in public companies held by our consolidated funds, and exchange traded funds held by SVB Leerink. Changes in equity securities measured at fair value are recognized through net income.
|
(5)
|
The following table shows the carrying value and our ownership percentage of each investment at December 31, 2019 and 2018 (equity method accounting):
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
Venture capital and private equity fund investments:
|
|
|
|
|
|
|
|
|
||||||
Strategic Investors Fund II, LP
|
|
$
|
3,612
|
|
|
8.6
|
%
|
|
$
|
4,670
|
|
|
8.6
|
%
|
Strategic Investors Fund III, LP
|
|
15,668
|
|
|
5.9
|
|
|
17,396
|
|
|
5.9
|
|
||
Strategic Investors Fund IV, LP
|
|
27,064
|
|
|
5.0
|
|
|
28,974
|
|
|
5.0
|
|
||
Strategic Investors Fund V funds
|
|
46,830
|
|
|
Various
|
|
|
28,189
|
|
|
Various
|
|
||
CP II, LP (i)
|
|
5,907
|
|
|
5.1
|
|
|
7,122
|
|
|
5.1
|
|
||
Other venture capital and private equity fund investments
|
|
116,286
|
|
|
Various
|
|
|
43,134
|
|
|
Various
|
|
||
Total venture capital and private equity fund investments
|
|
$
|
215,367
|
|
|
|
|
|
$
|
129,485
|
|
|
|
|
Debt funds:
|
|
|
|
|
|
|
|
|
||||||
Gold Hill Capital 2008, LP (ii)
|
|
$
|
5,525
|
|
|
15.5
|
%
|
|
$
|
3,901
|
|
|
15.5
|
%
|
Other debt funds
|
|
1,746
|
|
|
Various
|
|
|
1,925
|
|
|
Various
|
|
||
Total debt funds
|
|
$
|
7,271
|
|
|
|
|
$
|
5,826
|
|
|
|
||
Other investments:
|
|
|
|
|
|
|
|
|
||||||
SPD Silicon Valley Bank Co., Ltd.
|
|
$
|
74,190
|
|
|
50.0
|
%
|
|
$
|
76,412
|
|
|
50.0
|
%
|
Other investments
|
|
78,673
|
|
|
Various
|
|
|
45,309
|
|
|
Various
|
|
||
Total other investments
|
|
$
|
152,863
|
|
|
|
|
$
|
121,721
|
|
|
|
|
(i)
|
Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.
|
(ii)
|
Our ownership includes direct ownership interest of 11.5 percent in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.
|
(6)
|
The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of "other liabilities" on our consolidated balance sheets at December 31, 2019 and 2018:
|
(Dollars in thousands)
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Investments in qualified affordable housing projects, net
|
|
$
|
458,476
|
|
|
$
|
318,575
|
|
Other liabilities
|
|
302,031
|
|
|
205,685
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Tax credits and other tax benefits recognized
|
|
$
|
35,037
|
|
|
$
|
24,047
|
|
|
$
|
17,296
|
|
Amortization expense included in provision for income taxes (i)
|
|
28,267
|
|
|
18,876
|
|
|
17,362
|
|
|
(i)
|
All investments are amortized using the proportional amortization method and amortization expense is included in the provision for income taxes. Included in amortization expense for the year ended December 31, 2017 is a one-time cumulative effect adjustment of $3.8 million due to the decrease in value of deductions in the 2018 tax year and going forward, due to the TCJ Act federal corporate income tax rate reduction.
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Net gains (losses) on non-marketable and other equity securities:
|
|
|
|
|
|
|
||||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
||||||
Consolidated venture capital and private equity fund investments
|
|
$
|
22,507
|
|
|
$
|
20,999
|
|
|
$
|
27,186
|
|
Unconsolidated venture capital and private equity fund investments (1)
|
|
31,482
|
|
|
39,075
|
|
|
21,377
|
|
|||
Other investments without a readily determinable fair value (1)
|
|
2,742
|
|
|
3,206
|
|
|
3,842
|
|
|||
Other equity securities in public companies (fair value accounting) (1)
|
|
7,772
|
|
|
(25,483
|
)
|
|
241
|
|
|||
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
||||||
Venture capital and private equity fund investments
|
|
73,813
|
|
|
49,341
|
|
|
14,472
|
|
|||
Debt funds
|
|
1,647
|
|
|
541
|
|
|
8,950
|
|
|||
Other investments
|
|
(1,388
|
)
|
|
1,155
|
|
|
(6,276
|
)
|
|||
Total net gains on non-marketable and other equity securities
|
|
$
|
138,575
|
|
|
$
|
88,834
|
|
|
$
|
69,792
|
|
Less: Realized net gains (losses) on the sales and OTTI of non-marketable and other equity securities (2)
|
|
4,744
|
|
|
(26,097
|
)
|
|
(355
|
)
|
|||
Net gains on non-marketable and other equity securities still held
|
|
$
|
133,831
|
|
|
$
|
114,931
|
|
|
$
|
70,147
|
|
|
(1)
|
Presentation for year-ended December 31, 2017 amounts are not determined in a manner consistent with the December 31, 2018 and 2019 presentation due to the adoption of ASU 2016-01.
|
(2)
|
Realized gains and losses include sales and OTTI of non-marketable and other equity securities. Includes gains of $5.2 million on sales and $0.4 million of OTTI for the period ended December 31, 2019. Includes losses of $20.8 million and gains of $3.8 million on sales and $5.3 million and $4.2 million of OTTI for the periods ended December 31, 2018 and 2017, respectively.
|
10.
|
Loans, Allowance for Loan Losses and Allowance for Unfunded Credit Commitments
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Commercial loans:
|
|
|
|
|
||||
Software/internet
|
|
$
|
6,199,548
|
|
|
$
|
6,154,755
|
|
Hardware
|
|
1,371,159
|
|
|
1,234,557
|
|
||
Private equity/venture capital
|
|
17,801,324
|
|
|
14,110,560
|
|
||
Life science/healthcare
|
|
2,368,048
|
|
|
2,385,612
|
|
||
Premium wine
|
|
267,487
|
|
|
249,266
|
|
||
Other
|
|
420,555
|
|
|
321,978
|
|
||
Total commercial loans
|
|
28,428,121
|
|
|
24,456,728
|
|
||
Real estate secured loans:
|
|
|
|
|
||||
Premium wine (1)
|
|
820,730
|
|
|
710,397
|
|
||
Consumer loans (2)
|
|
3,286,737
|
|
|
2,612,971
|
|
||
Other
|
|
38,880
|
|
|
40,435
|
|
||
Total real estate secured loans
|
|
4,146,347
|
|
|
3,363,803
|
|
||
Construction loans
|
|
100,219
|
|
|
97,077
|
|
||
Consumer loans
|
|
489,949
|
|
|
420,672
|
|
||
Total loans, net of unearned income (3)
|
|
$
|
33,164,636
|
|
|
$
|
28,338,280
|
|
|
(1)
|
Included in our premium wine portfolio are gross construction loans of $83 million and $99 million at December 31, 2019 and 2018, respectively.
|
(2)
|
Consumer loans secured by real estate at December 31, 2019 and 2018 were comprised of the following:
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Loans for personal residence
|
|
$
|
2,829,880
|
|
|
$
|
2,251,292
|
|
Loans to eligible employees
|
|
401,396
|
|
|
290,194
|
|
||
Home equity lines of credit
|
|
55,461
|
|
|
71,485
|
|
||
Consumer loans secured by real estate
|
|
$
|
3,286,737
|
|
|
$
|
2,612,971
|
|
(3)
|
Included within our total loan portfolio are credit card loans of $395 million and $335 million at December 31, 2019 and 2018, respectively.
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Commercial loans:
|
|
|
|
|
||||
Software/internet
|
|
$
|
6,199,548
|
|
|
$
|
6,154,755
|
|
Hardware
|
|
1,371,159
|
|
|
1,234,557
|
|
||
Private equity/venture capital
|
|
17,801,324
|
|
|
14,110,560
|
|
||
Life science/healthcare
|
|
2,368,048
|
|
|
2,385,612
|
|
||
Premium wine
|
|
1,088,217
|
|
|
959,663
|
|
||
Other
|
|
559,654
|
|
|
459,490
|
|
||
Total commercial loans
|
|
29,387,950
|
|
|
25,304,637
|
|
||
Consumer loans:
|
|
|
|
|
||||
Real estate secured loans
|
|
3,286,737
|
|
|
2,612,971
|
|
||
Other consumer loans
|
|
489,949
|
|
|
420,672
|
|
||
Total consumer loans
|
|
3,776,686
|
|
|
3,033,643
|
|
||
Total loans, net of unearned income
|
|
$
|
33,164,636
|
|
|
$
|
28,338,280
|
|
(Dollars in thousands)
|
|
30 - 59
Days Past
Due
|
|
60 - 89
Days Past
Due
|
|
Equal to or Greater Than 90 Days Past Due
|
|
Total Past
Due
|
|
Current
|
|
Loans Past Due 90 Days or More Still Accruing Interest
|
||||||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
19,839
|
|
|
$
|
4,225
|
|
|
$
|
—
|
|
|
$
|
24,064
|
|
|
$
|
6,136,230
|
|
|
$
|
—
|
|
Hardware
|
|
104
|
|
|
18,084
|
|
|
—
|
|
|
18,188
|
|
|
1,357,379
|
|
|
—
|
|
||||||
Private equity/venture capital
|
|
97,893
|
|
|
383
|
|
|
3,150
|
|
|
101,426
|
|
|
17,715,964
|
|
|
3,150
|
|
||||||
Life science/healthcare
|
|
445
|
|
|
8,420
|
|
|
—
|
|
|
8,865
|
|
|
2,387,203
|
|
|
—
|
|
||||||
Premium wine
|
|
7,543
|
|
|
—
|
|
|
—
|
|
|
7,543
|
|
|
1,070,111
|
|
|
—
|
|
||||||
Other
|
|
9
|
|
|
24
|
|
|
—
|
|
|
33
|
|
|
579,446
|
|
|
—
|
|
||||||
Total commercial loans
|
|
125,833
|
|
|
31,136
|
|
|
3,150
|
|
|
160,119
|
|
|
29,246,333
|
|
|
3,150
|
|
||||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Real estate secured loans
|
|
6,282
|
|
|
—
|
|
|
365
|
|
|
6,647
|
|
|
3,271,318
|
|
|
365
|
|
||||||
Other consumer loans
|
|
164
|
|
|
283
|
|
|
—
|
|
|
447
|
|
|
489,831
|
|
|
—
|
|
||||||
Total consumer loans
|
|
6,446
|
|
|
283
|
|
|
365
|
|
|
7,094
|
|
|
3,761,149
|
|
|
365
|
|
||||||
Total gross loans excluding impaired loans
|
|
132,279
|
|
|
31,419
|
|
|
3,515
|
|
|
167,213
|
|
|
33,007,482
|
|
|
3,515
|
|
||||||
Impaired loans
|
|
5,096
|
|
|
6,805
|
|
|
12,473
|
|
|
24,374
|
|
|
128,635
|
|
|
—
|
|
||||||
Total gross loans
|
|
$
|
137,375
|
|
|
$
|
38,224
|
|
|
$
|
15,988
|
|
|
$
|
191,587
|
|
|
$
|
33,136,117
|
|
|
$
|
3,515
|
|
December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
28,134
|
|
|
$
|
6,944
|
|
|
$
|
378
|
|
|
$
|
35,456
|
|
|
$
|
6,059,672
|
|
|
$
|
378
|
|
Hardware
|
|
300
|
|
|
34
|
|
|
4
|
|
|
338
|
|
|
1,233,956
|
|
|
4
|
|
||||||
Private equity/venture capital
|
|
59,481
|
|
|
11
|
|
|
—
|
|
|
59,492
|
|
|
14,054,940
|
|
|
—
|
|
||||||
Life science/healthcare
|
|
16,082
|
|
|
817
|
|
|
19
|
|
|
16,918
|
|
|
2,410,091
|
|
|
19
|
|
||||||
Premium wine
|
|
2,953
|
|
|
14
|
|
|
—
|
|
|
2,967
|
|
|
956,285
|
|
|
—
|
|
||||||
Other
|
|
7,391
|
|
|
163
|
|
|
1
|
|
|
7,555
|
|
|
477,442
|
|
|
1
|
|
||||||
Total commercial loans
|
|
114,341
|
|
|
7,983
|
|
|
402
|
|
|
122,726
|
|
|
25,192,386
|
|
|
402
|
|
||||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Real estate secured loans
|
|
3,598
|
|
|
1,750
|
|
|
1,562
|
|
|
6,910
|
|
|
2,598,496
|
|
|
1,562
|
|
||||||
Other consumer loans
|
|
361
|
|
|
—
|
|
|
—
|
|
|
361
|
|
|
420,359
|
|
|
—
|
|
||||||
Total consumer loans
|
|
3,959
|
|
|
1,750
|
|
|
1,562
|
|
|
7,271
|
|
|
3,018,855
|
|
|
1,562
|
|
||||||
Total gross loans excluding impaired loans
|
|
118,300
|
|
|
9,733
|
|
|
1,964
|
|
|
129,997
|
|
|
28,211,241
|
|
|
1,964
|
|
||||||
Impaired loans
|
|
2,843
|
|
|
1,181
|
|
|
25,092
|
|
|
29,116
|
|
|
140,958
|
|
|
—
|
|
||||||
Total gross loans
|
|
$
|
121,143
|
|
|
$
|
10,914
|
|
|
$
|
27,056
|
|
|
$
|
159,113
|
|
|
$
|
28,352,199
|
|
|
$
|
1,964
|
|
(Dollars in thousands)
|
|
Impaired loans for
which there is a related allowance for loan losses
|
|
Impaired loans for
which there is no related allowance for loan losses
|
|
Total carrying value of impaired loans
|
|
Total unpaid principal of impaired loans
|
||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
Software/internet
|
|
$
|
64,100
|
|
|
$
|
31,472
|
|
|
$
|
95,572
|
|
|
$
|
109,736
|
|
Hardware
|
|
2,143
|
|
|
3,315
|
|
|
5,458
|
|
|
10,049
|
|
||||
Private equity/venture capital
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Life science/healthcare
|
|
25,941
|
|
|
5,671
|
|
|
31,612
|
|
|
70,600
|
|
||||
Premium wine
|
|
204
|
|
|
11,718
|
|
|
11,922
|
|
|
12,010
|
|
||||
Other
|
|
1,284
|
|
|
1,681
|
|
|
2,965
|
|
|
3,114
|
|
||||
Total commercial loans
|
|
93,672
|
|
|
53,857
|
|
|
147,529
|
|
|
205,509
|
|
||||
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
Real estate secured loans
|
|
1,766
|
|
|
3,714
|
|
|
5,480
|
|
|
8,527
|
|
||||
Total consumer loans
|
|
1,766
|
|
|
3,714
|
|
|
5,480
|
|
|
8,527
|
|
||||
Total
|
|
$
|
95,438
|
|
|
$
|
57,571
|
|
|
$
|
153,009
|
|
|
$
|
214,036
|
|
December 31, 2018:
|
|
|
|
|
|
|
|
|
||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
Software/internet
|
|
$
|
49,625
|
|
|
$
|
65,225
|
|
|
$
|
114,850
|
|
|
$
|
131,858
|
|
Hardware
|
|
1,256
|
|
|
10,250
|
|
|
11,506
|
|
|
12,159
|
|
||||
Private equity/venture capital
|
|
—
|
|
|
3,700
|
|
|
3,700
|
|
|
3,700
|
|
||||
Life science/healthcare
|
|
17,791
|
|
|
16,276
|
|
|
34,067
|
|
|
44,446
|
|
||||
Premium wine
|
|
—
|
|
|
1,301
|
|
|
1,301
|
|
|
1,365
|
|
||||
Other
|
|
411
|
|
|
—
|
|
|
411
|
|
|
411
|
|
||||
Total commercial loans
|
|
69,083
|
|
|
96,752
|
|
|
165,835
|
|
|
193,939
|
|
||||
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
Real estate secured loans
|
|
3,919
|
|
|
320
|
|
|
4,239
|
|
|
5,969
|
|
||||
Total consumer loans
|
|
3,919
|
|
|
320
|
|
|
4,239
|
|
|
5,969
|
|
||||
Total
|
|
$
|
73,002
|
|
|
$
|
97,072
|
|
|
$
|
170,074
|
|
|
$
|
199,908
|
|
Year ended December 31,
(Dollars in thousands)
|
|
Average impaired loans
|
|
Interest income recognized on impaired loans
|
||||||||||||||||||||
|
2019
|
|
2018
|
|
2017
|
|
2019
|
|
2018
|
|
2017
|
|||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
88,628
|
|
|
$
|
112,493
|
|
|
$
|
119,557
|
|
|
$
|
2,813
|
|
|
$
|
1,513
|
|
|
$
|
2,263
|
|
Hardware
|
|
12,500
|
|
|
28,540
|
|
|
35,022
|
|
|
464
|
|
|
312
|
|
|
1,061
|
|
||||||
Private equity/venture capital
|
|
2,264
|
|
|
1,327
|
|
|
556
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Life science/healthcare
|
|
44,827
|
|
|
30,144
|
|
|
30,842
|
|
|
919
|
|
|
756
|
|
|
90
|
|
||||||
Premium wine
|
|
2,912
|
|
|
2,605
|
|
|
3,249
|
|
|
311
|
|
|
68
|
|
|
152
|
|
||||||
Other
|
|
2,050
|
|
|
171
|
|
|
576
|
|
|
21
|
|
|
—
|
|
|
—
|
|
||||||
Total commercial loans
|
|
153,181
|
|
|
175,280
|
|
|
189,802
|
|
|
4,528
|
|
|
2,649
|
|
|
3,566
|
|
||||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Real estate secured loans
|
|
7,159
|
|
|
4,028
|
|
|
1,514
|
|
|
54
|
|
|
15
|
|
|
—
|
|
||||||
Other consumer loans
|
|
7
|
|
|
358
|
|
|
1,804
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total consumer loans
|
|
7,166
|
|
|
4,386
|
|
|
3,318
|
|
|
54
|
|
|
15
|
|
|
—
|
|
||||||
Total average impaired loans
|
|
$
|
160,347
|
|
|
$
|
179,666
|
|
|
$
|
193,120
|
|
|
$
|
4,582
|
|
|
$
|
2,664
|
|
|
$
|
3,566
|
|
Year ended December 31, 2019
(Dollars in thousands)
|
|
Beginning Balance December 31, 2018
|
|
Charge-offs
|
|
Recoveries
|
|
Provision for Loan Losses
|
|
Foreign Currency Translation Adjustments
|
|
Ending Balance December 31, 2019
|
||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
103,567
|
|
|
$
|
(46,930
|
)
|
|
$
|
11,363
|
|
|
$
|
31,766
|
|
|
$
|
457
|
|
|
$
|
100,223
|
|
Hardware
|
|
19,725
|
|
|
(10,056
|
)
|
|
7,069
|
|
|
2,740
|
|
|
166
|
|
|
19,644
|
|
||||||
Private equity/venture capital
|
|
98,581
|
|
|
(2,047
|
)
|
|
2,047
|
|
|
16,989
|
|
|
235
|
|
|
115,805
|
|
||||||
Life science/healthcare
|
|
32,180
|
|
|
(31,950
|
)
|
|
267
|
|
|
38,178
|
|
|
570
|
|
|
39,245
|
|
||||||
Premium wine
|
|
3,355
|
|
|
(174
|
)
|
|
—
|
|
|
1,813
|
|
|
154
|
|
|
5,148
|
|
||||||
Other
|
|
3,558
|
|
|
(415
|
)
|
|
36
|
|
|
328
|
|
|
(154
|
)
|
|
3,353
|
|
||||||
Total commercial loans
|
|
260,966
|
|
|
(91,572
|
)
|
|
20,782
|
|
|
91,814
|
|
|
1,428
|
|
|
283,418
|
|
||||||
Consumer loans
|
|
19,937
|
|
|
(1,031
|
)
|
|
256
|
|
|
2,369
|
|
|
(25
|
)
|
|
21,506
|
|
||||||
Total allowance for loan losses
|
|
$
|
280,903
|
|
|
$
|
(92,603
|
)
|
|
$
|
21,038
|
|
|
$
|
94,183
|
|
|
$
|
1,403
|
|
|
$
|
304,924
|
|
Year ended December 31, 2018
(Dollars in thousands)
|
|
Beginning Balance December 31, 2017
|
|
Charge-offs
|
|
Recoveries
|
|
Provision for (Reduction of) Loan Losses
|
|
Foreign Currency Translation Adjustments
|
|
Ending Balance December 31, 2018
|
||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
96,104
|
|
|
$
|
(42,315
|
)
|
|
$
|
5,664
|
|
|
$
|
45,068
|
|
|
$
|
(954
|
)
|
|
$
|
103,567
|
|
Hardware
|
|
27,614
|
|
|
(16,148
|
)
|
|
1,849
|
|
|
6,555
|
|
|
(145
|
)
|
|
19,725
|
|
||||||
Private equity/venture capital
|
|
82,468
|
|
|
(112
|
)
|
|
13
|
|
|
16,485
|
|
|
(273
|
)
|
|
98,581
|
|
||||||
Life science/healthcare
|
|
24,924
|
|
|
(6,662
|
)
|
|
348
|
|
|
14,347
|
|
|
(777
|
)
|
|
32,180
|
|
||||||
Premium wine
|
|
3,532
|
|
|
—
|
|
|
—
|
|
|
(182
|
)
|
|
5
|
|
|
3,355
|
|
||||||
Other
|
|
3,941
|
|
|
(2,391
|
)
|
|
3,275
|
|
|
(1,320
|
)
|
|
53
|
|
|
3,558
|
|
||||||
Total commercial loans
|
|
238,583
|
|
|
(67,628
|
)
|
|
11,149
|
|
|
80,953
|
|
|
(2,091
|
)
|
|
260,966
|
|
||||||
Consumer loans
|
|
16,441
|
|
|
(289
|
)
|
|
487
|
|
|
3,339
|
|
|
(41
|
)
|
|
19,937
|
|
||||||
Total allowance for loan losses
|
|
$
|
255,024
|
|
|
$
|
(67,917
|
)
|
|
$
|
11,636
|
|
|
$
|
84,292
|
|
|
$
|
(2,132
|
)
|
|
$
|
280,903
|
|
Year ended December 31, 2017
(Dollars in thousands) |
|
Beginning Balance December 31, 2016
|
|
Charge-offs
|
|
Recoveries
|
|
Provision for (Reduction of) Loan Losses
|
|
Foreign Currency Translation Adjustments
|
|
Ending Balance December 31, 2017
|
||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Software/internet
|
|
$
|
97,388
|
|
|
$
|
(45,012
|
)
|
|
$
|
4,649
|
|
|
$
|
38,462
|
|
|
$
|
617
|
|
|
$
|
96,104
|
|
Hardware
|
|
31,166
|
|
|
(10,414
|
)
|
|
487
|
|
|
6,051
|
|
|
324
|
|
|
27,614
|
|
||||||
Private equity/venture capital
|
|
50,299
|
|
|
(323
|
)
|
|
—
|
|
|
31,625
|
|
|
867
|
|
|
82,468
|
|
||||||
Life science/healthcare
|
|
25,446
|
|
|
(8,210
|
)
|
|
189
|
|
|
7,414
|
|
|
85
|
|
|
24,924
|
|
||||||
Premium wine
|
|
4,115
|
|
|
—
|
|
|
—
|
|
|
(540
|
)
|
|
(43
|
)
|
|
3,532
|
|
||||||
Other
|
|
4,768
|
|
|
(1,156
|
)
|
|
1,850
|
|
|
(1,459
|
)
|
|
(62
|
)
|
|
3,941
|
|
||||||
Total commercial loans
|
|
213,182
|
|
|
(65,115
|
)
|
|
7,175
|
|
|
81,553
|
|
|
1,788
|
|
|
238,583
|
|
||||||
Consumer loans
|
|
12,184
|
|
|
(1,567
|
)
|
|
1,363
|
|
|
4,386
|
|
|
75
|
|
|
16,441
|
|
||||||
Total allowance for loan losses
|
|
$
|
225,366
|
|
|
$
|
(66,682
|
)
|
|
$
|
8,538
|
|
|
$
|
85,939
|
|
|
$
|
1,863
|
|
|
$
|
255,024
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Allowance for unfunded credit commitments, beginning balance
|
|
$
|
55,183
|
|
|
$
|
51,770
|
|
|
$
|
45,265
|
|
Provision for unfunded credit commitments
|
|
12,233
|
|
|
3,578
|
|
|
6,365
|
|
|||
Foreign currency translation adjustments
|
|
240
|
|
|
(165
|
)
|
|
140
|
|
|||
Allowance for unfunded credit commitments, ending balance (1)
|
|
$
|
67,656
|
|
|
$
|
55,183
|
|
|
$
|
51,770
|
|
|
(1)
|
The “allowance for unfunded credit commitments” is included as a component of “other liabilities” on our consolidated balance sheets. See Note 22—“Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional disclosures related to our commitments to extend credit.
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||||||||||||||||
|
|
Individually Evaluated for Impairment
|
|
Collectively Evaluated for
Impairment
|
|
Individually Evaluated for Impairment
|
|
Collectively Evaluated for
Impairment
|
||||||||||||||||||||||||
(Dollars in thousands)
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
|
Allowance for loan losses
|
|
Recorded investment in loans
|
||||||||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Software/internet
|
|
$
|
26,613
|
|
|
$
|
95,572
|
|
|
$
|
73,610
|
|
|
$
|
6,103,976
|
|
|
$
|
28,527
|
|
|
$
|
114,850
|
|
|
$
|
75,040
|
|
|
$
|
6,039,905
|
|
Hardware
|
|
1,214
|
|
|
5,458
|
|
|
18,430
|
|
|
1,365,701
|
|
|
1,253
|
|
|
11,506
|
|
|
18,472
|
|
|
1,223,051
|
|
||||||||
Private equity/venture capital
|
|
—
|
|
|
—
|
|
|
115,805
|
|
|
17,801,324
|
|
|
—
|
|
|
3,700
|
|
|
98,581
|
|
|
14,106,860
|
|
||||||||
Life science/healthcare
|
|
16,414
|
|
|
31,612
|
|
|
22,831
|
|
|
2,336,436
|
|
|
7,484
|
|
|
34,067
|
|
|
24,696
|
|
|
2,351,545
|
|
||||||||
Premium wine
|
|
204
|
|
|
11,922
|
|
|
4,944
|
|
|
1,076,295
|
|
|
—
|
|
|
1,301
|
|
|
3,355
|
|
|
958,362
|
|
||||||||
Other
|
|
203
|
|
|
2,965
|
|
|
3,150
|
|
|
556,689
|
|
|
411
|
|
|
411
|
|
|
3,147
|
|
|
459,079
|
|
||||||||
Total commercial loans
|
|
44,648
|
|
|
147,529
|
|
|
238,770
|
|
|
29,240,421
|
|
|
37,675
|
|
|
165,835
|
|
|
223,291
|
|
|
25,138,802
|
|
||||||||
Total consumer loans
|
|
211
|
|
|
5,480
|
|
|
21,295
|
|
|
3,771,206
|
|
|
266
|
|
|
4,239
|
|
|
19,671
|
|
|
3,029,404
|
|
||||||||
Total
|
|
$
|
44,859
|
|
|
$
|
153,009
|
|
|
$
|
260,065
|
|
|
$
|
33,011,627
|
|
|
$
|
37,941
|
|
|
$
|
170,074
|
|
|
$
|
242,962
|
|
|
$
|
28,168,206
|
|
(Dollars in thousands)
|
|
Pass
|
|
Performing
(Criticized)
|
|
Performing Impaired (Criticized)
|
|
Nonperforming Impaired (Nonaccrual)
|
|
Total
|
||||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet
|
|
$
|
5,704,283
|
|
|
$
|
456,011
|
|
|
$
|
28,417
|
|
|
$
|
67,155
|
|
|
$
|
6,255,866
|
|
Hardware
|
|
1,266,077
|
|
|
109,490
|
|
|
3,315
|
|
|
2,143
|
|
|
1,381,025
|
|
|||||
Private equity/venture capital
|
|
17,813,128
|
|
|
4,262
|
|
|
—
|
|
|
—
|
|
|
17,817,390
|
|
|||||
Life science/healthcare
|
|
2,197,679
|
|
|
198,389
|
|
|
5,211
|
|
|
26,401
|
|
|
2,427,680
|
|
|||||
Premium wine
|
|
1,053,021
|
|
|
24,633
|
|
|
11,717
|
|
|
205
|
|
|
1,089,576
|
|
|||||
Other
|
|
571,040
|
|
|
8,439
|
|
|
1,680
|
|
|
1,285
|
|
|
582,444
|
|
|||||
Total commercial loans
|
|
28,605,228
|
|
|
801,224
|
|
|
50,340
|
|
|
97,189
|
|
|
29,553,981
|
|
|||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Real estate secured loans
|
|
3,266,748
|
|
|
11,217
|
|
|
—
|
|
|
5,480
|
|
|
3,283,445
|
|
|||||
Other consumer loans
|
|
489,903
|
|
|
375
|
|
|
—
|
|
|
—
|
|
|
490,278
|
|
|||||
Total consumer loans
|
|
3,756,651
|
|
|
11,592
|
|
|
—
|
|
|
5,480
|
|
|
3,773,723
|
|
|||||
Total gross loans
|
|
$
|
32,361,879
|
|
|
$
|
812,816
|
|
|
$
|
50,340
|
|
|
$
|
102,669
|
|
|
$
|
33,327,704
|
|
December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Software/internet
|
|
$
|
5,574,332
|
|
|
$
|
520,796
|
|
|
$
|
48,069
|
|
|
$
|
66,781
|
|
|
$
|
6,209,978
|
|
Hardware
|
|
1,146,985
|
|
|
87,309
|
|
|
10,250
|
|
|
1,256
|
|
|
1,245,800
|
|
|||||
Private equity/venture capital
|
|
14,098,281
|
|
|
16,151
|
|
|
—
|
|
|
3,700
|
|
|
14,118,132
|
|
|||||
Life science/healthcare
|
|
2,291,356
|
|
|
135,653
|
|
|
16,276
|
|
|
17,791
|
|
|
2,461,076
|
|
|||||
Premium wine
|
|
909,965
|
|
|
49,287
|
|
|
1,017
|
|
|
284
|
|
|
960,553
|
|
|||||
Other
|
|
467,653
|
|
|
17,344
|
|
|
—
|
|
|
411
|
|
|
485,408
|
|
|||||
Total commercial loans
|
|
24,488,572
|
|
|
826,540
|
|
|
75,612
|
|
|
90,223
|
|
|
25,480,947
|
|
|||||
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Real estate secured loans
|
|
2,584,261
|
|
|
21,145
|
|
|
320
|
|
|
3,919
|
|
|
2,609,645
|
|
|||||
Other consumer loans
|
|
419,771
|
|
|
949
|
|
|
—
|
|
|
—
|
|
|
420,720
|
|
|||||
Total consumer loans
|
|
3,004,032
|
|
|
22,094
|
|
|
320
|
|
|
3,919
|
|
|
3,030,365
|
|
|||||
Total gross loans
|
|
$
|
27,492,604
|
|
|
$
|
848,634
|
|
|
$
|
75,932
|
|
|
$
|
94,142
|
|
|
$
|
28,511,312
|
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Loans modified in TDRs:
|
|
|
|
|
||||
Commercial loans:
|
|
|
|
|
||||
Software/internet
|
|
$
|
71,136
|
|
|
$
|
58,089
|
|
Hardware
|
|
1,685
|
|
|
9,665
|
|
||
Life science/healthcare
|
|
20,600
|
|
|
12,738
|
|
||
Premium wine
|
|
13,457
|
|
|
2,883
|
|
||
Total commercial loans
|
|
106,878
|
|
|
83,375
|
|
||
Consumer loans:
|
|
|
|
|
||||
Other consumer loans
|
|
2,104
|
|
|
320
|
|
||
Total loans modified in TDRs
|
|
$
|
108,982
|
|
|
$
|
83,695
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Loans modified in TDRs during the period:
|
|
|
|
|
|
|
||||||
Commercial loans:
|
|
|
|
|
|
|
||||||
Software/internet
|
|
$
|
62,367
|
|
|
$
|
30,429
|
|
|
$
|
42,184
|
|
Hardware
|
|
1,685
|
|
|
9,665
|
|
|
51,132
|
|
|||
Private equity/venture capital
|
|
—
|
|
|
—
|
|
|
350
|
|
|||
Life science/healthcare
|
|
13,309
|
|
|
660
|
|
|
—
|
|
|||
Premium wine
|
|
11,017
|
|
|
—
|
|
|
177
|
|
|||
Total commercial loans
|
|
88,378
|
|
|
40,754
|
|
|
93,843
|
|
|||
Consumer loans:
|
|
|
|
|
|
|
||||||
Other consumer loans
|
|
1,793
|
|
|
320
|
|
|
—
|
|
|||
Total loans modified in TDRs during the period (1)
|
|
$
|
90,171
|
|
|
$
|
41,074
|
|
|
$
|
93,843
|
|
|
(1)
|
There were $11.3 million, $4.6 million and $3.0 million of partial charge-offs during 2019, 2018 and 2017, respectively.
|
|
|
December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
TDRs modified within the previous 12 months that defaulted during the period:
|
|
|
|
|
|
|
||||||
Commercial loans:
|
|
|
|
|
|
|
||||||
Software/internet
|
|
$
|
37,294
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Life science/healthcare
|
|
10,639
|
|
|
—
|
|
|
—
|
|
|||
Total TDRs modified within the previous 12 months that defaulted in the period
|
|
$
|
47,933
|
|
|
$
|
—
|
|
|
$
|
—
|
|
11.
|
Premises and Equipment
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Computer software
|
|
$
|
261,643
|
|
|
$
|
217,017
|
|
Computer hardware
|
|
82,643
|
|
|
70,247
|
|
||
Leasehold improvements
|
|
121,907
|
|
|
98,237
|
|
||
Furniture and equipment
|
|
46,300
|
|
|
42,319
|
|
||
Total
|
|
512,493
|
|
|
427,820
|
|
||
Accumulated depreciation and amortization
|
|
(350,617
|
)
|
|
(298,607
|
)
|
||
Premises and equipment, net
|
|
$
|
161,876
|
|
|
$
|
129,213
|
|
(Dollars in thousands)
|
|
December 31, 2019
|
||
Assets:
|
|
|
||
Right-of-use assets - operating leases (1)
|
|
$
|
197,365
|
|
Liabilities:
|
|
|
||
Lease liabilities - operating leases (1)
|
|
218,847
|
|
|
(1)
|
Included in these amounts are $21.7 million and $30.0 million of ROU assets and lease liabilities, respectively, attributable to the inclusion of SVB Leerink in our financial results at December 31, 2019.
|
(Dollars in thousands)
|
|
2019
|
||
Operating lease cost
|
|
$
|
41,049
|
|
Short-term lease cost
|
|
1,823
|
|
|
Variable lease cost
|
|
3,477
|
|
|
Less: sublease income
|
|
(4,492
|
)
|
|
Total lease expense, net
|
|
$
|
41,857
|
|
Supplemental cash flows information:
|
|
|
||
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
||
Cash paid for operating leases
|
|
$
|
44,976
|
|
Noncash items during the period:
|
|
|
||
Lease obligations in exchange for obtaining right-of-use assets:
|
|
|
||
Operating leases
|
|
$
|
33,167
|
|
|
|
December 31, 2019
|
|
Weighted-average remaining term (in years) - operating leases
|
|
6.29
|
|
Weighted-average discount rate - operating leases (1)
|
|
2.92
|
%
|
|
(1)
|
The incremental borrowing rate used to calculate the lease liability was determined based on the facts and circumstances of the economic environment and the Company’s credit standing as of the effective date of ASC 842. Additionally, the total lease term and total lease payments were also considered in determining the rate. Based on these considerations the Company identified credit terms available under its existing credit lines which represent a collateralized borrowing rate that has varying credit terms that could be matched to total lease terms and total lease payments in ultimately determining the implied borrowing rate in each lease contract.
|
Years ended December 31,
(Dollars in thousands)
|
|
Operating Leases
|
||
2020
|
|
$
|
44,791
|
|
2021
|
|
42,683
|
|
|
2022
|
|
37,669
|
|
|
2023
|
|
36,914
|
|
|
2024
|
|
26,602
|
|
|
2025 and thereafter
|
|
52,128
|
|
|
Total lease payments (1)
|
|
$
|
240,787
|
|
Less: imputed interest
|
|
(21,940
|
)
|
|
Total lease liabilities
|
|
$
|
218,847
|
|
|
(1)
|
As of December 31, 2019, we have additional leases that have not yet commenced. We estimate that we will record additional lease liabilities of $29.1 million upon commencement. These leases will commence in 2020 with lease terms of two to five years.
|
(Dollars in thousands)
|
|
Amount
|
||
2019
|
|
$
|
38,609
|
|
2020
|
|
37,575
|
|
|
2021
|
|
35,854
|
|
|
2022
|
|
31,659
|
|
|
2023
|
|
30,904
|
|
|
2024 and thereafter
|
|
49,071
|
|
|
Total minimum future payments
|
|
$
|
223,672
|
|
13.
|
Goodwill and Other Intangible Assets
|
(Dollars in thousands)
|
|
Goodwill
|
||
Beginning balance at December 31, 2018
|
|
$
|
—
|
|
Acquisitions (1)
|
|
137,823
|
|
|
Ending balance at December 31, 2019
|
|
$
|
137,823
|
|
|
(1)
|
All reported goodwill amounts have been allocated to the SVB Leerink reporting segment and are expected to be deductible for tax purposes. Refer to Note 25—“Segment Reporting” of the “Notes to the Consolidated Financial Statements” under Part II, Item 8 of this report for additional information.
|
|
|
December 31, 2019
|
||||||||||
(Dollars in thousands)
|
|
Gross Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
||||||
Other intangible assets:
|
|
|
|
|
|
|
||||||
Customer relationships
|
|
$
|
42,000
|
|
|
$
|
3,818
|
|
|
$
|
38,182
|
|
Other
|
|
18,900
|
|
|
7,665
|
|
|
11,235
|
|
|||
Total other intangible assets
|
|
$
|
60,900
|
|
|
$
|
11,483
|
|
|
$
|
49,417
|
|
Years ended December 31,
(Dollars in thousands)
|
|
Other
Intangible Assets
|
||
2020
|
|
$
|
5,382
|
|
2021
|
|
4,732
|
|
|
2022
|
|
4,732
|
|
|
2023
|
|
4,732
|
|
|
2024
|
|
4,732
|
|
|
2025 and thereafter
|
|
25,107
|
|
|
Total future amortization expense
|
|
$
|
49,417
|
|
14.
|
Deposits
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Noninterest-bearing demand
|
|
$
|
40,841,570
|
|
|
$
|
39,103,422
|
|
Interest-bearing checking and savings accounts
|
|
568,256
|
|
|
648,468
|
|
||
Money market
|
|
17,749,736
|
|
|
7,498,205
|
|
||
Money market deposits in foreign offices
|
|
352,437
|
|
|
152,781
|
|
||
Sweep deposits in foreign offices
|
|
2,057,715
|
|
|
1,875,298
|
|
||
Time
|
|
188,093
|
|
|
50,726
|
|
||
Total deposits
|
|
$
|
61,757,807
|
|
|
$
|
49,328,900
|
|
15.
|
Short-Term Borrowings and Long-Term Debt
|
|
|
|
|
|
|
Carrying Value
|
||||||||
(Dollars in thousands)
|
|
Maturity
|
|
Principal value at December 31, 2019
|
|
December 31,
2019 |
|
December 31,
2018 |
||||||
Short-term borrowings:
|
|
|
|
|
|
|
|
|
||||||
Short-term FHLB advances
|
|
|
|
|
|
|
$
|
—
|
|
|
$
|
300,000
|
|
|
Securities sold under agreement to repurchase
|
|
(1)
|
|
|
|
—
|
|
|
319,414
|
|
||||
Other short-term borrowings
|
|
(2)
|
|
$
|
17,430
|
|
|
17,430
|
|
|
11,998
|
|
||
Total short-term borrowings
|
|
|
|
|
|
$
|
17,430
|
|
|
$
|
631,412
|
|
||
Long-term debt:
|
|
|
|
|
|
|
|
|
||||||
3.50% Senior Notes
|
|
January 29, 2025
|
|
$
|
350,000
|
|
|
$
|
347,987
|
|
|
$
|
347,639
|
|
5.375% Senior Notes
|
|
|
|
|
|
|
—
|
|
|
348,826
|
|
|||
Total long-term debt
|
|
|
|
|
|
$
|
347,987
|
|
|
$
|
696,465
|
|
|
(1)
|
Securities sold under repurchase agreements are effectively short-term borrowings collateralized by U.S. Treasury securities.
|
(2)
|
Represents cash collateral received from certain counterparties in relation to market value exposures of derivative contracts in our favor.
|
Year ended December 31,
(Dollars in thousands)
|
|
Amount
|
||
2020
|
|
$
|
—
|
|
2021
|
|
—
|
|
|
2022
|
|
—
|
|
|
2023
|
|
—
|
|
|
2024
|
|
—
|
|
|
2025 and thereafter
|
|
347,987
|
|
|
Total
|
|
$
|
347,987
|
|
16.
|
Derivative Financial Instruments
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||||||||
|
|
Notional or
Contractual
Amount
|
|
Fair Value
|
|
Notional or
Contractual
Amount
|
|
Fair Value
|
||||||||||||||||
(Dollars in thousands)
|
|
|
Derivative Assets (1)
|
|
Derivative Liabilities (1)
|
|
|
Derivative Assets (1)
|
|
Derivative Liabilities (1)
|
||||||||||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate risks:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
|
$
|
1,915,000
|
|
|
$
|
22,676
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Interest rate swaps
|
|
3,085,000
|
|
|
—
|
|
|
25,623
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Currency exchange risks:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign exchange forwards
|
|
—
|
|
|
—
|
|
|
—
|
|
|
263,733
|
|
|
4,767
|
|
|
—
|
|
||||||
Foreign exchange forwards
|
|
300,250
|
|
|
—
|
|
|
2,154
|
|
|
178,310
|
|
|
—
|
|
|
1,094
|
|
||||||
Other derivative instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Equity warrant assets
|
|
225,893
|
|
|
165,473
|
|
|
—
|
|
|
223,532
|
|
|
149,238
|
|
|
—
|
|
||||||
Client foreign exchange forwards
|
|
4,661,517
|
|
|
114,546
|
|
|
—
|
|
|
2,759,878
|
|
|
93,876
|
|
|
—
|
|
||||||
Client foreign exchange forwards
|
|
4,326,059
|
|
|
—
|
|
|
94,745
|
|
|
2,568,085
|
|
|
—
|
|
|
85,706
|
|
||||||
Client foreign currency options
|
|
154,985
|
|
|
1,308
|
|
|
—
|
|
|
93,556
|
|
|
1,759
|
|
|
—
|
|
||||||
Client foreign currency options
|
|
154,985
|
|
|
—
|
|
|
1,308
|
|
|
93,579
|
|
|
—
|
|
|
1,759
|
|
||||||
Client interest rate derivatives (2)
|
|
1,275,190
|
|
|
28,811
|
|
|
—
|
|
|
1,020,416
|
|
|
8,499
|
|
|
—
|
|
||||||
Client interest rate derivatives (2)
|
|
1,372,914
|
|
|
—
|
|
|
14,154
|
|
|
1,337,328
|
|
|
—
|
|
|
9,491
|
|
||||||
Total Derivatives not designated as hedging instruments
|
|
|
|
310,138
|
|
|
112,361
|
|
|
|
|
|
258,139
|
|
|
98,050
|
|
|||||||
Total derivatives
|
|
|
|
$
|
332,814
|
|
|
$
|
137,984
|
|
|
|
|
$
|
258,139
|
|
|
$
|
98,050
|
|
|
(1)
|
Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities", respectively, on our consolidated balance sheets.
|
(2)
|
The amount reported reflects reductions of approximately $17.4 million of derivative liabilities and $0.4 million of derivative assets at December 31, 2019 and 2018, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses.
|
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
Statement of income location
|
|
2019
|
|
2018
|
|
2017
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
||||||
Interest rate risks:
|
|
|
|
|
|
|
|
|
||||||
Amounts reclassified from accumulated other comprehensive income into income
|
|
Interest income—loans
|
|
$
|
(5,358
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Net cash benefit associated with interest rate swaps
|
|
Interest expense—borrowings
|
|
—
|
|
|
—
|
|
|
1,053
|
|
|||
Changes in fair value of interest rate swaps
|
|
Other noninterest income
|
|
—
|
|
|
—
|
|
|
(7
|
)
|
|||
Net (losses) gains associated with interest rate risk derivatives
|
|
|
|
$
|
(5,358
|
)
|
|
$
|
—
|
|
|
$
|
1,046
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
||||||
Currency exchange risks:
|
|
|
|
|
|
|
|
|
||||||
Gains (losses) on revaluations of internal foreign currency instruments, net
|
|
Other noninterest income
|
|
$
|
1,444
|
|
|
$
|
(373
|
)
|
|
$
|
33,161
|
|
(Losses) gains on internal foreign exchange forward contracts, net
|
|
Other noninterest income
|
|
(1,853
|
)
|
|
52
|
|
|
(32,286
|
)
|
|||
Net (losses) gains associated with internal currency risk
|
|
|
|
$
|
(409
|
)
|
|
$
|
(321
|
)
|
|
$
|
875
|
|
Other derivative instruments:
|
|
|
|
|
|
|
|
|
||||||
(Losses) gains on revaluations of client foreign currency instruments, net
|
|
Other noninterest income
|
|
$
|
(15,146
|
)
|
|
$
|
4,998
|
|
|
$
|
10,882
|
|
Gains (losses) on client foreign exchange forward contracts, net
|
|
Other noninterest income
|
|
15,900
|
|
|
(4,011
|
)
|
|
(9,969
|
)
|
|||
Net gains associated with client currency risk
|
|
|
|
$
|
754
|
|
|
$
|
987
|
|
|
$
|
913
|
|
Net gains on equity warrant assets
|
|
Gains on equity warrant assets, net
|
|
$
|
138,078
|
|
|
$
|
89,142
|
|
|
$
|
54,555
|
|
Net losses on other derivatives
|
|
Other noninterest income
|
|
$
|
(1,190
|
)
|
|
$
|
(179
|
)
|
|
$
|
(564
|
)
|
(Dollars in thousands)
|
|
Gross Amounts of Recognized Assets
|
|
Gross Amounts offset in the Statement of Financial Position
|
|
Net Amounts of Assets Presented in the Statement of Financial Position
|
|
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
|
|
Net Amount
|
||||||||||||||
|
|
|
|
Financial Instruments
|
|
Cash Collateral Received (1)
|
|
|||||||||||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
|
$
|
22,676
|
|
|
$
|
—
|
|
|
$
|
22,676
|
|
|
$
|
(22,598
|
)
|
|
$
|
—
|
|
|
$
|
78
|
|
Foreign exchange forwards
|
|
114,546
|
|
|
—
|
|
|
114,546
|
|
|
(36,855
|
)
|
|
(17,095
|
)
|
|
60,596
|
|
||||||
Foreign currency options
|
|
1,308
|
|
|
—
|
|
|
1,308
|
|
|
(848
|
)
|
|
(335
|
)
|
|
125
|
|
||||||
Client interest rate derivatives
|
|
28,811
|
|
|
—
|
|
|
28,811
|
|
|
(28,811
|
)
|
|
—
|
|
|
—
|
|
||||||
Total derivative assets:
|
|
167,341
|
|
|
—
|
|
|
167,341
|
|
|
(89,112
|
)
|
|
(17,430
|
)
|
|
60,799
|
|
||||||
Reverse repurchase, securities borrowing, and similar arrangements
|
|
289,340
|
|
|
—
|
|
|
289,340
|
|
|
(289,340
|
)
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
456,681
|
|
|
$
|
—
|
|
|
$
|
456,681
|
|
|
$
|
(378,452
|
)
|
|
$
|
(17,430
|
)
|
|
$
|
60,799
|
|
December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign exchange forwards
|
|
$
|
98,643
|
|
|
$
|
—
|
|
|
$
|
98,643
|
|
|
$
|
(38,213
|
)
|
|
$
|
(11,825
|
)
|
|
$
|
48,605
|
|
Foreign currency options
|
|
1,759
|
|
|
—
|
|
|
1,759
|
|
|
(613
|
)
|
|
(90
|
)
|
|
1,056
|
|
||||||
Client interest rate derivatives
|
|
8,499
|
|
|
—
|
|
|
8,499
|
|
|
(8,416
|
)
|
|
(83
|
)
|
|
—
|
|
||||||
Total derivative assets:
|
|
108,901
|
|
|
—
|
|
|
108,901
|
|
|
(47,242
|
)
|
|
(11,998
|
)
|
|
49,661
|
|
||||||
Reverse repurchase, securities borrowing, and similar arrangements
|
|
123,611
|
|
|
—
|
|
|
123,611
|
|
|
(123,611
|
)
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
232,512
|
|
|
$
|
—
|
|
|
$
|
232,512
|
|
|
$
|
(170,853
|
)
|
|
$
|
(11,998
|
)
|
|
$
|
49,661
|
|
|
(1)
|
Cash collateral received from our counterparties in relation to market value exposures of derivative contracts in our favor is recorded as a component of “short-term borrowings” on our consolidated balance sheets.
|
(Dollars in thousands)
|
|
Gross Amounts of Recognized Liabilities
|
|
Gross Amounts offset in the Statement of Financial Position
|
|
Net Amounts of Liabilities Presented in the Statement of Financial Position
|
|
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
|
|
Net Amount
|
||||||||||||||
|
|
|
|
Financial Instruments
|
|
Cash Collateral Pledged (1)
|
|
|||||||||||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
|
$
|
25,623
|
|
|
$
|
—
|
|
|
$
|
25,623
|
|
|
$
|
(22,676
|
)
|
|
$
|
(2,947
|
)
|
|
$
|
—
|
|
Foreign exchange forwards
|
|
96,899
|
|
|
—
|
|
|
96,899
|
|
|
(33,314
|
)
|
|
(22,030
|
)
|
|
41,555
|
|
||||||
Foreign currency options
|
|
1,308
|
|
|
—
|
|
|
1,308
|
|
|
(531
|
)
|
|
—
|
|
|
777
|
|
||||||
Client interest rate derivatives
|
|
14,154
|
|
|
—
|
|
|
14,154
|
|
|
—
|
|
|
(13,936
|
)
|
|
218
|
|
||||||
Total derivative liabilities:
|
|
137,984
|
|
|
—
|
|
|
137,984
|
|
|
(56,521
|
)
|
|
(38,913
|
)
|
|
42,550
|
|
||||||
Repurchase, securities lending, and similar arrangements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
137,984
|
|
|
$
|
—
|
|
|
$
|
137,984
|
|
|
$
|
(56,521
|
)
|
|
$
|
(38,913
|
)
|
|
$
|
42,550
|
|
December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign exchange forwards
|
|
$
|
86,800
|
|
|
$
|
—
|
|
|
$
|
86,800
|
|
|
$
|
(24,778
|
)
|
|
$
|
(20,732
|
)
|
|
$
|
41,290
|
|
Foreign currency options
|
|
1,759
|
|
|
—
|
|
|
1,759
|
|
|
(1,054
|
)
|
|
—
|
|
|
705
|
|
||||||
Client interest rate derivatives
|
|
9,491
|
|
|
—
|
|
|
9,491
|
|
|
—
|
|
|
(9,207
|
)
|
|
284
|
|
||||||
Total derivative liabilities:
|
|
98,050
|
|
|
—
|
|
|
98,050
|
|
|
(25,832
|
)
|
|
(29,939
|
)
|
|
42,279
|
|
||||||
Repurchase, securities lending, and similar arrangements
|
|
319,414
|
|
|
—
|
|
|
319,414
|
|
|
—
|
|
|
—
|
|
|
319,414
|
|
||||||
Total
|
|
$
|
417,464
|
|
|
$
|
—
|
|
|
$
|
417,464
|
|
|
$
|
(25,832
|
)
|
|
$
|
(29,939
|
)
|
|
$
|
361,693
|
|
|
(1)
|
Cash collateral pledged to our counterparties in relation to market value exposures of derivative contracts in a liability position and repurchase agreements are recorded as a component of “cash and cash equivalents" on our consolidated balance sheets.
|
17.
|
Noninterest Income
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Noninterest income:
|
|
|
|
|
|
|
||||||
Gains on investment securities, net
|
|
$
|
134,670
|
|
|
$
|
88,094
|
|
|
$
|
64,603
|
|
Gains on equity warrant assets, net
|
|
138,078
|
|
|
89,142
|
|
|
54,555
|
|
|||
Client investment fees
|
|
182,068
|
|
|
130,360
|
|
|
56,136
|
|
|||
Foreign exchange fees
|
|
159,262
|
|
|
138,812
|
|
|
115,760
|
|
|||
Credit card fees
|
|
118,719
|
|
|
94,072
|
|
|
76,543
|
|
|||
Deposit service charges
|
|
89,200
|
|
|
76,097
|
|
|
58,715
|
|
|||
Lending related fees
|
|
49,920
|
|
|
41,949
|
|
|
43,265
|
|
|||
Letters of credit and standby letters of credit fees
|
|
42,669
|
|
|
34,600
|
|
|
28,544
|
|
|||
Investment banking revenue
|
|
195,177
|
|
|
—
|
|
|
—
|
|
|||
Commissions
|
|
56,346
|
|
|
—
|
|
|
—
|
|
|||
Other
|
|
55,370
|
|
|
51,858
|
|
|
59,110
|
|
|||
Total noninterest income
|
|
$
|
1,221,479
|
|
|
$
|
744,984
|
|
|
$
|
557,231
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Gains on non-marketable and other equity securities, net
|
|
$
|
138,575
|
|
|
$
|
88,834
|
|
|
$
|
69,792
|
|
Losses on sales of available-for-sale debt securities, net
|
|
(3,905
|
)
|
|
(740
|
)
|
|
(5,189
|
)
|
|||
Total gains on investment securities, net
|
|
$
|
134,670
|
|
|
$
|
88,094
|
|
|
$
|
64,603
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Equity warrant assets:
|
|
|
|
|
|
|
||||||
Gains on exercises, net
|
|
$
|
107,168
|
|
|
$
|
58,186
|
|
|
$
|
48,275
|
|
Terminations
|
|
(3,502
|
)
|
|
(5,964
|
)
|
|
(4,422
|
)
|
|||
Changes in fair value, net
|
|
34,412
|
|
|
36,920
|
|
|
10,702
|
|
|||
Total net gains on equity warrant assets
|
|
$
|
138,078
|
|
|
$
|
89,142
|
|
|
$
|
54,555
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Client investment fees by type:
|
|
|
|
|
|
|
||||||
Sweep money market fees
|
|
$
|
104,236
|
|
|
$
|
75,654
|
|
|
$
|
28,485
|
|
Asset management fees (1)
|
|
28,665
|
|
|
23,882
|
|
|
16,831
|
|
|||
Repurchase agreement fees
|
|
49,167
|
|
|
30,824
|
|
|
10,820
|
|
|||
Total client investment fees (2)
|
|
$
|
182,068
|
|
|
$
|
130,360
|
|
|
$
|
56,136
|
|
|
(1)
|
Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.
|
(2)
|
Represents fees earned on client investment funds which are maintained at third-party financial institutions and are not recorded on our balance sheet.
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Foreign exchange fees by instrument type:
|
|
|
|
|
|
|
||||||
Spot contract commissions
|
|
$
|
145,915
|
|
|
$
|
127,459
|
|
|
$
|
104,344
|
|
Forward contract commissions
|
|
13,068
|
|
|
10,940
|
|
|
10,934
|
|
|||
Option premium fees
|
|
279
|
|
|
413
|
|
|
482
|
|
|||
Total foreign exchange fees
|
|
$
|
159,262
|
|
|
$
|
138,812
|
|
|
$
|
115,760
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Credit card fees by instrument type:
|
|
|
|
|
|
|
||||||
Card interchange fees, net
|
|
$
|
93,553
|
|
|
$
|
74,381
|
|
|
$
|
60,224
|
|
Merchant service fees
|
|
18,355
|
|
|
14,420
|
|
|
11,584
|
|
|||
Card service fees
|
|
6,811
|
|
|
5,271
|
|
|
4,735
|
|
|||
Total credit card fees
|
|
$
|
118,719
|
|
|
$
|
94,072
|
|
|
$
|
76,543
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Lending related fees by instrument type:
|
|
|
|
|
|
|
||||||
Unused commitment fees
|
|
$
|
34,829
|
|
|
$
|
32,452
|
|
|
$
|
34,110
|
|
Other
|
|
15,091
|
|
|
9,497
|
|
|
9,155
|
|
|||
Total lending related fees
|
|
$
|
49,920
|
|
|
$
|
41,949
|
|
|
$
|
43,265
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Investment banking revenue:
|
|
|
|
|
|
|
||||||
Underwriting fees
|
|
$
|
153,306
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Advisory fees
|
|
37,846
|
|
|
—
|
|
|
—
|
|
|||
Private placements and other
|
|
4,025
|
|
|
—
|
|
|
—
|
|
|||
Total investment banking revenue
|
|
$
|
195,177
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Other noninterest income by instrument type:
|
|
|
|
|
|
|
||||||
Fund management fees
|
|
$
|
32,522
|
|
|
$
|
23,016
|
|
|
$
|
21,214
|
|
Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)
|
|
345
|
|
|
666
|
|
|
1,788
|
|
|||
(Losses) gains on extinguishment of debt
|
|
(8,960
|
)
|
|
—
|
|
|
2,731
|
|
|||
Other service revenue
|
|
31,463
|
|
|
28,176
|
|
|
33,377
|
|
|||
Total other noninterest income
|
|
$
|
55,370
|
|
|
$
|
51,858
|
|
|
$
|
59,110
|
|
|
(1)
|
Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.
|
(Dollars in thousands)
|
|
Global
Commercial
Bank (2)
|
|
SVB Private
Bank
|
|
SVB Capital (2)
|
|
SVB Leerink (2)
|
|
Other Income
|
|
Total
|
||||||||||||
Revenue from contracts with customers:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Client investment fees
|
|
$
|
180,152
|
|
|
$
|
1,916
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
182,068
|
|
Spot contract commissions
|
|
144,930
|
|
|
510
|
|
|
—
|
|
|
—
|
|
|
475
|
|
|
145,915
|
|
||||||
Card interchange fees, gross
|
|
154,197
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
756
|
|
|
154,953
|
|
||||||
Merchant service fees
|
|
18,355
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18,355
|
|
||||||
Deposit service charges
|
|
88,136
|
|
|
137
|
|
|
—
|
|
|
—
|
|
|
927
|
|
|
89,200
|
|
||||||
Investment banking revenue
|
|
—
|
|
|
—
|
|
|
—
|
|
|
195,177
|
|
|
—
|
|
|
195,177
|
|
||||||
Commissions
|
|
—
|
|
|
—
|
|
|
—
|
|
|
56,346
|
|
|
—
|
|
|
56,346
|
|
||||||
Fund management fees
|
|
—
|
|
|
—
|
|
|
26,850
|
|
|
5,672
|
|
|
—
|
|
|
32,522
|
|
||||||
Correspondent bank rebates
|
|
6,415
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,415
|
|
||||||
Total revenue from contracts with customers
|
|
$
|
592,185
|
|
|
$
|
2,563
|
|
|
$
|
26,850
|
|
|
$
|
257,195
|
|
|
$
|
2,158
|
|
|
$
|
880,951
|
|
Revenues outside the scope of ASC 606 (1)
|
|
45,737
|
|
|
803
|
|
|
95,544
|
|
|
7,321
|
|
|
191,123
|
|
|
340,528
|
|
||||||
Total noninterest income
|
|
$
|
637,922
|
|
|
$
|
3,366
|
|
|
$
|
122,394
|
|
|
$
|
264,516
|
|
|
$
|
193,281
|
|
|
$
|
1,221,479
|
|
|
(1)
|
Amounts are accounted for under separate guidance than ASC 606.
|
(2)
|
Global Commercial Bank’s, SVB Capital’s and SVB Leerink's components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."
|
(Dollars in thousands)
|
|
Global
Commercial
Bank (2)
|
|
SVB Private
Bank
|
|
SVB Capital (2)
|
|
Other Income
|
|
Total
|
||||||||||
Revenue from contracts with customers:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Client investment fees (3)
|
|
$
|
128,834
|
|
|
$
|
1,526
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
130,360
|
|
Spot contract commissions
|
|
126,445
|
|
|
691
|
|
|
—
|
|
|
323
|
|
|
127,459
|
|
|||||
Card interchange fees, gross
|
|
134,074
|
|
|
—
|
|
|
—
|
|
|
428
|
|
|
134,502
|
|
|||||
Merchant service fees
|
|
14,415
|
|
|
4
|
|
|
—
|
|
|
1
|
|
|
14,420
|
|
|||||
Deposit service charges
|
|
74,348
|
|
|
108
|
|
|
—
|
|
|
1,641
|
|
|
76,097
|
|
|||||
Fund management fees
|
|
—
|
|
|
—
|
|
|
23,016
|
|
|
—
|
|
|
23,016
|
|
|||||
Correspondent bank rebates
|
|
5,802
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,802
|
|
|||||
Total revenue from contracts with customers
|
|
$
|
483,918
|
|
|
$
|
2,329
|
|
|
$
|
23,016
|
|
|
$
|
2,393
|
|
|
$
|
511,656
|
|
Revenues outside the scope of ASC 606 (1)
|
|
36,384
|
|
|
(48
|
)
|
|
78,165
|
|
|
118,827
|
|
|
233,328
|
|
|||||
Total noninterest income
|
|
$
|
520,302
|
|
|
$
|
2,281
|
|
|
$
|
101,181
|
|
|
$
|
121,220
|
|
|
$
|
744,984
|
|
|
(1)
|
Amounts are accounted for under separate guidance than ASC 606.
|
(2)
|
Global Commercial Bank’s and SVB Capital’s components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."
|
(3)
|
For the year ended December 31, 2018, the amount of client investment fees previously reported as "Other Items" has been correctly allocated to the reportable segment "Global Commercial Bank" to properly reflect the source of such revenue. The correction of this immaterial error had no impact on the "Total" amount of client investment fees.
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Lending and other client related processing costs
|
|
$
|
28,491
|
|
|
$
|
24,237
|
|
|
$
|
23,768
|
|
Correspondent bank fees
|
|
14,503
|
|
|
13,713
|
|
|
12,976
|
|
|||
Investment banking activities
|
|
13,733
|
|
|
—
|
|
|
—
|
|
|||
Trade order execution costs
|
|
10,813
|
|
|
—
|
|
|
—
|
|
|||
Data processing services
|
|
12,536
|
|
|
10,811
|
|
|
10,251
|
|
|||
Telephone
|
|
9,861
|
|
|
9,404
|
|
|
10,647
|
|
|||
Dues and publications
|
|
4,603
|
|
|
4,605
|
|
|
3,263
|
|
|||
Postage and supplies
|
|
3,198
|
|
|
2,799
|
|
|
2,797
|
|
|||
Other
|
|
54,841
|
|
|
21,682
|
|
|
21,419
|
|
|||
Total other noninterest expense
|
|
$
|
152,579
|
|
|
$
|
87,251
|
|
|
$
|
85,121
|
|
19.
|
Income Taxes
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Current provision:
|
|
|
|
|
|
|
||||||
Federal
|
|
$
|
296,400
|
|
|
$
|
249,358
|
|
|
$
|
263,231
|
|
State
|
|
132,357
|
|
|
123,264
|
|
|
67,046
|
|
|||
Deferred (benefit) expense:
|
|
|
|
|
|
|
||||||
Federal
|
|
(1,530
|
)
|
|
(11,777
|
)
|
|
24,654
|
|
|||
State
|
|
(1,542
|
)
|
|
(9,284
|
)
|
|
532
|
|
|||
Income tax expense
|
|
$
|
425,685
|
|
|
$
|
351,561
|
|
|
$
|
355,463
|
|
|
|
December 31,
|
|||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
|||
Federal statutory income tax rate
|
|
21.0
|
%
|
|
21.0
|
%
|
|
35.0
|
%
|
State income taxes, net of the federal tax effect
|
|
7.0
|
|
|
7.2
|
|
|
5.8
|
|
Net deferred tax assets revaluation (TCJ Act)
|
|
—
|
|
|
—
|
|
|
4.3
|
|
Meals and entertainment
|
|
0.4
|
|
|
0.3
|
|
|
0.3
|
|
Disallowed officers' compensation
|
|
0.2
|
|
|
0.2
|
|
|
0.1
|
|
FDIC premiums
|
|
0.2
|
|
|
0.5
|
|
|
—
|
|
Share-based compensation expense on incentive stock options and ESPP
|
|
(0.6
|
)
|
|
(1.4
|
)
|
|
(2.1
|
)
|
Qualified affordable housing project tax credits
|
|
(0.3
|
)
|
|
(0.3
|
)
|
|
(0.4
|
)
|
Tax-exempt interest income
|
|
(0.6
|
)
|
|
(0.6
|
)
|
|
(0.3
|
)
|
Other, net
|
|
(0.1
|
)
|
|
(0.4
|
)
|
|
(0.7
|
)
|
Effective income tax rate
|
|
27.2
|
%
|
|
26.5
|
%
|
|
42.0
|
%
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Deferred tax assets:
|
|
|
|
|
||||
Allowance for loan losses
|
|
$
|
103,267
|
|
|
$
|
93,580
|
|
Net unrealized losses on AFS debt securities
|
|
—
|
|
|
19,704
|
|
||
Share-based compensation expense
|
|
14,233
|
|
|
10,642
|
|
||
State income taxes
|
|
16,097
|
|
|
13,854
|
|
||
Accrued compensation
|
|
22,578
|
|
|
8,291
|
|
||
Deferred rent
|
|
—
|
|
|
7,940
|
|
||
Lease liability
|
|
60,635
|
|
|
—
|
|
||
Other accruals
|
|
12,383
|
|
|
7,061
|
|
||
Net operating loss
|
|
6,386
|
|
|
2,447
|
|
||
Goodwill and intangibles
|
|
3,141
|
|
|
—
|
|
||
Other
|
|
7,923
|
|
|
11,339
|
|
||
Deferred tax assets
|
|
246,643
|
|
|
174,858
|
|
||
Valuation allowance
|
|
(5,919
|
)
|
|
(2,107
|
)
|
||
Net deferred tax assets after valuation allowance
|
|
240,724
|
|
|
172,751
|
|
||
|
|
|
|
|
||||
Deferred tax liabilities:
|
|
|
|
|
||||
Derivative equity warrant assets
|
|
(45,533
|
)
|
|
(32,861
|
)
|
||
Change in accounting method (section 481(a))
|
|
(1,841
|
)
|
|
(8,034
|
)
|
||
Net unrealized gains on AFS debt securities
|
|
(33,480
|
)
|
|
—
|
|
||
Non-marketable and other equity securities
|
|
(54,239
|
)
|
|
(45,759
|
)
|
||
Premises and equipment and other intangibles
|
|
(16,459
|
)
|
|
(10,284
|
)
|
||
Right-of-use asset and deferred rent assets
|
|
(50,493
|
)
|
|
—
|
|
||
Other
|
|
(10,246
|
)
|
|
(10,380
|
)
|
||
Deferred tax liabilities
|
|
(212,291
|
)
|
|
(107,318
|
)
|
||
Net deferred tax assets
|
|
$
|
28,433
|
|
|
$
|
65,433
|
|
(Dollars in thousands)
|
|
Reconciliation of Unrecognized Tax Benefit
|
|
Interest and Penalties
|
|
Total
|
||||||
Balance at December 31, 2016
|
|
$
|
5,269
|
|
|
$
|
442
|
|
|
$
|
5,711
|
|
Additions for tax positions for current year
|
|
3,141
|
|
|
—
|
|
|
3,141
|
|
|||
Additions for tax positions for prior years
|
|
3,378
|
|
|
754
|
|
|
4,132
|
|
|||
Reduction for tax positions for prior years
|
|
(223
|
)
|
|
(1
|
)
|
|
(224
|
)
|
|||
Lapse of the applicable statute of limitations
|
|
(60
|
)
|
|
(17
|
)
|
|
(77
|
)
|
|||
Balance at December 31, 2017
|
|
$
|
11,505
|
|
|
$
|
1,178
|
|
|
$
|
12,683
|
|
Additions for tax positions for current year
|
|
4,171
|
|
|
—
|
|
|
4,171
|
|
|||
Additions for tax positions for prior years
|
|
631
|
|
|
823
|
|
|
1,454
|
|
|||
Reduction for tax positions for prior years
|
|
(1,865
|
)
|
|
(243
|
)
|
|
(2,108
|
)
|
|||
Lapse of the applicable statute of limitations
|
|
(435
|
)
|
|
(86
|
)
|
|
(521
|
)
|
|||
Reduction as a result of settlement
|
|
(1,318
|
)
|
|
(222
|
)
|
|
(1,540
|
)
|
|||
Balance at December 31, 2018
|
|
$
|
12,689
|
|
|
$
|
1,450
|
|
|
$
|
14,139
|
|
Additions for tax positions for current year
|
|
3,712
|
|
|
—
|
|
|
3,712
|
|
|||
Additions for tax positions for prior years
|
|
63
|
|
|
826
|
|
|
889
|
|
|||
Reduction for tax positions for prior years
|
|
(884
|
)
|
|
(524
|
)
|
|
(1,408
|
)
|
|||
Lapse of the applicable statute of limitations
|
|
(1,826
|
)
|
|
(569
|
)
|
|
(2,395
|
)
|
|||
Reduction as a result of settlement
|
|
(1,142
|
)
|
|
$
|
(17
|
)
|
|
$
|
(1,159
|
)
|
|
Balance at December 31, 2019
|
|
$
|
12,612
|
|
|
$
|
1,166
|
|
|
$
|
13,778
|
|
20.
|
Employee Compensation and Benefit Plans
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Incentive Compensation Plan
|
|
$
|
143,888
|
|
|
$
|
160,293
|
|
|
$
|
125,584
|
|
Direct Drive Incentive Compensation Plan
|
|
37,315
|
|
|
40,578
|
|
|
18,721
|
|
|||
Retention Program
|
|
2,438
|
|
|
1,438
|
|
|
1,317
|
|
|||
Warrant Incentive Plan
|
|
14,881
|
|
|
9,112
|
|
|
15,386
|
|
|||
Deferred Compensation Plan
|
|
—
|
|
|
—
|
|
|
203
|
|
|||
SVBFG 401(k) Plan
|
|
25,687
|
|
|
21,323
|
|
|
17,860
|
|
|||
SVBFG ESOP
|
|
4,197
|
|
|
6,435
|
|
|
4,719
|
|
|||
SVB Leerink Incentive Compensation Plan
|
|
106,871
|
|
|
—
|
|
|
—
|
|
|||
SVB Leerink Retention Award
|
|
12,015
|
|
|
—
|
|
|
—
|
|
21.
|
Related Parties
|
22.
|
Off-Balance Sheet Arrangements, Guarantees and Other Commitments
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Loan commitments available for funding: (1)
|
|
|
|
|
||||
Fixed interest rate commitments
|
|
$
|
2,434,042
|
|
|
$
|
1,839,190
|
|
Variable interest rate commitments
|
|
19,309,317
|
|
|
14,821,815
|
|
||
Total loan commitments available for funding
|
|
21,743,359
|
|
|
16,661,005
|
|
||
Commercial and standby letters of credit (2)
|
|
2,778,561
|
|
|
2,252,016
|
|
||
Total unfunded credit commitments
|
|
$
|
24,521,920
|
|
|
$
|
18,913,021
|
|
Commitments unavailable for funding (3)
|
|
$
|
3,051,075
|
|
|
$
|
2,723,835
|
|
Allowance for unfunded credit commitments (4)
|
|
67,656
|
|
|
55,183
|
|
|
(1)
|
Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.
|
(2)
|
See below for additional information on our commercial and standby letters of credit.
|
(3)
|
Represents commitments which are currently unavailable for funding due to clients failing to meet all collateral, compliance and financial covenants under loan commitment agreements.
|
(4)
|
Our allowance for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.
|
(Dollars in thousands)
|
|
Expires In One Year or Less
|
|
Expires After One Year
|
|
Total Amount Outstanding
|
|
Maximum Amount of Future Payments
|
||||||||
Financial standby letters of credit
|
|
$
|
2,566,623
|
|
|
$
|
79,207
|
|
|
$
|
2,645,830
|
|
|
$
|
2,645,830
|
|
Performance standby letters of credit
|
|
105,993
|
|
|
19,618
|
|
|
125,611
|
|
|
125,611
|
|
||||
Commercial letters of credit
|
|
7,120
|
|
|
—
|
|
|
7,120
|
|
|
7,120
|
|
||||
Total
|
|
$
|
2,679,736
|
|
|
$
|
98,825
|
|
|
$
|
2,778,561
|
|
|
$
|
2,778,561
|
|
(Dollars in thousands)
|
|
SVBFG Capital Commitments
|
|
SVBFG Unfunded
Commitments
|
|
SVBFG Ownership
of each Fund (3)
|
|||||
CP I, LP
|
|
$
|
6,000
|
|
|
$
|
270
|
|
|
10.7
|
%
|
CP II, LP (1)
|
|
1,200
|
|
|
162
|
|
|
5.1
|
|
||
Capital Preferred Return Fund, LP
|
|
12,688
|
|
|
—
|
|
|
20.0
|
|
||
Growth Partners, LP
|
|
24,670
|
|
|
1,340
|
|
|
33.0
|
|
||
Strategic Investors Fund, LP
|
|
15,300
|
|
|
688
|
|
|
12.6
|
|
||
Strategic Investors Fund II, LP
|
|
15,000
|
|
|
1,050
|
|
|
8.6
|
|
||
Strategic Investors Fund III, LP
|
|
15,000
|
|
|
1,275
|
|
|
5.9
|
|
||
Strategic Investors Fund IV, LP
|
|
12,239
|
|
|
2,325
|
|
|
5.0
|
|
||
Strategic Investors Fund V funds
|
|
515
|
|
|
131
|
|
|
Various
|
|
||
Other venture capital and private equity fund investments (equity method accounting)
|
|
21,801
|
|
|
5,732
|
|
|
Various
|
|
||
Debt funds (equity method accounting)
|
|
58,493
|
|
|
—
|
|
|
Various
|
|
||
Other fund investments (2)
|
|
284,758
|
|
|
6,119
|
|
|
Various
|
|
||
Total
|
|
$
|
467,664
|
|
|
$
|
19,092
|
|
|
|
|
(1)
|
Our ownership includes direct ownership of 1.3 percent and indirect ownership of 3.8 percent through our investment in Strategic Investors Fund II, LP.
|
(2)
|
Represents commitments to 211 funds (primarily venture capital funds) where our ownership interest is generally less than five percent of the voting interests of each such fund.
|
(3)
|
We are subject to the Volcker Rule which restricts or limits us from sponsoring or having ownership interests in “covered” funds including venture capital and private equity funds. See “Business - Supervision and Regulation” under Part I, Item 1 of this report.
|
(Dollars in thousands)
|
|
Unfunded Commitments
|
||
Strategic Investors Fund, LP
|
|
$
|
1,338
|
|
Capital Preferred Return Fund, LP
|
|
1,540
|
|
|
Growth Partners, LP
|
|
2,468
|
|
|
Total
|
|
$
|
5,346
|
|
23.
|
Fair Value of Financial Instruments
|
(Dollars in thousands)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Balance at December 31, 2019
|
||||||||
Assets
|
|
|
|
|
|
|
|
|
||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
6,894,010
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,894,010
|
|
U.S. agency debentures
|
|
—
|
|
|
99,547
|
|
|
—
|
|
|
99,547
|
|
||||
Foreign government debt securities
|
|
9,038
|
|
|
—
|
|
|
—
|
|
|
9,038
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued mortgage-backed securities
|
|
—
|
|
|
4,148,791
|
|
|
—
|
|
|
4,148,791
|
|
||||
Agency-issued collateralized mortgage obligations— fixed rate
|
|
—
|
|
|
1,538,343
|
|
|
—
|
|
|
1,538,343
|
|
||||
Agency-issued commercial mortgage-backed securities
|
|
—
|
|
|
1,325,190
|
|
|
—
|
|
|
1,325,190
|
|
||||
Total available-for-sale securities
|
|
6,903,048
|
|
|
7,111,871
|
|
|
—
|
|
|
14,014,919
|
|
||||
Non-marketable and other equity securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
Non-marketable securities:
|
|
|
|
|
|
|
|
|
||||||||
Venture capital and private equity fund investments measured at net asset value
|
|
—
|
|
|
—
|
|
|
—
|
|
|
265,263
|
|
||||
Venture capital and private equity fund investments not measured at net asset value (1)
|
|
—
|
|
|
—
|
|
|
134
|
|
|
134
|
|
||||
Other equity securities in public companies
|
|
17,290
|
|
|
41,910
|
|
|
—
|
|
|
59,200
|
|
||||
Total non-marketable and other equity securities (fair value
accounting)
|
|
17,290
|
|
|
41,910
|
|
|
134
|
|
|
324,597
|
|
||||
Other assets:
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward and option contracts
|
|
—
|
|
|
115,854
|
|
|
—
|
|
|
115,854
|
|
||||
Equity warrant assets
|
|
—
|
|
|
4,435
|
|
|
161,038
|
|
|
165,473
|
|
||||
Interest rate swaps
|
|
—
|
|
|
22,676
|
|
|
—
|
|
|
22,676
|
|
||||
Client interest rate derivatives
|
|
—
|
|
|
28,811
|
|
|
—
|
|
|
28,811
|
|
||||
Total assets
|
|
$
|
6,920,338
|
|
|
$
|
7,325,557
|
|
|
$
|
161,172
|
|
|
$
|
14,672,330
|
|
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward and option contracts
|
|
$
|
—
|
|
|
$
|
98,207
|
|
|
$
|
—
|
|
|
$
|
98,207
|
|
Interest rate swaps
|
|
—
|
|
|
25,623
|
|
|
—
|
|
|
25,623
|
|
||||
Client interest rate derivatives
|
|
—
|
|
|
14,154
|
|
|
—
|
|
|
14,154
|
|
||||
Total liabilities
|
|
$
|
—
|
|
|
$
|
137,984
|
|
|
$
|
—
|
|
|
$
|
137,984
|
|
|
(1)
|
Included in Level 3 assets is $120 thousand attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
(Dollars in thousands)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Balance at December 31, 2018
|
||||||||
Assets
|
|
|
|
|
|
|
|
|
||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
4,738,258
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,738,258
|
|
U.S. agency debentures
|
|
—
|
|
|
1,084,117
|
|
|
—
|
|
|
1,084,117
|
|
||||
Foreign government debt securities
|
|
5,812
|
|
|
—
|
|
|
—
|
|
|
5,812
|
|
||||
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
Agency-issued collateralized mortgage obligations— fixed rate
|
|
—
|
|
|
1,880,218
|
|
|
—
|
|
|
1,880,218
|
|
||||
Agency-issued collateralized mortgage obligations— variable rate
|
|
—
|
|
|
81,638
|
|
|
—
|
|
|
81,638
|
|
||||
Total available-for-sale securities
|
|
4,744,070
|
|
|
3,045,973
|
|
|
—
|
|
|
7,790,043
|
|
||||
Non-marketable and other equity securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
Non-marketable securities:
|
|
|
|
|
|
|
|
|
||||||||
Venture capital and private equity fund investments measured at net asset value
|
|
—
|
|
|
—
|
|
|
—
|
|
|
318,352
|
|
||||
Venture capital and private equity fund investments not measured at net asset value (1)
|
|
—
|
|
|
—
|
|
|
1,079
|
|
|
1,079
|
|
||||
Other equity securities in public companies (1)
|
|
1,181
|
|
|
19,217
|
|
|
—
|
|
|
20,398
|
|
||||
Total non-marketable and other equity securities (fair value
accounting)
|
|
1,181
|
|
|
19,217
|
|
|
1,079
|
|
|
339,829
|
|
||||
Other assets:
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward and option contracts
|
|
—
|
|
|
100,402
|
|
|
—
|
|
|
100,402
|
|
||||
Equity warrant assets
|
|
—
|
|
|
4,039
|
|
|
145,199
|
|
|
149,238
|
|
||||
Client interest rate derivatives
|
|
—
|
|
|
8,499
|
|
|
—
|
|
|
8,499
|
|
||||
Total assets
|
|
$
|
4,745,251
|
|
|
$
|
3,178,130
|
|
|
$
|
146,278
|
|
|
$
|
8,388,011
|
|
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward and option contracts
|
|
$
|
—
|
|
|
$
|
88,559
|
|
|
$
|
—
|
|
|
$
|
88,559
|
|
Client interest rate derivatives
|
|
—
|
|
|
9,491
|
|
|
—
|
|
|
9,491
|
|
||||
Total liabilities
|
|
$
|
—
|
|
|
$
|
98,050
|
|
|
$
|
—
|
|
|
$
|
98,050
|
|
|
(1)
|
Included in Level 3 assets is $964 thousand attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
(Dollars in thousands)
|
|
Beginning
Balance
|
|
Total Realized and Unrealized Gains, net Included in Income
|
|
Purchases
|
|
Sales/Exits
|
|
Issuances
|
|
Distributions and Other Settlements
|
|
Transfers Out of Level 3
|
|
Ending
Balance
|
||||||||||||||||
Year ended December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Non-marketable and other equity securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Venture capital and private equity fund investments not measured at net asset value (1)
|
|
$
|
1,079
|
|
|
$
|
12
|
|
|
$
|
—
|
|
|
$
|
(960
|
)
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
134
|
|
Other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Equity warrant assets (2)
|
|
145,199
|
|
|
133,910
|
|
|
575
|
|
|
(130,392
|
)
|
|
16,453
|
|
|
—
|
|
|
(4,707
|
)
|
|
161,038
|
|
||||||||
Total assets
|
|
$
|
146,278
|
|
|
$
|
133,922
|
|
|
$
|
575
|
|
|
$
|
(131,352
|
)
|
|
$
|
16,453
|
|
|
$
|
3
|
|
|
$
|
(4,707
|
)
|
|
$
|
161,172
|
|
Year ended December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Non-marketable and other equity securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Venture capital and private equity fund investments not measured at net asset value (1)
|
|
$
|
919
|
|
|
$
|
457
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(297
|
)
|
|
$
|
—
|
|
|
$
|
1,079
|
|
Other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Equity warrant assets (2)
|
|
121,331
|
|
|
87,982
|
|
|
—
|
|
|
(78,752
|
)
|
|
17,941
|
|
|
—
|
|
|
(3,303
|
)
|
|
145,199
|
|
||||||||
Total assets
|
|
$
|
122,250
|
|
|
$
|
88,439
|
|
|
$
|
—
|
|
|
$
|
(78,752
|
)
|
|
$
|
17,941
|
|
|
$
|
(297
|
)
|
|
$
|
(3,303
|
)
|
|
$
|
146,278
|
|
Year ended December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Non-marketable and other equity securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Venture capital and private equity fund investments not measured at net asset value (1)
|
|
$
|
2,040
|
|
|
$
|
971
|
|
|
$
|
—
|
|
|
$
|
(2,092
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
919
|
|
Other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Equity warrant assets (2)
|
|
128,813
|
|
|
54,263
|
|
|
—
|
|
|
(74,769
|
)
|
|
14,537
|
|
|
—
|
|
|
(1,513
|
)
|
|
121,331
|
|
||||||||
Total assets
|
|
$
|
130,853
|
|
|
$
|
55,234
|
|
|
$
|
—
|
|
|
$
|
(76,861
|
)
|
|
$
|
14,537
|
|
|
$
|
—
|
|
|
$
|
(1,513
|
)
|
|
$
|
122,250
|
|
|
(1)
|
Realized and unrealized gains (losses) are recorded in the line item “Gains on investment securities, net,” a component of noninterest income.
|
(2)
|
Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net,” a component of noninterest income.
|
|
|
Year ended December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Non-marketable and other equity securities (fair value accounting):
|
|
|
|
|
||||
Venture capital and private equity fund investments not measured at net asset value (1)
|
|
$
|
(222
|
)
|
|
$
|
160
|
|
Other assets:
|
|
|
|
|
||||
Equity warrant assets (2)
|
|
34,691
|
|
|
37,564
|
|
||
Total unrealized gains, net
|
|
$
|
34,469
|
|
|
$
|
37,724
|
|
Unrealized (losses) gains attributable to noncontrolling interests (1)
|
|
$
|
(199
|
)
|
|
$
|
143
|
|
|
(1)
|
Unrealized gains are recorded in the line item “Gains on investment securities, net,” a component of noninterest income.
|
(2)
|
Unrealized gains are recorded in the line item “Gains on equity warrant assets, net,” a component of noninterest income.
|
(Dollars in thousands)
|
|
Fair Value
|
|
Valuation Technique
|
|
Significant Unobservable Inputs
|
|
Weighted Average
|
|||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|||
Venture capital and private equity fund investments (fair value accounting)
|
|
$
|
134
|
|
|
Private company equity pricing
|
|
(1)
|
|
(1)
|
|
Equity warrant assets (public portfolio)
|
|
346
|
|
|
Black-Scholes option pricing model
|
|
Volatility
|
|
50.7
|
%
|
|
Risk-Free interest rate
|
1.9
|
|
|||||||||
Sales restrictions discount (2)
|
13.6
|
|
|||||||||
Equity warrant assets (private portfolio)
|
|
160,692
|
|
|
Black-Scholes option pricing model
|
|
Volatility
|
|
38.2
|
|
|
Risk-Free interest rate
|
1.6
|
|
|||||||||
Marketability discount (3)
|
17.5
|
|
|||||||||
Remaining life assumption (4)
|
45.0
|
|
|||||||||
December 31, 2018:
|
|
|
|
|
|
|
|
|
|||
Venture capital and private equity fund investments (fair value accounting)
|
|
$
|
1,079
|
|
|
Private company equity pricing
|
|
(1)
|
|
(1)
|
|
Equity warrant assets (public portfolio)
|
|
2,757
|
|
|
Black-Scholes option pricing model
|
|
Volatility
|
|
54.7
|
%
|
|
Risk-Free interest rate
|
2.6
|
|
|||||||||
Sales restrictions discount (2)
|
18.5
|
|
|||||||||
Equity warrant assets (private portfolio)
|
|
142,442
|
|
|
Black-Scholes option pricing model
|
|
Volatility
|
|
38.5
|
|
|
Risk-Free interest rate
|
2.5
|
|
|||||||||
Marketability discount (3)
|
17.7
|
|
|||||||||
Remaining life assumption (4)
|
45.0
|
|
|
(1)
|
In determining the fair value of our venture capital and private equity fund investment portfolio (not measured at net asset value), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation
|
(2)
|
We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions which typically range from three to six months.
|
(3)
|
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.
|
(4)
|
We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At December 31, 2019, the weighted average contractual remaining term was 6.1 years, compared to our estimated remaining life of 2.8 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.
|
|
|
|
|
Estimated Fair Value
|
||||||||||||||||
(Dollars in thousands)
|
|
Carrying Amount
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
6,781,783
|
|
|
$
|
6,781,783
|
|
|
$
|
6,781,783
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Held-to-maturity securities
|
|
13,842,946
|
|
|
14,115,272
|
|
|
—
|
|
|
14,115,272
|
|
|
—
|
|
|||||
Non-marketable securities not measured at net asset value
|
|
195,405
|
|
|
195,405
|
|
|
—
|
|
|
—
|
|
|
195,405
|
|
|||||
Non-marketable securities measured at net asset value
|
|
235,351
|
|
|
235,351
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net commercial loans
|
|
29,104,532
|
|
|
29,615,176
|
|
|
—
|
|
|
—
|
|
|
29,615,176
|
|
|||||
Net consumer loans
|
|
3,755,180
|
|
|
3,820,804
|
|
|
—
|
|
|
—
|
|
|
3,820,804
|
|
|||||
FHLB and Federal Reserve Bank stock
|
|
60,258
|
|
|
60,258
|
|
|
—
|
|
|
—
|
|
|
60,258
|
|
|||||
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Short-term borrowings
|
|
17,430
|
|
|
17,430
|
|
|
—
|
|
|
17,430
|
|
|
—
|
|
|||||
Non-maturity deposits (1)
|
|
61,569,714
|
|
|
61,569,714
|
|
|
61,569,714
|
|
|
—
|
|
|
—
|
|
|||||
Time deposits
|
|
188,093
|
|
|
187,980
|
|
|
—
|
|
|
187,980
|
|
|
—
|
|
|||||
3.50% Senior Notes
|
|
347,987
|
|
|
366,856
|
|
|
—
|
|
|
366,856
|
|
|
—
|
|
|||||
Off-balance sheet financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commitments to extend credit
|
|
—
|
|
|
27,197
|
|
|
—
|
|
|
—
|
|
|
27,197
|
|
|||||
December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
3,571,539
|
|
|
$
|
3,571,539
|
|
|
$
|
3,571,539
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Held-to-maturity securities
|
|
15,487,442
|
|
|
15,188,236
|
|
|
—
|
|
|
15,188,236
|
|
|
—
|
|
|||||
Non-marketable securities not measured at net asset value
|
|
131,453
|
|
|
131,453
|
|
|
—
|
|
|
—
|
|
|
131,453
|
|
|||||
Non-marketable securities measured at net asset value
|
|
151,247
|
|
|
151,247
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net commercial loans
|
|
25,043,671
|
|
|
25,463,968
|
|
|
—
|
|
|
—
|
|
|
25,463,968
|
|
|||||
Net consumer loans
|
|
3,013,706
|
|
|
3,064,093
|
|
|
—
|
|
|
—
|
|
|
3,064,093
|
|
|||||
FHLB and Federal Reserve Bank stock
|
|
58,878
|
|
|
58,878
|
|
|
—
|
|
|
—
|
|
|
58,878
|
|
|||||
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Short-term borrowings
|
|
631,412
|
|
|
631,412
|
|
|
—
|
|
|
631,412
|
|
|
—
|
|
|||||
Non-maturity deposits (1)
|
|
49,278,174
|
|
|
49,278,174
|
|
|
49,278,174
|
|
|
—
|
|
|
—
|
|
|||||
Time deposits
|
|
50,726
|
|
|
50,337
|
|
|
—
|
|
|
50,337
|
|
|
—
|
|
|||||
3.50% Senior Notes
|
|
347,639
|
|
|
336,088
|
|
|
—
|
|
|
336,088
|
|
|
—
|
|
|||||
5.375% Senior Notes
|
|
348,826
|
|
|
361,281
|
|
|
—
|
|
|
361,281
|
|
|
—
|
|
|||||
Off-balance sheet financial assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Commitments to extend credit
|
|
—
|
|
|
22,930
|
|
|
—
|
|
|
—
|
|
|
22,930
|
|
|
(1)
|
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
|
(Dollars in thousands)
|
|
Carrying Amount
|
|
Fair Value
|
|
Unfunded Commitments
|
||||||
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
||||||
Venture capital and private equity fund investments (1)
|
|
$
|
265,263
|
|
|
$
|
265,263
|
|
|
$
|
10,579
|
|
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
||||||
Venture capital and private equity fund investments (2)
|
|
215,367
|
|
|
215,367
|
|
|
10,675
|
|
|||
Debt funds (2)
|
|
7,271
|
|
|
7,271
|
|
|
—
|
|
|||
Other investments (2)
|
|
12,713
|
|
|
12,713
|
|
|
886
|
|
|||
Total
|
|
$
|
500,614
|
|
|
$
|
500,614
|
|
|
$
|
22,140
|
|
|
(1)
|
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $64.6 million and $4.0 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
|
(2)
|
Venture capital and private equity fund investments, debt funds and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.
|
24.
|
Regulatory Matters
|
|
|
Capital Ratios
|
|
Capital Amounts
|
||||||||||||||||
(Dollars in thousands)
|
|
Actual
|
|
Required Minimum (1)
|
|
Well Capitalized Minimum
|
|
Actual
|
|
Required Minimum (1)
|
|
Well Capitalized Minimum
|
||||||||
December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
CET 1 risk-based capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
12.58
|
%
|
|
7.0
|
%
|
|
N/A
|
|
$
|
5,857,744
|
|
|
$
|
3,260,424
|
|
|
N/A
|
|
|
Bank
|
|
11.12
|
|
|
7.0
|
|
|
6.5
|
|
4,949,393
|
|
|
3,115,151
|
|
|
$
|
2,892,640
|
|
||
Tier 1 risk-based capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
13.43
|
|
|
8.5
|
|
|
6.0
|
|
6,257,442
|
|
|
3,959,086
|
|
|
2,794,649
|
|
|||
Bank
|
|
11.12
|
|
|
8.5
|
|
|
8.0
|
|
4,949,393
|
|
|
3,782,683
|
|
|
3,560,172
|
|
|||
Total risk-based capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
14.23
|
|
|
10.5
|
|
|
10.0
|
|
6,630,022
|
|
|
4,890,636
|
|
|
4,657,748
|
|
|||
Bank
|
|
11.96
|
|
|
10.5
|
|
|
10.0
|
|
5,321,850
|
|
|
4,672,726
|
|
|
4,450,215
|
|
|||
Tier 1 leverage:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
9.06
|
|
|
4.0
|
|
|
N/A
|
|
6,257,442
|
|
|
2,763,146
|
|
|
N/A
|
|
|||
Bank
|
|
7.30
|
|
|
4.0
|
|
|
5.0
|
|
4,949,393
|
|
|
2,713,367
|
|
|
3,391,709
|
|
|||
December 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
CET 1 risk-based capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
13.41
|
%
|
|
6.4
|
%
|
|
N/A
|
|
$
|
5,167,270
|
|
|
$
|
2,456,151
|
|
|
N/A
|
|
|
Bank
|
|
12.41
|
|
|
6.4
|
|
|
6.5
|
|
4,604,689
|
|
|
2,365,385
|
|
|
$
|
2,411,765
|
|
||
Tier 1 risk-based capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
13.58
|
|
|
7.9
|
|
|
6.0
|
|
5,231,476
|
|
|
3,034,068
|
|
|
2,311,671
|
|
|||
Bank
|
|
12.41
|
|
|
7.9
|
|
|
8.0
|
|
4,604,689
|
|
|
2,921,946
|
|
|
2,968,326
|
|
|||
Total risk-based capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
14.45
|
|
|
9.9
|
|
|
10.0
|
|
5,567,562
|
|
|
3,804,625
|
|
|
3,852,785
|
|
|||
Bank
|
|
13.32
|
|
|
9.9
|
|
|
10.0
|
|
4,940,776
|
|
|
3,664,028
|
|
|
3,710,408
|
|
|||
Tier 1 leverage:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SVB Financial
|
|
9.06
|
|
|
4.0
|
|
|
N/A
|
|
5,231,476
|
|
|
2,308,592
|
|
|
N/A
|
|
|||
Bank
|
|
8.10
|
|
|
4.0
|
|
|
5.0
|
|
4,604,689
|
|
|
2,272,912
|
|
|
2,841,139
|
|
|
N/A
|
"Well-Capitalized Minimum" CET 1 risk-based capital and Tier 1 leverage ratios are not formally defined under applicable banking regulations for bank holding companies.
|
(1)
|
The percentages as of December 31,2019 represent the minimum capital ratios plus, the fully phased-in 2.5% CET1 capital conservation buffer under the Capital Rules.
|
25.
|
Segment Reporting
|
•
|
Global Commercial Bank is comprised of results from the following:
|
◦
|
Our Commercial Bank products and services are provided by the Bank and its subsidiaries to commercial clients primarily in the technology, life science/healthcare and private equity/venture capital industries. The Bank provides solutions to the financial needs of commercial clients through credit, treasury management, foreign exchange, trade finance and other services. We broadly serve clients within the U.S., as well as non-U.S. clients in key international innovation markets. In addition, the Bank and its subsidiaries offer a variety of investment services and solutions to its clients that enable them to effectively manage their assets.
|
◦
|
Our Global Funds Banking (formerly Private Equity) Division provides banking products and services primarily to our private equity and venture capital clients.
|
◦
|
SVB Wine provides banking products and services to our premium wine industry clients, including vineyard development loans.
|
◦
|
Debt Fund Investments is comprised of our investments in certain debt funds in which we are a strategic investor.
|
•
|
SVB Private Bank is the private banking division of the Bank, which provides a range of personal financial solutions for consumers. Our clients are primarily private equity/venture capital professionals and executive leaders of the innovation companies they support. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted stock purchase loans, capital call lines of credit and other secured and unsecured lending products, as well as cash and wealth management services.
|
•
|
SVB Capital is the funds management business of SVBFG, which focuses primarily on venture capital investments. SVB Capital manages funds (primarily venture capital funds) on behalf of third-party limited partners and, on a more limited basis, SVB Financial Group. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. SVB Capital generates income for the Company primarily from investment returns (including carried interest allocations) and management fees.
|
•
|
SVB Leerink is an investment bank specializing in the equity and convertible capital markets, mergers and acquisitions, equity research and sales and trading for growth and innovation-minded healthcare and life science companies and operates as a wholly-owned subsidiary of SVB Financial. SVB Leerink provides investment banking
|
(Dollars in thousands)
|
|
Global
Commercial
Bank (1)
|
|
SVB Private
Bank
|
|
SVB Capital
(1)
|
|
SVB Leerink (1)
|
|
Other Items
(2)
|
|
Total
|
||||||||||||
Year ended December 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net interest income
|
|
$
|
1,850,391
|
|
|
$
|
51,022
|
|
|
$
|
38
|
|
|
$
|
1,252
|
|
|
$
|
193,898
|
|
|
$
|
2,096,601
|
|
Provision for credit losses
|
|
(91,814
|
)
|
|
(2,369
|
)
|
|
—
|
|
|
—
|
|
|
(12,233
|
)
|
|
(106,416
|
)
|
||||||
Noninterest income
|
|
637,922
|
|
|
3,366
|
|
|
122,394
|
|
|
264,516
|
|
|
193,281
|
|
|
1,221,479
|
|
||||||
Noninterest expense (3)
|
|
(874,854
|
)
|
|
(40,151
|
)
|
|
(30,798
|
)
|
|
(252,678
|
)
|
|
(402,781
|
)
|
|
(1,601,262
|
)
|
||||||
Income (loss) before income tax expense (4)
|
|
$
|
1,521,645
|
|
|
$
|
11,868
|
|
|
$
|
91,634
|
|
|
$
|
13,090
|
|
|
$
|
(27,835
|
)
|
|
$
|
1,610,402
|
|
Total average loans, net of unearned income
|
|
$
|
26,031,284
|
|
|
$
|
3,341,188
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
543,735
|
|
|
$
|
29,916,207
|
|
Total average assets (5) (6)
|
|
56,043,321
|
|
|
3,371,052
|
|
|
405,152
|
|
|
397,650
|
|
|
2,994,455
|
|
|
63,211,630
|
|
||||||
Total average deposits
|
|
53,053,665
|
|
|
1,524,232
|
|
|
—
|
|
|
—
|
|
|
479,053
|
|
|
55,056,950
|
|
||||||
Year ended December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net interest income
|
|
$
|
1,623,488
|
|
|
$
|
64,902
|
|
|
$
|
23
|
|
|
$
|
—
|
|
|
$
|
205,575
|
|
|
$
|
1,893,988
|
|
Provision for credit losses
|
|
(80,953
|
)
|
|
(3,339
|
)
|
|
—
|
|
|
—
|
|
|
(3,578
|
)
|
|
(87,870
|
)
|
||||||
Noninterest income (7)
|
|
520,302
|
|
|
2,281
|
|
|
101,181
|
|
|
—
|
|
|
121,220
|
|
|
744,984
|
|
||||||
Noninterest expense (3)
|
|
(793,159
|
)
|
|
(25,064
|
)
|
|
(22,792
|
)
|
|
—
|
|
|
(347,178
|
)
|
|
(1,188,193
|
)
|
||||||
Income (loss) before income tax expense (4)
|
|
$
|
1,269,678
|
|
|
$
|
38,780
|
|
|
$
|
78,412
|
|
|
$
|
—
|
|
|
$
|
(23,961
|
)
|
|
$
|
1,362,909
|
|
Total average loans, net of unearned income
|
|
$
|
22,354,305
|
|
|
$
|
2,850,271
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
425,944
|
|
|
$
|
25,630,520
|
|
Total average assets (5) (8)
|
|
48,854,416
|
|
|
2,871,743
|
|
|
380,543
|
|
|
—
|
|
|
3,122,358
|
|
|
55,229,060
|
|
||||||
Total average deposits
|
|
46,039,570
|
|
|
1,502,308
|
|
|
—
|
|
|
—
|
|
|
533,466
|
|
|
48,075,344
|
|
||||||
Year ended December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net interest income
|
|
$
|
1,274,366
|
|
|
$
|
58,131
|
|
|
$
|
48
|
|
|
$
|
—
|
|
|
$
|
87,824
|
|
|
$
|
1,420,369
|
|
Provision for credit losses
|
|
(81,553
|
)
|
|
(4,386
|
)
|
|
—
|
|
|
—
|
|
|
(6,365
|
)
|
|
(92,304
|
)
|
||||||
Noninterest income (7)
|
|
392,101
|
|
|
2,175
|
|
|
58,992
|
|
|
—
|
|
|
103,963
|
|
|
557,231
|
|
||||||
Noninterest expense (3)
|
|
(707,666
|
)
|
|
(17,693
|
)
|
|
(19,340
|
)
|
|
—
|
|
|
(265,956
|
)
|
|
(1,010,655
|
)
|
||||||
Income (loss) before income tax expense (4)
|
|
$
|
877,248
|
|
|
$
|
38,227
|
|
|
$
|
39,700
|
|
|
$
|
—
|
|
|
$
|
(80,534
|
)
|
|
$
|
874,641
|
|
Total average loans, net of unearned income
|
|
$
|
18,479,793
|
|
|
$
|
2,423,078
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
256,523
|
|
|
$
|
21,159,394
|
|
Total average assets (5) (8)
|
|
43,704,667
|
|
|
2,445,220
|
|
|
325,939
|
|
|
—
|
|
|
1,904,446
|
|
|
48,380,272
|
|
||||||
Total average deposits
|
|
41,043,731
|
|
|
1,303,542
|
|
|
—
|
|
|
—
|
|
|
397,875
|
|
|
42,745,148
|
|
|
(1)
|
Global Commercial Bank’s, SVB Capital’s and SVB Leerink's components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within "Other Items."
|
(2)
|
The "Other Items" column reflects the adjustments necessary to reconcile the results of the operating segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest
|
(3)
|
The Global Commercial Bank segment includes direct depreciation and amortization of $20.4 million, $21.8 million and $25.3 million for 2019, 2018 and 2017, respectively.
|
(4)
|
The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.
|
(5)
|
Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP.
|
(6)
|
Included in the total average assets for SVB Leerink is goodwill of $137.8 million for the year ended December 31, 2019 related to the acquisition effective January 4, 2019.
|
(7)
|
For the years ended December 31, 2018 and 2017, amounts of client investment fees included in the line item "Noninterest Income" previously reported as "Other Items" have been correctly allocated to our reportable segment "Global Commercial Bank" to properly reflect the source of such revenue. The correction of this immaterial error had no impact on the "Total" amount of noninterest income.
|
(8)
|
For the years ended December 31, 2018 and 2017, amounts for average assets previously reported as "Other Items" have been correctly allocated to the reportable segments "Global Commercial Bank" and “SVB Private Bank” to properly reflect the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for “Global Commercial Bank” and “SVB Private Bank.” The correction of this immaterial error had no impact on the "Total" amount of average assets.
|
26.
|
Parent Company Only Condensed Financial Information
|
|
|
December 31,
|
||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
||||
Assets:
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
800,926
|
|
|
$
|
553,049
|
|
Investment securities
|
|
474,842
|
|
|
510,836
|
|
||
Loans, net of unearned income
|
|
15,245
|
|
|
—
|
|
||
Lease right-of-use assets
|
|
71,847
|
|
|
—
|
|
||
Other assets
|
|
214,167
|
|
|
204,301
|
|
||
Investment in subsidiaries:
|
|
|
|
|
||||
Bank subsidiary
|
|
5,034,095
|
|
|
4,554,813
|
|
||
Nonbank subsidiaries
|
|
432,073
|
|
|
116,968
|
|
||
Total assets
|
|
$
|
7,043,195
|
|
|
$
|
5,939,967
|
|
|
|
|
|
|
||||
Liabilities and SVBFG stockholders’ equity:
|
|
|
|
|
||||
3.50% Senior Notes
|
|
$
|
347,987
|
|
|
$
|
347,639
|
|
5.375% Senior Notes
|
|
—
|
|
|
348,826
|
|
||
Lease liabilities
|
|
87,999
|
|
|
—
|
|
||
Other liabilities
|
|
136,903
|
|
|
127,293
|
|
||
Total liabilities
|
|
$
|
572,889
|
|
|
$
|
823,758
|
|
SVBFG stockholders’ equity
|
|
6,470,306
|
|
|
5,116,209
|
|
||
Total liabilities and SVBFG stockholders’ equity
|
|
$
|
7,043,195
|
|
|
$
|
5,939,967
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Interest income
|
|
$
|
4,473
|
|
|
$
|
3,307
|
|
|
$
|
2,077
|
|
Interest expense
|
|
(31,666
|
)
|
|
(32,037
|
)
|
|
(34,932
|
)
|
|||
Dividend income from bank subsidiary
|
|
733,000
|
|
|
140,000
|
|
|
90,000
|
|
|||
Gains on equity warrant assets, net
|
|
138,078
|
|
|
89,142
|
|
|
54,555
|
|
|||
Gains on investment securities, net
|
|
45,345
|
|
|
13,546
|
|
|
37,132
|
|
|||
Fund management fees and other noninterest income
|
|
21,567
|
|
|
26,388
|
|
|
24,613
|
|
|||
General and administrative expenses
|
|
(94,712
|
)
|
|
(70,976
|
)
|
|
(63,077
|
)
|
|||
Income tax (expense) benefit
|
|
(40,218
|
)
|
|
(14,383
|
)
|
|
10,367
|
|
|||
Income before net income of subsidiaries
|
|
775,867
|
|
|
154,987
|
|
|
120,735
|
|
|||
Equity in undistributed net income of bank subsidiary
|
|
303,618
|
|
|
793,641
|
|
|
356,769
|
|
|||
Equity in undistributed net income of nonbank subsidiaries
|
|
57,371
|
|
|
25,212
|
|
|
13,002
|
|
|||
Net income available to common stockholders
|
|
$
|
1,136,856
|
|
|
$
|
973,840
|
|
|
$
|
490,506
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Net income available to common stockholders
|
|
$
|
1,136,856
|
|
|
$
|
973,840
|
|
|
$
|
490,506
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
||||||
Foreign currency translation gains (losses)
|
|
2,319
|
|
|
(4,107
|
)
|
|
3,769
|
|
|||
Changes in fair value on cash flow hedges
|
|
(2,130
|
)
|
|
—
|
|
|
—
|
|
|||
Changes in unrealized holding gains and losses on AFS securities
|
|
2,310
|
|
|
120
|
|
|
22,285
|
|
|||
Equity in other comprehensive income (loss) of bank and nonbank subsidiaries
|
|
136,066
|
|
|
(19,171
|
)
|
|
(50,956
|
)
|
|||
Reclassifications to retained earnings for the adoption of new accounting guidance
|
|
—
|
|
|
(29,490
|
)
|
|
—
|
|
|||
Other comprehensive income (loss), net of tax
|
|
138,565
|
|
|
(52,648
|
)
|
|
(24,902
|
)
|
|||
Total comprehensive income
|
|
$
|
1,275,421
|
|
|
$
|
921,192
|
|
|
$
|
465,604
|
|
|
|
Year ended December 31,
|
||||||||||
(Dollars in thousands)
|
|
2019
|
|
2018
|
|
2017
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
|
||||||
Net income available to common stockholders
|
|
$
|
1,136,856
|
|
|
$
|
973,840
|
|
|
$
|
490,506
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
||||||
Gains on equity warrant assets, net
|
|
(138,078
|
)
|
|
(89,142
|
)
|
|
(54,555
|
)
|
|||
Gains on investment securities, net
|
|
(45,345
|
)
|
|
(13,546
|
)
|
|
(17,060
|
)
|
|||
Distributions of earnings from investment securities
|
|
49,776
|
|
|
47,596
|
|
|
14,015
|
|
|||
Net income of bank subsidiary
|
|
(1,036,618
|
)
|
|
(933,641
|
)
|
|
(446,769
|
)
|
|||
Net income on nonbank subsidiaries
|
|
(57,371
|
)
|
|
(25,212
|
)
|
|
(13,002
|
)
|
|||
Cash dividends from bank subsidiary
|
|
733,000
|
|
|
140,000
|
|
|
90,000
|
|
|||
Amortization of share-based compensation
|
|
66,815
|
|
|
45,675
|
|
|
36,900
|
|
|||
Decrease in other assets
|
|
27,205
|
|
|
51,169
|
|
|
12,959
|
|
|||
Increase in other liabilities
|
|
21,391
|
|
|
21,619
|
|
|
11,774
|
|
|||
Other, net
|
|
8,084
|
|
|
(31,024
|
)
|
|
316
|
|
|||
Net cash provided by operating activities
|
|
765,715
|
|
|
187,334
|
|
|
125,084
|
|
|||
|
|
|
|
|
|
|
||||||
Cash flows from investing activities:
|
|
|
|
|
|
|
||||||
Net decrease (increase) in investment securities from purchases, sales and maturities
|
|
128,635
|
|
|
73,742
|
|
|
(152,015
|
)
|
|||
Net (increase) decrease in loans
|
|
(15,245
|
)
|
|
—
|
|
|
13,337
|
|
|||
Increase in investment in bank subsidiary
|
|
(42,952
|
)
|
|
(31,292
|
)
|
|
(38,927
|
)
|
|||
Decrease (increase) in investment in nonbank subsidiaries
|
|
23,275
|
|
|
(5,323
|
)
|
|
34,374
|
|
|||
Acquisition of SVB Leerink
|
|
(265,601
|
)
|
|
—
|
|
|
—
|
|
|||
Net cash (used for) provided by investing activities
|
|
(171,888
|
)
|
|
37,127
|
|
|
(143,231
|
)
|
|||
|
|
|
|
|
|
|
||||||
Cash flows from financing activities:
|
|
|
|
|
|
|
||||||
Principal payments of long-term debt
|
|
(358,395
|
)
|
|
—
|
|
|
(51,546
|
)
|
|||
Proceeds from issuance of common stock, ESPP and ESOP
|
|
24,818
|
|
|
18,387
|
|
|
27,003
|
|
|||
Net proceeds from the issuance of preferred stock
|
|
340,138
|
|
|
—
|
|
|
—
|
|
|||
Common stock repurchase
|
|
(352,511
|
)
|
|
(147,123
|
)
|
|
—
|
|
|||
Net cash (used for) by financing activities
|
|
(345,950
|
)
|
|
(128,736
|
)
|
|
(24,543
|
)
|
|||
Net increase (decrease) in cash and cash equivalents
|
|
247,877
|
|
|
95,725
|
|
|
(42,690
|
)
|
|||
Cash and cash equivalents at beginning of period
|
|
553,049
|
|
|
457,324
|
|
|
500,014
|
|
|||
Cash and cash equivalents at end of period
|
|
$
|
800,926
|
|
|
$
|
553,049
|
|
|
$
|
457,324
|
|
27.
|
Unaudited Quarterly Financial Data
|
|
|
Three months ended
|
||||||||||||||
(Dollars in thousands, except per share amounts)
|
|
March 31,
|
|
June 30,
|
|
September 30,
|
|
December 31,
|
||||||||
2019:
|
|
|
|
|
|
|
|
|
||||||||
Interest income
|
|
$
|
551,014
|
|
|
$
|
585,767
|
|
|
$
|
583,892
|
|
|
$
|
588,735
|
|
Interest expense
|
|
38,128
|
|
|
56,364
|
|
|
63,248
|
|
|
55,067
|
|
||||
Net interest income
|
|
512,886
|
|
|
529,403
|
|
|
520,644
|
|
|
533,668
|
|
||||
Provision for credit losses
|
|
28,551
|
|
|
23,946
|
|
|
36,536
|
|
|
17,383
|
|
||||
Noninterest income
|
|
280,376
|
|
|
333,750
|
|
|
294,009
|
|
|
313,344
|
|
||||
Noninterest expense
|
|
365,664
|
|
|
383,522
|
|
|
391,324
|
|
|
460,752
|
|
||||
Income before income tax expense
|
|
399,047
|
|
|
455,685
|
|
|
386,793
|
|
|
368,877
|
|
||||
Income tax expense
|
|
107,435
|
|
|
119,114
|
|
|
105,075
|
|
|
94,061
|
|
||||
Net income before noncontrolling interests
|
|
291,612
|
|
|
336,571
|
|
|
281,718
|
|
|
274,816
|
|
||||
Net income attributable to noncontrolling interests
|
|
(2,880
|
)
|
|
(18,584
|
)
|
|
(14,437
|
)
|
|
(11,960
|
)
|
||||
Net income available to common stockholders
|
|
$
|
288,732
|
|
|
$
|
317,987
|
|
|
$
|
267,281
|
|
|
$
|
262,856
|
|
Earnings per common share—basic
|
|
$
|
5.49
|
|
|
$
|
6.12
|
|
|
$
|
5.19
|
|
|
$
|
5.10
|
|
Earnings per common share—diluted
|
|
5.44
|
|
|
6.08
|
|
|
5.15
|
|
|
5.06
|
|
||||
2018:
|
|
|
|
|
|
|
|
|
||||||||
Interest income
|
|
$
|
432,398
|
|
|
$
|
481,301
|
|
|
$
|
513,313
|
|
|
$
|
542,897
|
|
Interest expense
|
|
12,535
|
|
|
14,858
|
|
|
20,091
|
|
|
28,437
|
|
||||
Net interest income
|
|
419,863
|
|
|
466,443
|
|
|
493,222
|
|
|
514,460
|
|
||||
Provision for credit losses
|
|
27,972
|
|
|
29,080
|
|
|
17,174
|
|
|
13,644
|
|
||||
Noninterest income
|
|
155,518
|
|
|
192,689
|
|
|
210,070
|
|
|
186,707
|
|
||||
Noninterest expense
|
|
265,417
|
|
|
305,739
|
|
|
309,445
|
|
|
307,592
|
|
||||
Income before income tax expense
|
|
281,992
|
|
|
324,313
|
|
|
376,673
|
|
|
379,931
|
|
||||
Income tax expense
|
|
73,966
|
|
|
77,287
|
|
|
95,308
|
|
|
105,000
|
|
||||
Net income before noncontrolling interests
|
|
208,026
|
|
|
247,026
|
|
|
281,365
|
|
|
274,931
|
|
||||
Net income attributable to noncontrolling interests
|
|
(13,065
|
)
|
|
(9,228
|
)
|
|
(6,548
|
)
|
|
(8,667
|
)
|
||||
Net income available to common stockholders
|
|
$
|
194,961
|
|
|
$
|
237,798
|
|
|
$
|
274,817
|
|
|
$
|
266,264
|
|
Earnings per common share—basic
|
|
$
|
3.69
|
|
|
$
|
4.48
|
|
|
$
|
5.16
|
|
|
$
|
5.01
|
|
Earnings per common share—diluted
|
|
3.63
|
|
|
4.42
|
|
|
5.10
|
|
|
4.96
|
|
28.
|
Legal Matters
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
(a)
|
Disclosure Controls and Procedures
|
(b)
|
Management's Report on Internal Control over Financial Reporting
|
ITEM 9B.
|
OTHER INFORMATION
|
ITEM 10.
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
ITEM 11.
|
EXECUTIVE COMPENSATION
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT, AND RELATED STOCKHOLDER MATTERS
|
Plan category
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights (1)
|
|
Weighted average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans (2)
|
||||
Equity compensation plans approved by stockholders
|
|
625,407
|
|
|
$
|
169.33
|
|
|
4,759,542
|
|
Equity compensation plans not approved by stockholders
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
Total
|
|
625,407
|
|
|
$
|
169.33
|
|
|
4,759,542
|
|
|
(1)
|
Represents options granted under our 2006 Equity Incentive Plan. This number does not include securities to be issued for unvested restricted stock units of 847,972 shares.
|
(2)
|
Includes shares available for issuance under our 2006 Equity Incentive Plan and 1,337,808 shares available for issuance under the 1999 Employee Stock Purchase Plan. This amount excludes securities already granted under our 2006 Equity Incentive Plan (as discussed above).
|
ITEM 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
ITEM 14.
|
PRINCIPAL ACCOUNTING FEES AND SERVICES
|
ITEM 15.
|
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
|
(a)
|
Financial Statements and Exhibits:
|
|
|
Page
|
|
|
|
(1)
|
Financial Statements. The following consolidated financial statements of the registrant and its subsidiaries are included in Part II Item 8:
|
|
|
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
(2)
|
Financial Statement Schedule. The consolidated financial statements and supplementary data are contained in Part II Item 8. All schedules other than as set forth above are omitted because of the absence of the conditions under which they are required or because the required information is included in the consolidated financial statements or related notes in Part II Item 8.
|
|
|
|
|
(3)
|
Exhibits.
|
ITEM 16.
|
FORM 10-K SUMMARY
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||||
|
|
10-Q
|
|
000-15637
|
|
3.1
|
|
May 9, 2019
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
3.2
|
|
February 20, 2019
|
|
|
||
|
|
|
8-A
|
|
000-15637
|
|
3.2
|
|
December 6, 2019
|
|
|
|
|
|
8-K
|
|
000-15637
|
|
4.1
|
|
September 20, 2010
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
4.2
|
|
January 29, 2015
|
|
|
||
|
|
|
|
8-K
|
|
000-15637
|
|
4.2
|
|
December 9, 2019
|
|
|
|
|
8-K
|
|
000-15637
|
|
4.2
|
|
January 29, 2015
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
8-K
|
|
000-15637
|
|
10.28
|
|
September 20, 2004
|
|
|
||
|
|
10-K
|
|
000-15637
|
|
10.2
|
|
February 27, 2014
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.4
|
|
August 7, 2008
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.1
|
|
August 8, 2016
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.7
|
|
November 6, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.1
|
|
August 7, 2018
|
|
|
||
|
|
10-K
|
|
000-15637
|
|
10.7
|
|
February 28, 2019
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.14
|
|
March 15, 2012
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.1
|
|
May 10, 2016
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.16
|
|
August 7, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.17
|
|
August 7, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.18
|
|
August 7, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.19
|
|
August 7, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.20
|
|
August 7, 2009
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.31
|
|
April 17, 2007
|
|
|
||
|
|
8-K/A
|
|
000-15637
|
|
10.32
|
|
May 2, 2007
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.23
|
|
August 7, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.24
|
|
November 10, 2008
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.27
|
|
November 10, 2008
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.26
|
|
August 7, 2008
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.31
|
|
May 14, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.32
|
|
August 7, 2009
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.33
|
|
August 7, 2009
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||||
|
|
|
10-Q
|
|
000-15637
|
|
10.34
|
|
August 7, 2009
|
|
|
|
|
|
|
|
10-K
|
|
000-15637
|
|
10.33
|
|
February 27, 2014
|
|
|
|
|
|
|
10-K
|
|
000-15637
|
|
10.34
|
|
February 27, 2014
|
|
|
|
|
|
|
10-K
|
|
000-15637
|
|
10.35
|
|
February 27, 2014
|
|
|
|
|
10-K
|
|
000-15637
|
|
10.36
|
|
February 27, 2014
|
|
|
||
|
|
10-K
|
|
000-15637
|
|
10.37
|
|
February 27, 2014
|
|
|
||
|
|
10-K
|
|
000-15637
|
|
10.38
|
|
February 27, 2014
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.3
|
|
May 9, 2014
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.4
|
|
May 9, 2014
|
|
|
||
|
|
10-Q
|
|
000-15637
|
|
10.5
|
|
May 9, 2014
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.2
|
|
January 9, 2015
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.3
|
|
January 9, 2015
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.4
|
|
January 9, 2015
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.5
|
|
January 9, 2015
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.6
|
|
January 9, 2015
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.7
|
|
January 9, 2015
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.8
|
|
January 9, 2015
|
|
|
||
|
|
10-K
|
|
000-15637
|
|
10.47
|
|
February 26, 2015
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.1
|
|
May 12, 2017
|
|
|
||
|
|
8-K
|
|
000-15637
|
|
10.2
|
|
May 12, 2017
|
|
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
*
|
Denotes management contract or any compensatory plan, contract or arrangement.
|
+
|
Forms applicable to grants made under the 2006 Equity Incentive Plan during 2013 and prior years.
|
++
|
Forms applicable to grants made under the 2006 Equity Incentive Plan during 2014.
|
+++
|
Forms applicable to grants made under the 2006 Equity Incentive Plan beginning in 2015.
|
SVB Financial Group
|
|
/s/ GREG W. BECKER
|
Greg W. Becker
|
President and Chief Executive Officer
|
Dated: February 28, 2020
|
Signature
|
Title
|
Date
|
|
|
|
/s/ ROGER F. DUNBAR
|
Chairman of the Board of Directors and Director
|
February 28, 2020
|
Roger F. Dunbar
|
|
|
|
|
|
/s/ GREG W. BECKER
|
President, Chief Executive Officer and Director (Principal Executive Officer)
|
February 28, 2020
|
Greg W. Becker
|
|
|
|
|
|
/s/ DANIEL J. BECK
|
Chief Financial Officer (Principal Financial Officer)
|
February 28, 2020
|
Daniel J. Beck
|
|
|
|
|
|
/s/ KAREN HON
|
Interim Chief Accounting Officer (Principal Accounting Officer)
|
February 28, 2020
|
Karen Hon
|
|
|
|
|
|
/s/ ERIC A. BENHAMOU
|
Director
|
February 28, 2020
|
Eric A. Benhamou
|
|
|
|
|
|
/s/ JOHN S. CLENDENING
|
Director
|
February 28, 2020
|
John S. Clendening
|
|
|
|
|
|
/s/ JOEL P. FRIEDMAN
|
Director
|
February 28, 2020
|
Joel P. Friedman
|
|
|
|
|
|
/s/ KIMBERLY A. JABAL
|
Director
|
February 28, 2020
|
Kimberly A. Jabal
|
|
|
|
|
|
/s/ JEFFREY N. MAGGIONCALDA
|
Director
|
February 28, 2020
|
Jeffrey N. Maggioncalda
|
|
|
|
|
|
/s/ KAY MATTHEWS
|
Director
|
February 28, 2020
|
Kay Matthews
|
|
|
|
|
|
/s/ MARY J. MILLER
|
Director
|
February 28, 2020
|
Mary J. Miller
|
|
|
|
|
|
/s/ KATE D. MITCHELL
|
Director
|
February 28, 2020
|
Kate D. Mitchell
|
|
|
|
|
|
/s/ JOHN F. ROBINSON
|
Director
|
February 28, 2020
|
John F. Robinson
|
|
|
|
|
|
/s/ GAREN K. STAGLIN
|
Director
|
February 28, 2020
|
Garen K. Staglin
|
|
•
|
senior to our common stock and any other class or series of our stock that ranks junior to the Series A Preferred Stock in the payment of dividends or in the distribution of assets upon the liquidation, dissolution or winding-up of the Company;
|
•
|
senior to or on a parity with each other series of our preferred stock we may issue (except for any senior series that may be issued upon the requisite vote or consent of the holders of at least two-thirds of the shares of the Series A Preferred Stock at the time outstanding and entitled to vote, voting together as a single class with any other series of preferred stock entitled to vote thereon (to the exclusion of all other series of preferred stock)) with respect to the payment of dividends and distributions of assets upon any liquidation, dissolution or winding-up of the Company; and
|
•
|
with respect to distributions of assets upon any liquidation, dissolution or winding-up of the Company, junior to all existing and future indebtedness and other non-equity claims on us.
|
•
|
authorize or increase the authorized amount of, or issue shares of, any class or series of our capital stock ranking senior to the class of Series A Preferred Stock with respect to the payment of dividends or in the distribution of assets on any liquidation, dissolution or winding-up of the Company;
|
•
|
amend the provisions of our Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws or the Certificate of Designations that would alter or change the voting powers, preferences or special rights of the Series A Preferred Stock so as to affect them adversely; or
|
•
|
consummate a binding share-exchange or reclassification involving the Series A Preferred Stock, or a merger or consolidation of us with or into another entity unless the shares of Series A Preferred Stock (i) remain outstanding or (ii) are converted into or exchanged for preference securities of the surviving entity or any entity controlling such surviving entity and such new preference securities have terms that are not materially less favorable than the Series A Preferred Stock, taken as a whole.
|
Subsidiary
|
|
Jurisdiction of Incorporation or Organization
|
Gold Hill Venture Lending Partners 03, LLC
|
|
California
|
Gold Hill Venture Lending 03, LP
|
|
Delaware
|
Gold Hill Venture Lending 03-A, LP
|
|
Delaware
|
Gold Hill Venture Lending 03-B, LP
|
|
Delaware
|
Gold Hill Venture Lending 03-C, LP
|
|
Delaware
|
GHVL 03-C, Inc.
|
|
Delaware
|
GHVL, LP
|
|
Delaware
|
Silicon Valley Bank
|
|
California
|
SVB Asset Management
|
|
California
|
SVB Securities
|
|
California
|
SPD Silicon Valley Bank Co., Ltd.
|
|
China
|
SVB Wealth Advisory, Inc.
|
|
Delaware
|
SVB International Finance, Inc.
|
|
United States*
|
The Silicon Valley Bank Foundation
|
|
California
|
SVB Financial Group UK Limited
|
|
United Kingdom
|
SVB Global Financial, Inc.
|
|
Delaware
|
SVB Israel Advisors, Ltd.
|
|
Israel
|
SVB India Advisors, Pvt. Ltd.
|
|
India
|
SVB Global Services India LLP
|
|
India
|
SVB Business Partners (Beijing) Co. Ltd.
|
|
China
|
SVB Leerink Holdings LLC
|
|
Delaware
|
Leerink Partners Co-Investment Fund, LLC
|
|
Delaware
|
PharmaShares Advisors, LLC
|
|
Delaware
|
SVB Leerink LLC
|
|
Delaware
|
Silicon Valley BancVentures, Inc.
|
|
California
|
CP I, L.P.
|
|
California
|
SVB Capital Partners II, LLC
|
|
Delaware
|
CP II, L.P.
|
|
Delaware
|
SVB Capital Partners III, LLC
|
|
Delaware
|
Capital Partners III, L.P.
|
|
Delaware
|
SVB Capital Partners IV, LLC
|
|
Delaware
|
Capital Partners IV, L.P.
|
|
Delaware
|
SVB Venture Capital Investment Management (Shanghai) Co. Limited
|
|
China
|
Shanghai Yangpu Venture Capital Fund (LP)
|
|
China
|
Shengwei Shengxiang Capital Hangzhou Venture Capital Fund (LP)
|
|
China
|
Shanghai Shengyu Enterprise Management Ltd Co.
|
|
China
|
Beijing Zhongguancun Science City New Growth Driver Investment Management Co., Ltd
|
|
China
|
Shanghai Sheng Wei Dong Fang Jia Rui Equity Investment Fund Partnership
|
|
China
|
Qualified Investors Fund, LLC
|
|
California
|
Qualified Investors Fund II, LLC
|
|
Delaware
|
Qualified Investors Fund III, LLC
|
|
Delaware
|
Qualified Investors Fund IV, LLC
|
|
Delaware
|
Qualified Investors Fund V, LLC
|
|
Delaware
|
SVB Growth Investors, LLC
|
|
Delaware
|
Capital Preferred Return Fund, L.P.
|
|
Delaware
|
Growth Partners, L.P.
|
|
Delaware
|
SVB Strategic Investors, LLC
|
|
California
|
Strategic Investors Fund, L.P.
|
|
California
|
SVB Strategic Investors II, LLC
|
|
Delaware
|
Strategic Investors Fund II, L.P.
|
|
Delaware
|
SVB Strategic Investors III, LLC
|
|
Delaware
|
Strategic Investors Fund III, L.P.
|
|
Delaware
|
SVB Strategic Investors IV, LLC
|
|
Delaware
|
Strategic Investors Fund IV, L.P.
|
|
Delaware
|
Venture Investment Managers, L.P.
|
|
Delaware
|
SVB Strategic Investors V, LLC
|
|
Delaware
|
Strategic Investors Fund V, L.P.
|
|
Delaware
|
Strategic Investors Fund V-A, L.P
|
|
Delaware
|
Strategic Investors Fund V-A Opportunity, L.P
|
|
Delaware
|
Subsidiary
|
|
Jurisdiction of Incorporation or Organization
|
Strategic Investors Fund V-B, L.P.
|
|
Delaware
|
SVB Strategic Investors VI, LLC
|
|
Delaware
|
Strategic Investors Fund VI, L.P.
|
|
Delaware
|
Strategic Investors Fund VI-A, L.P.
|
|
Delaware
|
SVB Strategic Investors VII, LLC
|
|
Delaware
|
Strategic Investors Fund VII, L.P.
|
|
Delaware
|
Strategic Investors Fund VII-A, L.P.
|
|
Delaware
|
SVB Strategic Investors VIII, LLC
|
|
Delaware
|
Strategic Investors Fund VIII, L.P.
|
|
Delaware
|
Strategic Investors Fund VIII-A, L.P.
|
|
Delaware
|
Strategic Investors Fund VIII-B, L.P.
|
|
Delaware
|
Strategic Investors Fund VIII Cayman, L.P.
|
|
Cayman Islands
|
Strategic Investors Fund IX, LLC
|
|
Delaware
|
Strategic Investors Fund IX Cayman, L.P.
|
|
Cayman Islands
|
Strategic Investors Fund IX-A Cayman, L.P.
|
|
Cayman Islands
|
Strategic Investors Fund IX, L.P.
|
|
Delaware
|
Strategic Investors Fund IX-A, L.P.
|
|
Delaware
|
Strategic Investors Fund IX-B, L.P.
|
|
Delaware
|
Strategic Investors Fund IX Master, L.P.
|
|
Delaware
|
Sprout Endurance Partners, LLC
|
|
Delaware
|
Sprout Endurance Partners, L.P.
|
|
Delaware
|
Sprout Endurance Partners Cayman, L.P.
|
|
Cayman Islands
|
SVB Capital Venture Overage, LLC
|
|
Delaware
|
Venture Overage Fund, L.P.
|
|
Delaware
|
SVB Strategic Investors X, LLC
|
|
Delaware
|
Strategic Investors Fund X LS SPV, L.P.
|
|
Delaware
|
SVB Leerink Capital LLC
|
|
Delaware
|
Leerink Transformation Fund I GP LLC
|
|
Delaware
|
LTP K Holdings L.P.
|
|
Delaware
|
Leerink Transformation Investors I L.P.
|
|
Delaware
|
Leerink Transformation Fund I (Cayman Feeder) L.P.
|
|
Cayman Islands
|
Leerink Transformation Fund I GP L.P.
|
|
Delaware
|
Leerink Transformation Partners Strategic Fund L.P.
|
|
Delaware
|
Leerink Transformation Fund I L.P.
|
|
Delaware
|
Massachusetts Innovation Catalyst Fund I L.P.
|
|
Delaware
|
LTP BHE LP
|
|
Delaware
|
LTP Feeder BHE LP
|
|
Delaware
|
LTP BHE Corporation
|
|
Delaware
|
Leerink Kieger Capital Partners LLC
|
|
Delaware
|
Leerink Transformation Carry Vehicle L.P.
|
|
Delaware
|
Leerink Transformation Partners LLC
|
|
Delaware
|
Leerink Revelation Carry Vehicle LP
|
|
Delaware
|
*
|
Edge Act Corporation
|
1.
|
I have reviewed this annual report on Form 10-K of SVB Financial Group;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 28, 2020
|
|
/s/ GREG BECKER
|
|
|
Greg Becker
|
|
|
President and Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
1.
|
I have reviewed this annual report on Form 10-K of SVB Financial Group;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 28, 2020
|
|
/s/ DANIEL BECK
|
|
|
Daniel Beck
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
Date: February 28, 2020
|
|
/s/ GREG BECKER
|
|
|
Greg Becker
|
|
|
President and Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
Date: February 28, 2020
|
|
/s/ DANIEL BECK
|
|
|
Daniel Beck
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|